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Malignant catarrhal fever (MCF) is a fatal, incurable disease of large
ruminants. This disease is caused by two related gammaherpesviruses, Alcelaphine
herpesvirus 1 (A1HV-1) and Ovine herpesvirus 2 (OvHV-2). Lymphoproliferation
and infiltration by large granular lymphocytes (LGL) into lymphoid and non-
lymphoid organs are characteristic of MCF. LGL cell lines have been established
from animals with naturally or experimentally induced MCF. Previous studies have
shown these cell lines to be highly proliferative and cytotoxic with the ability to
cause disease when inoculated into rabbits. Some cell lines have demonstrated the
ability to grow and survive without the need for exogenous IL-2. However, IL-2
mRNA was not detected. The proliferative and cytotoxic LGL phenotype observed
in the absence of exogenous IL-2 is associated with virus infection of LGL cells.
The characteristics of MCF LGL cell lines are similar to other herpesvirus-infected
cell lines, in particular Herpesvirus saimiri (HVS).
The role of virus-infected large granular lymphocytes in pathogenesis of
MCF is not clear. In the absence of defined viral antigens the main objective of this
study was to investigate how MCF viruses interfere with LGL proliferation and
cytotoxicity.
In this study, IL-2 independence and a cell surface phenotype of T/ NK cells
was demonstrated in most cell lines analysed. The period of survival and growth
without exogenous IL-2 was variable but always exceeded that of uninfected control
cells. The possible role of IL-15 (a pro-inflammatory cytokine with actions similar
to IL-2) in LGL function was investigated. Results showed that IL-15 could generate
and maintain the proliferative and cytotoxic phenotype of these cell lines and may be
involved in the pathogenesis of MCF.
Virus interference with signal transduction pathways has been demonstrated
in other gammaherpesviruses. The hypothesis that the phenotype and function of the
LGL cell lines is generated through a similar mechanism was tested. The study
showed that the src kinases, Ick and Jyn, are constitutively activated in LGL cell
lines.
The identity of specific virus proteins involved in generating the observed
phenotype of the LGL cell lines had not been determined. During the course of this
x
study, the complete genomic sequence of the A1HV-1 genome was published. Prior
to this several open reading frames were detected in A1HV-1 that underwent genomic
rearrangement on transition from virulence to attenuation in vitro. Thus, a final
objective of this study was to determine whether these potential virulence genes are
associated with the ability of LGL cell lines to transmit disease. The proteins
encoded by these genes (ORF50, A6 and A7) were expressed in E. coli as
recombinant proteins and used to immunise rabbits. Recombinant virus protein-
specific rabbit polyclonal antibodies were generated. Using these reagents, the
expression of these proteins in LGL cell lines and A1HV-1-infected monolayer
cultures was investigated. The polymerase chain reaction (PCR) was used in parallel
experiments to determine the presence of DNA and mRNA encoding these proteins.
The results indicated that more complicated rearrangements of the A1HV-1 genome
may occur on attenuation of A1HV-1 after extensive passage than has been revealed
at present. However, the expression in LGL cells of mRNA encoded by ORF50 and
A6, that share sequence homology with the EBV R and Z transactivators, suggests
that virus replication occurs in LGL cells.
These results improve the understanding of the MCF viruses and their role in





1.1.1 Malignant catarrhal fever (MCF)
Malignant catarrhal fever is a fatal, incurable disease of large ruminants.
Disease-susceptible animals experience high fevers, profuse catarrh and widespread
tissue necrosis leading to death (Reid and Buxton, 1989) (Fig 1.1). Proliferation of
lymphocytes and infiltration by these cells into lymphoid and non-lymphoid tissues
are characteristic of MCF. Whilst normally sporadic, this disease has been reported
worldwide in Europe, America, Africa and Southeast Asia and has significant
economic impact, particularly in Africa and Asia. Two related gammaherpesviruses
Alcelaphine herpesvirus-1 (A1HV-1) and Ovine herpesvirus-2 (OvHV-2) are the
cause of disease in susceptible animals and are transmitted from asymptomatic
'carrier species'. The carrier species for A1HV-1 are wildebeest (Connochaetes spp.)
while domestic sheep are carriers for OvHV-2. However, the mechanisms of virus
infection, interference with cell function and subsequent destruction of tissues in
MCF-affected animals are not understood. Therefore, the study of these aspects of
MCF virus infection are important to give us a greater understanding of MCF
pathogenesis and the associated host immune response as well as a means to develop
specific disease control strategies.
1.1.2 Features of herpesviruses
Herpesviruses have long presented a challenge to the wellbeing of man and
animals alike. Some are the direct cause of, or are associated with disease while
others merely infect the host without causing any apparent illness. There are more
than a hundred different herpesvirus species (Fields et al, 1996). They all share
common properties such as a double stranded DNA genome, structurally similar
virus particles and the ability to persist (in a latent state) within host cells.
Differences in genomic organisation, in life cycle and host range as well as the
means by which they achieve latency have been used to classify the herpesviruses
into three sub-families: the alphaherpesviruses, betaherpesviruses and
gammaherpesviruses (Roizman et al, 1992).
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Fig 1.1: A cow presenting with profuse catarrhal nasal discharge typical
of MCF.
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The alphaherpesviruses exhibit a variable host range, short life cycle and
have the ability to spread rapidly in culture leading to the destruction of infected
cells. These viruses establish latency in neuronal cells (sensory ganglia). By
contrast, the betaherpesviruses have a long life cycle in a relatively restricted range
of host species. Cell to cell spread of these viruses in culture is slow and latency can
be maintained in lymphoreticular cells. Lastly, the ganrmaherpesviruses have a
relatively limited host range. In culture, gammaherpesviruses replicate (non-
productively) in lymphoblastoid cells though some can also undergo lytic replication
in epithelial and fibroblast cells. These viruses are lymphotropic, infecting T or B
lymphocytes in which latency can be established. Viruses belonging to the sub¬
families of herpesviruses are summarised in Table 1.1.
The work presented here will focus on the sub-family of
gammaherpesviruses. More specifically, the two viruses that cause MCF: A1HV-1
and OvHV-2. The following literature review will introduce the disease and the
viruses involved in more detail. The effect on host cells following viral infection
will be discussed with comparisons made to other well-studied gammaherpesviruses.
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Table 1.1: Viruses belonging to the family Herpesviridae
Subfamily Viruses Common name





Herpes simplex virus 1 (HSV-1)






















Table adapted from Roizman et al, 1992. *Schulz, 1998.
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1.2 Malignant catarrhal fever (MCF)
1.2.1 Viruses associated with MCF
1.2.1.1 Alcelaphine herpesvirus-1 and -2 (AIHV-1 and -2)
The gammaherpesvirus first classified as Bovine herpesvirus-3 (BHV-3) by
the World Health Organisation (WHO/FAO, 1976) is now better known as
Alcelaphine herpesvirus-1 (AIHV-1) (Reid, 1974; Reid et al, 1975; Roizman 1982;
Roizman et al, 1992) - named after the subfamily Alcelaphinae to which the carrier
species (wildebeest) belong. The virus was first isolated by Plowright and co¬
workers (Plowright et al, 1960) from the blood of the blue wildebeest
(Connochaetes taurinus) and later from nasal and ocular secretions of wildebeest
calves (Mushi et al, 1980a,b).
Virus particles typical of herpesviruses can be detected by electron
microscopy in infected cultures (Fig 1.2). These particles consist of an icosahedral
nucleocapsid of lOOnm with or without a viral envelope. When enveloped, the
virions measure 140-220nm in diameter (Plowright et al, 1965). Furthermore, the
virus was shown to develop in the host cell nucleus and to mature in the cytoplasm
(some being found in cytoplasmic vesicles) - a pattern of development typical of
herpesviruses (Castro and Daley, 1981). Other characteristics of AIHV-1, such as its
ability to induce a cytopathic effect (CPE) in permissive cell cultures, size on
filtration and sensitivity to ether and chloroform allow its classification as a
herpesvirus (Plowright, 1968, Rweyemamu et al, 1974, Plowright et al, 1965).
In cattle, and on initial isolation in culture, infectivity is cell-associated but
becomes cell-free after extensive passage in tissue culture (Plowright 1965a,
Plowright et al, 1965, Reid and Rowe 1973, Harkness and Jessett 1981, Russell
1980). In addition, infectivity in rabbits (an experimental model for MCF) is lost
after extended passage of the virus in tissue culture (Handley, 1993, Handley et al
1995). The two most commonly described isolates of AIHV-1 are called WC11 and
C500. The cell-free and extensively passaged virus WC11 was first isolated from
blue wildebeest (Plowright et al, 1960) and is attenuated in terms of its ability to
cause disease in cattle and rabbits. The cell-associated and virulent virus C500 was
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first isolated from infected cattle (Plowright et al, 1975) and also becomes cell-free
and attenuated after extensive passage in bovine turbinate cells (Handley et al, 1995).
Virus isolation has traditionally involved the co-culture of cells (e.g.
lymphocytes) or oculo-nasal secretions from infected animals with permissive cell
monolayer cultures. These latter cell types include fibroblast or epithelial cells such
as bovine thyroid cells, kidney cells (Reid and Rowe, 1973), bovine turbinate cells
and corneal cells (Mushi et al, 1981b), bovine testes cells and adrenal cells as well as
rabbit kidney cells (Plowright et al, 1960). The cytopathic effect (CPE) observed
with cell-associated A1HV-1 is characteristically syncitial (i.e. involving the
formation of large multinucleate cells) while cell-free virus produces rounded
refractile foci of infected cells.
Genomic Organisation of AIHV-1:
The genomic organisation of AIHV-1 was originally studied by restriction
enzyme analysis. The viral genome was shown to consist of a unique region of
approximately 110-130kilobases (kb) flanked by tandem repeat sequences of 30kb in
total (Bridgen, 1991; Bridgen et al, 1989; Ensser et al, 1997; Hsu et al, 1990a; Shih
et al, 1988). This type of genomic organisation is reminiscent of other
gammaherpesviruses, for example herpesvirus saimiri and herpesvirus ateles
(reviewed in Roizman and Baines, 1991). Restriction fragment patterns also showed
that Alcelaphine herpesviruses could be split into two groups, Alcelaphine
herpesvirus-1 (AIHV-1) and Alcelaphine herpesvirus-2 (A1HV-2). The natural hosts
of A1HV-2 are the hartebeest (Alcelaphus buselaphus) and topi (Damaliscus lunatus)
(Heuschele and Fletcher 1984; Seal et al, 1989; Shih et al, 1989). However, there is
no evidence for the occurrence of MCF due to natural transmission of A1HV-2 from
host animals to susceptible species. Hybridisation assays using AIHV-1-specific
DNA clones as probes suggested that some sequences are shared between AIHV-1
and bovine herpesvirus 4 (BHV-4), a common vims in cattle (Lahijani et al, 1995;
Shih et al 1988). This result correlates with the observed cross-reactivity of sera
from AIHV-1 infected animals with BHV-4 in immunofluorescent antibody tests
(Rossiter et al, 1977, 1980).
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Fig 1.2: Electron micrograph of an AIHV-1 -infected bovine embryo
kidney cell culture showing the presence of herpesvirus virions (from
Castro and Daley, 1982). N = nucleus; C = cytoplasm; PC = perinuclear
cisternae; arrow = virus particle; arrowheads = immature virions.
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I ORFs specific to the f3 + y subfamily
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ORFs common to all herpesviruses
Fig 1.3: Organisation of the AiHV-1 C500 genome, (after Ensser et al,
1997).
Open reading frames (ORFs) have been coloured to reflect the
conservation of genes between the a, <3 and y subfamilies of the
Herpesviridae as indicated above. ORFs are numbered according to
findings of Ensser et ai (1997). Arrows indicate direction of transcription.
Scale in kilobase pairs. H-DNA represents the variable, non-coding
region of the genome.
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During the course of this project, Ensser et al (1997) published the whole
genomic sequence for virulent A1HV-1 strain C500 (Fig 1.3). This work confirmed
that A1HV-1 is a gammaherpesvirus based on genomic organisation. Open reading
frames (ORFs) of interest with a potential immunomodulatory role were identified by
comparison with DNA and amino acid sequences of known immunomodulatory
proteins. ORF A3 was first identified by Ensser and Fleckenstein (1995) as a
semaphorin homologue - a protein also expressed by poxviruses with a possible role
in immunosuppression (Kolodkin et al, 1993). ORF A5 and A9 are homologous to
seven transmembrane, G-protein-coupled receptors (GCRs) and Bcl-2 respectively.
Both these proteins may allow virus evasion of the immune system and are discussed
in more detail in Chapter 1.3. An earlier restriction enzyme analysis was also
performed on the high passage attenuated C500 virus and compared to the low
passage virulent C500 virus (Handley, 1993; Handley et al, 1995). This analysis
revealed a rearrangement in the viral genome following attenuation. Several ORFs
were identified of which two encoded proteins that were thought to be involved in
the virulence to attenuation switch. These are now known to be proteins encoded by
ORF 50 and ORF A7 of Ensser's (1997) sequence. These two ORFs have colinear
homologues in equine herpesvirus-2 (EHV-2), herpesvirus saimiri (HVS), human
herpesvirus-8 (HHV-8) and Epstein-Barr virus (EBV) (where they encode proteins
involved in virus reactivation and entry, respectively). This will be discussed in
more detail in Chapter 1.3.
1.2.1.2 Ovine herpesvirus 2 (OvHV - 2)
While OvHV-2 virions have not yet been isolated (due to the lack of a
permissive system for virus growth), there is substantial evidence for its presence in
the carrier species (sheep) as well as in MCF susceptible animals (Chapter 1.2.2.2).
Propagation of lymphoblastoid cell lines derived from diseased animals has been
achieved. Some of these cells can transmit the disease to deer and rabbits (Berrie et
al 1984; Cook and Splitter 1988; Reid et al, 1985, 1986).
While the genomic sequence of OvHV-2 has only partially been determined,
molecular studies of the lymphoblastoid cell lines have been informative. A genomic
OvElV-2 DNA fragment has been identified with homology to an A1HV-1 WC11
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DNA clone located at the left terminal region of the genome (Bridgen and Reid
1991). This fragment was cloned, sequenced and used to develop an OvHV-2-
specific PCR to detect virus DNA in sheep, MCF-affected cattle and lymphoblastoid
cell lines (Baxter et al, 1993; Li et al, 1995).
1.2.1.3 Involvement of other viruses in MCF
Serological studies have indicated the presence of antibodies specific for
A1HV-1 in species of Bovidae other than wildebeest and sheep. These studies
suggest that these species are infected with and are carriers for, the same or similar
gammaherpesviruses (Table 1.2).
In vitro, viruses have been recovered from topi (Damaliscus korrigum)
(Mushi et al, 1981a), red hartebeest (Alcelaphus buselaphns) (Reid and Rowe, 1973)
- designated alcelaphine herpesvirus 2 (A1HV-2) - and the roan antelope
(Hippotragus equinus) (Heuschele and Fletcher, 1984) - designated hippotragine
herpesvirus 1 (HipHV-1). Experimental transmission of A1HV-2 from red hartebeest
to cattle and rabbits and HipHV-1 from roan antelope to rabbits produced MCF-like
syndromes (Reid and Bridgen, 1991; Reid and Rowe, 1973). Molecular studies of
A1HV-2 and HipHV-1 have confirmed that these are related to but distinct from
A1HV-1 (Reid and Bridgen, 1991; Seal et al, 1989; Shih et al, 1989). However,
there is no epidemiological evidence indicating that these viruses naturally spread to
susceptible animals and cause MCF.
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Table 1.2: Carrier species in the family Bovidae in which antibody
reactive with AIHV-1 or virus similar to AIHV-1 has been isolated.































Ovibovidae Ovibos moschatus Musk ox
'Viruses associated with natural and experimental MCF.
2Viruses associated with experimental MCF only. Natural transmission not
observed.
3No evidence for involvement in natural or experimental MCF.
References for the above are cited in the text (Chapter 1.2.1.3).
4Detected by serology (Heuschele and Fletcher, 1984) and OHV-2-specific PCR
(Wiyono et al, 1994). Virus not yet isolated.
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1.2.2 Epidemiology
Malignant catarrhal fever was first reported in Europe by Goetz in 1930. At
that time, the aetiology of the disease was obscure though the presence of sheep in
the vicinity of susceptible ruminants was associated with the occurrence of disease.
In South Africa a similar syndrome was described which could be transmitted from
wildebeest (Connochaetes gnu) to susceptible animals (Mettam, 1923). MCF-
susceptible animals include domestic cattle, water buffalo, Bali cattle, many species
of deer and other exotic ruminant species in zoological collections (Table 1.2) (Reid
and Buxton 1989). Identification of the 'carrier species' led to the naming of two
forms of MCF: wildebeest-associated MCF (WA-MCF) and sheep-associated MCF
(SA-MCF). The epidemiology of these two forms of MCF will be discussed in the
following sections.
1.2.2.1 Wildebeest-associated MCF (WA-MCF) - also known as 'snot
sickness' or 'snotsiekte'
Mettam (1923) showed that WA-MCF could be directly transmitted to cattle
using blood from the black wildebeest (Connochaetes gnou). The blue wildebeest
0Connochaetes taurinus) was also implicated as a carrier species for the causal agent
of MCF (Daubney and Hudson, 1936). In 1960, the causal agent of WA-MCF was
identified as a virus (Plowright et al, 1960). The virus, now referred to as
Alcelaphine herpesvirus-1 (A1HV-1), was characterised as a herpesvirus (Plowright
et al, 1965) (see Chapter 1.2.1.1).
Infection of natural hosts / carrier species
In wildebeest (C. taurinus), the carrier species, infection with A1HV-1 is found
throughout the population. Most wildebeest calves become infected during the first 3
months of life with 90% of calves between the ages of 4 to 12 months having
antibody to A1HV-1 (Plowright, 1965a, 1965b, 1967). In adult wildebeest,
neutralising antibody to A1HV-1 is present and very little virus can be detected
(Plowright, 1967). The appearance of viraemia following pregnancy suggests that in
adult wildebeest A1HV-1 is latent but can be reactivated. Stress, malnutrition and
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administration of corticosteroids to adult wildebeest can also lead to reactivation and
isolation of virus (Plowright 1965a, b, Rweyemamu et al, 1974). The detection of
virus in a proportion of foetuses demonstrated the possibility of vertical transmission
(Plowright, 1965a, 1965b). However, in the majority of cases, wildebeest calves
acquire the vims as neonates while maternal antibodies are still present with no
evidence of any clinical response following infection (Mushi et al, 1981b). The
major source of A1HV-1 infection in wildebeest is thought to be 6-8 week old
wildebeest calves as cell-free vims can be detected in both nasal and ocular
secretions (Rweyemamu et al 1974; Mushi et al 1980a). The spread of A1HV-1 by
aerosol would explain the efficiency of transmission within the wildebeest
population.
Studies indicated that A1HV-1 infection of wildebeest calves leads to a
primary lytic viral replication (probably in the mucosal epithelium) and vims
shedding (Rweyemamu et al 1974; Mushi et al 1980a, 1980b). The presence of a
mucosal immune response in calves was demonstrated by the presence of
neutralising IgA antibodies (Rurangirwa et al, 1982). The production of neutralising
IgA may drive the virus from productive replication to latency. This may explain the
cessation of virus shedding at 3 months of age and the appearance of latent and
persistent virus within the adult wildebeest population.
Transmission to susceptible species
The seasonal occurrence of MCF was related to the coincidence between the calving
season of wildebeest and the appearance of MCF in cattle. Under laboratory
conditions, Plowright (1965b) demonstrated the association between wildebeest
calves and the occurrence of MCF by housing wildebeest calves and cattle together.
The presence of viraemic wildebeest calves up to 3 months of age was associated
with the occurrence of MCF in cattle. Cattle did not contract MCF in the presence of
wildebeest calves over the age of 3 months. The route of transmission of A1HV-1
from wildebeest to cattle through the spread of vims in wildebeest foetal fluids and
afterbirths was suggested by anecdotal evidence from the Masai people of East
Africa. This theory was tested, but no virus could be detected in foetal membranes
or fluids (Rossiter et al, 1983). In addition, Rossiter showed that A1HV-1 (in culture
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medium) could be inactivated by strong ultraviolet light under pasture conditions.
These experiments implied that, in open pasture, survival of the virus in oculo-nasal
secretions or afterbirth is unlikely due to rapid inactivation. However, this has not
been proven and conditions in culture medium cannot be directly compared to those
in secretory fluid. Therefore, the detection of cell-free virus in nasal and ocular
secretions of wildebeest calves (Rweyemamu et al 1974; Mushi et al 1980a) is
further evidence that wildebeest calves are the source of infection for cattle. Cases of
MCF have been reported outwith the wildebeest calving season (Barnard et al, 1989)
but are likely to be a consequence of long incubation periods following infection of
cattle (Reid and Buxton, 1989).
Infection of susceptible species
In contrast to wildebeest, the infection of cattle by A1HV-1 does not lead to
contagious spread within the remaining herd. The lack of natural transmission from
cattle is thought to be due to the cell-associated nature of the virus in cattle (Mushi
and Rurangirwa, 1981a). It has been suggested that in cattle virus replication is
repressed or incomplete as detection of virus antigen or DNA in MCF-affected tissue
is low (Bridgen et al, 1992). Also, when tested for reactivity to A1HV-1 envelope
glycoproteins, wildebeest sera consistently detected 6 polypeptides in contrast to the
3 polypeptides recognised by sera from A1HV-1-infected cattle (Herring et al, 1989).
This suggests that all viral transcripts are not expressed in cattle and may explain the
lack of natural transmission from cattle. In a small number of cases, congenital
transmission of A1HV-1 from MCF-recovered cows to their calves has been
demonstrated with a proportion of those calves developing MCF (Plowright et al,
1972). This suggests that in animals that recover from MCF, infection with A1HV-1
is persistent and latent where subsequent pregnancy may reactivate the virus leading
to infection of the foetus. The recovered animal is also immune to subsequent
challenge with virus. Reactivation and recurrence of MCF in recovered deer have
also been achieved following administration of immunosuppressants (Heuschele et
al, 1985). However, in most cases, infection of susceptible animals with A1HV-1
leads to disease and death.
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1.2.2.2 Sheep-associated MCF (SA-MCF)
Of the two forms of MCF, the SA-MCF form appears to have a wider range
of susceptible species including domestic cattle, water buffalo, Bali cattle and pigs
(Piercy, 1954; Loken et al, 1998; Rossiter et al, 1989; Wiyono et al, 1994). Several
species of farmed deer also seem to be highly susceptible (Denholm and Westbury,
1982; Heuschele et al, 1985; Reid et al, 1987; Wyand et al, 1971). Though normally
sporadic where only one or two animals in the herd are affected, more severe
outbreaks have been reported thus demonstrating the importance of studying this
second form of MCF (Reid and Buxton, 1989).
Infection of natural/ carrier species
As the name suggests, sheep are the carrier species for this form of MCF. The body
of evidence supports this claim. Firstly, cases of SA-MCF often coincide with the
sheep lambing season (Reid et al, 1984). Furthermore, cattle have also developed
MCF following the introduction (to the same premises) of sheep obtained from farms
where cases of MCF have occurred (Kock and Neitz, 1950, Piercy 1954). While
direct contact between sheep and susceptible species is not always readily established
(Hoffman et al, 1984, Reid et al, 1987) the presence of antibodies reactive with
A1HV-1 was demonstrated in the majority of sheep sera tested and in cattle affected
by SA-MCF (Rossiter 1981, 1983). Therefore, a virus was present in all sheep tested
and in cattle affected by SA-MCF that is antigenically similar to A1HV-1. This virus
is now referred to as Ovine herpesvirus 2 (OvHV-2).
Further serological and molecular evidence demonstrated the relationship of
OvHV-2 to A1HV-1. For example, Li and others developed a competitive inhibition
enzyme-linked immunosorbent assay (CI-ELISA) specific for A1HV-1 that also
detects OvHV-2 (Li et al, 1994) but not other common herpesviruses of cattle.
Using this assay MCF virus-specific antibody was detected in some clinically
affected cattle, deer and bison as well as in asymptomatic sheep (Li et al, 1995).
Furthermore, DNA from OvHV-2-infected cattle and deer cell lines and lymphoid
cells of sheep hybridised with A1HV-1 DNA clones (Bridgen et al, 1989; Bridgen
and Reid, 1991; Baxter et al, 1993). An OvHV-2 genomic DNA fragment with
homology to an A1HV-1 DNA clone which contained sequences with homology to
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the 140 and 160kDa tegument proteins of the gammaherpesviruses Epstein-Barr
virus (EBV) and herpesvirus saimiri (HVS) respectively (Bridgen and Reid 1991)
formed the basis of a polymerase chain reaction (PCR)-based assay for specifically
identifying the SA-MCF virus.
OvHV-2 virions have not been isolated. However, using the PCR and
serological assays mentioned above, the epidemiology of OvHV-2 infection has been
studied. The pattern of infection in lambs is similar to that of wildebeest calves
infected with A1HV-1. The source of OvHV-2 infection is thought to be lambs up to
3 months of age (Li et al, 1995) where the presence of viral DNA has been
demonstrated in nasal and ocular secretions as well as mucosal epithelia (Baxter et
al, 1997). Some in utero infection has also been noted (H. Reid, personal
communication) and the presence of virus in colostrum suggests an additional source
of infection for lambs (Li et al, 1995). PCR tests showed that the majority (>95%) of
sheep tested (n = 26) were infected with virus by the age of one year and that B cells
are a site of latent infection (Baxter et al, 1997, Li et al, 1998). While reactivation
might theoretically occur in immunosuppressed sheep, no studies to look for
herpesvirus particles in such animals have been performed.
Transmission and infection of susceptible species
The source of OvHV-2 infection is likely to include contaminated secretions from
lambs. Aerosol transmission of OvHV-2 appears to be just as efficient as that of
A1HV-1 with cases of SA-MCF occurring when cattle and sheep have been separated
by up to 100 meters (Reid et al, 1986).
As with A1HV-1 infection, infection of cattle by OvHV-2 does not lead to
spread of MCF to other cattle and healthy individuals in MCF-affected herds do not
have virus-specific antibody (Reid et al, 1986). The reasons for an individual's
susceptibility to MCF is unknown and has not been associated with the presence of
prior illness or other potential predisposing factors.
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1.2.3 Clinical symptoms and pathological features of MCF
Malignant catarrhal fever is recognised in three forms: (1) head and eye, (2)
intestinal and (3) neurological forms (Goetz, 1930). The disease is associated with
variable but characteristic pathological indicators. It is proposed that inappropriate
responses of susceptible species to viral infection may contribute to the pathological
changes observed (Reid and Buxton, 1989).
The following sections will review the clinical symptoms followed by a
description of the pathological signs. These features will be discussed with respect
to MCF caused by either A1HV-1 or OvHV-2, as many of the features are common
to both forms of the disease.
1.2.3.1 Clinical symptoms associated with MCF
The pathology and symptoms associated with MCF have been most
thoroughly studied in cattle. The symptoms appear following a variable incubation
period of a few weeks to six months. In experimental transmission studies, the
variation in incubation period is a function of the virus inoculum used and the route
of infection (Mushi and Wafula 1983; Pierson et al, 1973; Plowright, 1968). The
symptoms may vary according to the course of the disease and are grouped into four
forms: peracute, acute, subacute or chronic.
Most commonly, an animal will first appear to have a decreased appetite
accompanied by a raised temperature (41-42°C) and pulse rate (Daubney and Hudson
1936; Liggitt et al, 1978; Reid et al, 1979; Selrnan et al, 1974). Watery secretions
from the eye nose and mouth progresses to a profuse and coloured muco-purulent
discharge (Selman et al, 1978). At this stage, a progressive corneal opacity is
commonly observed where both eyes are affected. Photophobia and swelling of the
eyelids are also found. The muzzle, initially dry and hot, may crack and bleed with
time (Selman et al, 1978). The nares are often occluded with catarrhal discharge and
in severe cases can block the nasal passages entirely. Superficial lymph node
enlargement can be palpated prior to the onset of pyrexia (Daubney and Hudson
1936; Selman et al, 1978) and swelling of the joints can occur. Hyperaemia also
occurs (after the onset of pyrexia) in the oral mucosa accompanied by focal erosion
19
on the lips, tongue, hard palate and buccal papillae. Symptoms, involving the
nervous system, have also been reported i.e. the neurological form of MCF. These
include hyperaesthesia, depression, muscular tremors, lack of co-ordination, circling
and nystagmus (small involuntary movements of the eyes) (Clark et al, 1970;
Daubney and Hudson 1936; Selman et al 1978). These symptoms are consistent
with the acute and subacute forms of MCF - also known as the 'head and eye' form.
Constipation is a common symptom and often followed by haemorrhagic diarrhoea
until death. However, this is more often seen in deer where the course of the disease
is peracute.
The symptoms of peracute cases are less severe and less common. For
example, corneal opacity and enlargement of the superficial lymph nodes are not
marked and erosion of the oral mucosa is limited to the buccal papillae. In the
peracute form, death can occur within one to three days of onset of pyrexia. The
disease in deer is commonly associated with acute diarrhoea and dysentery (Orr and
MacKintosh 1987). The urine may contain blood and albumin. This set of clinical
features is also known as the 'intestinal form' of MCF and can last for up to nine days
before death. At the other extreme, death can occur without any prior clinical signs
(Reid et al, 1987; Wyand et al, 1971).
In chronic cases, pyrexia can sometimes be short-lived and corneal symptoms
can extend to erosion and ulceration (Daubney and Hudson 1936). In general,
symptoms observed in chronic cases tend to be severe and/or more widespread than
those described for the acute and subacute cases of MCF. In a recently described
form of cutaneous MCF, lesions on the back, neck and flanks were found (Holliman
et al, 1994; Michel, 1994) as a feature of a chronic case of MCF. Secondary
bacterial infections following the appearance of skin lesions, fever and enlarged
subcutaneous lymph nodes were also observed.
A mild form of MCF has also been reported where the symptoms are few and
the animals survive. This form was first observed in experimental transmission
studies (Goetz, 1930). More recently, cases have been reported where cattle and deer
have recovered from naturally transmitted MCF. In the cases involving cattle,
treatment with steroids following the appearance of clinical signs may have
contributed to the recovery (Milne and Reid 1990; Penny, 1998). However, the
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timing of steroid administration may affect the outcome of the disease. For example,
the application of steroids to a sika deer (Cervus nippon) showing signs of MCF did
not improve the symptoms and the deer continued to develop symptoms typical of
chronic MCF leading to death (Wilson et al, 1983). In another case where recovery
was observed, the disease was re-activated following steroid treatment and chronic
symptoms returned (Heuschele et al, 1985). Other cases of recovery have been
reported (Mushi and Rurangirwa 1981b; Plowright, 1981) but the true frequency of
natural recovery is difficult to determine due to the involvement of medical
intervention and the potential for misdiagnosis.
1.2.3.2 Macroscopic lesions
The diagnosis of MCF has traditionally only been possible after post-mortem
examination. Certain macroscopic lesions are characteristic of MCF.
In all forms of MCF, enlargement, hyperplasia and oedema of the peripheral
lymph nodes are common. In addition, the spleen is often grossly swollen,
particularly in A1HV-1-induced MCF. In deer and chronic cattle cases where
necrosis has occurred, the lymph nodes and spleen can appear smaller than normal
(Plowright, 1953; Reid et al, 1979). Haemorrhagic areas in the retropharyngeal
lymph nodes accompany necrosis (Denholm and Westbury 1982; Oliver et al, 1983;
Selman et al, 1974, 1978).
Mucosal surfaces are affected to a greater or lesser degree. In the buccal
cavity, pharynx, soft palate, tongue, oesophagus and fore-stomach, patches of
necrosis can be found (Daubney and Hudson 1936; Selman et al, 1978). The
intestine is usually severely affected with haemorrhages and erosions. Deer seem to
be particularly susceptible to these changes with additional oedema of the intestinal
wall and mucosal surfaces of the respiratory system. Pathology can sometimes be
seen in the genital tract but is usually confined to erosion of the vaginal mucosa
(Denholm and Westbury 1982; Oliver et al, 1983; Reid et al, 1979, 1987; Wyand et
al, 1971).
Enlargement of the liver (Daubney and Hudson 1936) and spleen is found in
the 'intestinal' and 'head and eye' form of MCF. This is unlike the peracute form in
which the liver pathology does not appear to be involved. Cystitis is also apparent in
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the two more severe forms. Additionally, raised white foci can be observed on the
kidney in the 'head and eye' form of MCF (Goetz 1930). Other macroscopic lesions
are found in the synovial membranes (appearing swollen) and the brain (with
excessive and cloudy cerebro-spinal fluid) (Daubney and Hudson 1936; Liggitt et al,
1978).
1.2.3.3 Microscopic lesions
As discussed above, macroscopic lesions can be highly variable and
dependent on affected species. In contrast, microscopic lesions are much more
consistent. They can be divided into four groups: hyperplasia and necrosis in
lymphoid organs, interstitial accumulation of lymphocytes in non-lymphoid organs,
vasculitis and epithelial degeneration.
Hyperplasia involves the spleen and lymph nodes. In the spleen, hyperplasia
is limited to the periarteriolar lymphoid sheaths (PALS). Very little follicular
development is observed. The severity of the lesion increases with duration of
illness. In some cases, only a few clusters of lymphoid cells remain in the PALS
(Reid et al, 1979). Hyperplasia in lymph nodes is concentrated in the paracortical
region. This involves the expansion in numbers of lymphoblastoid cells (Selman et
al, 1974,1978). The cortex may show signs of necrosis and haemorrhage but
hyperplasia is not as severe as in the paracortex (Denholm and Westbury, 1982).
Again, follicular and germinal centre development is rare (Selman et al, 1978).
Macrophages and lymphoblasts occupy most of the medullary region (Selman et al,
1974; Wyand et al, 1971).
On histopathological examination, interstitial lymphoid cell accumulation of
non-lymphoid organs is widespread. Organs involved include the liver, renal cortex,
trachea, urinary bladder, pancreas, lachrymal and salivary glands and the cardiac and
skeletal muscles. This type of lesion in the cornea is very characteristic of MCF
(Berkman et al, 1960; Liggitt et al, 1978; Liggitt and De Martini 1980b; Reid et al,
1979). Lesions in the brain are also consistently present (Liggitt et al, 1978; Reid et
al 1979). The types of cells involved in these accumulations have been identified as
lymphocytes and lymphoblasts. Neutrophils can be detected in severely ulcerated
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corneas. Macrophages have also been detected but are much rarer (Edington et al,
1979; Liggitt and De Martini 1980a,b; Patel and Edington 1980, 1981).
Vasculitis (affecting arteries, arterioles, veins and venules) and epithelial
degeneration are characteristic lesions of MCF (Berkman et al, 1960; Daubney and
Hudson 1936). Again, the severity of lesions is related to the duration of illness.
The organs commonly affected are the eyes, liver, kidneys, lungs, oral epithelium,
brain and gastrointestinal tract. Accumulations of mononuclear cells are consistently
associated with the appearance of these lesions and may be important in the
pathogenesis of MCF (see Chapter 1.2.3).
1.2.3.4 Pathological features induced by AIHV-1 and OvHV-2 in rabbits
In experimentally infected rabbits, some differences in AIHV-1 and OvHV-2-
induced pathology have been observed. OvHV-2 infection in rabbits is associated
with enlargement of the mesenteric and submandibular lymph nodes, appendix and
spleen (Buxton and Reid 1980; Buxton et al, 1984; Westbury and Denholm 1982).
Epithelial lesions and diarrhoea are present but are much less severe than in ruminant
MCF. Dysentery, lesions of the urinary bladder and lymphoid infiltration of kidneys
are uncommon. Arteritis is also uncommon but can sometimes be found in the lungs
(Buxton et al, 1984).
The lymph nodes in rabbits affected with AIHV-1-induced MCF are similar
to those in OvHV-2-infected rabbits. However, the spleen and submandibular lymph
nodes tend to be even larger than in rabbits infected with OvHV-2. Conversely, the
mesenteric lymph node is smaller by comparison. In AIHV-1 infection frequent
occurrence of arteritis, degeneration of the thymus and lymphoid infiltration in the
kidneys has been observed (Edington et al, 1979).
1.2.4 Pathogenesis and immunopathology
1.2.4.1 Experimental transmission of MCF
The mechanisms underlying the pathogenesis of MCF are still not fully
understood. Experimental transmission studies have been useful for the study of
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MCF pathogenesis. Transmission of MCF to cattle and laboratory animals has been
achieved through the transfer of whole blood or lymphoid cell suspensions from
cases of MCF and are described in the following section.
Using blood from cases of MCF in cattle, infection of healthy cattle with
A1HV-1 has been followed. Viraemia was detectable 8-17 days after inoculation and
the first sign of clinical disease (pyrexia) was noted 3-15 days thereafter. Clinical
disease as described in the previous section ensued over the next 5-8 days leading to
death. During clinical disease, virus was detectable first in the lymphoid organs (e.g.
lymph nodes, spleen) then disseminated to the non-lymphoid organs (e.g. lungs,
kidney, liver, ocular and nasal epithelium). The average incubation period (ie. time
taken to develop pyrexia) was 22 days (Plowright, 1968). The average incubation
period in experimental infections using OvHV-2 was similar to that seen with
experimental A1HV-1 infection (Piercy 1952a, b).
Transmission of MCF to laboratory animals such as rabbits, hamsters, guinea
pigs and rats using A1FIV-1 and to rabbits and hamsters using OvHV-2 have been
successful (Buxton et al 1988; Jacoby et al, 1988; Kalunda et al, 1981; Reid et al,
1986). Rabbits in particular are good models for the disease as the pathology seen is
similar to that seen in ruminant MCF, with an incubation period of 10-14 days
(Piercy, 1955; Rossiter, 1981). The site of primary replication and the initial cell
type targeted by A1FIV-1 in vivo is unknown although the presence of cell-associated
virus in nasal and ocular secretions of infected cattle would suggest that the mucosal
epithelia are the target for primary infection (Mushi and Rurangirwa, 1981a).
Studies in rabbits inoculated intravenously with lymph node cells from a rabbit
infected with A1HV-1 demonstrated that the spleen was the first lymphoid organ to
show signs of virus infection and productive replication (Edington and Patel, 1981).
Virus infection in the spleen was detected four days after inoculation. Twelve days
after inoculation virus spread to other lymphoid tissue with the onset of pyrexia.
Infected cells were identified by indirect immunofluorescence as medium sized
lymphocytes. Viral antigens were detected in the nucleus and cytoplasm of these
cells. However, these modes of transmission are not the natural route of infection.
The presence of cell-free virus in wildebeest oculo-nasal secretions and OvHV-2
DNA in sheep nasal secretions suggests that the natural route of infection could be
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intranasal. Animals inoculated by the intranasal route with cell-free A1HV-1 from
wildebeest secretions experienced shorter incubation periods compared to the
intravenous route of infection (Mushi and Wafula, 1983). The longer half-life of the
virus in vitro at 32°C compared to 37°C (Harkness and Jessett, 1981) may also
account for the shorter incubation periods recorded in intranasal compared to
intravenous inoculation.
Antibody responses to A1HV-1 and OvHV-2 infection have also been studied.
The immunofluorescent antibody test has been widely used in serological studies.
Using this method, the presence of antibody was demonstrated in cattle and rabbits
experimentally infected with A1HV-1. Antibody was detected approximately one
week before pyrexia with titres increasing until death (Rossiter, 1982a). However,
this form of serological test is limited by cross-reactivity with the common bovine
herpesviruses, BHV-2 and BHV-4 (Rossiter et al, 1980). Using the virus
neutralisation assay, neutralising antibody was detected in all wildebeest tested. In
experimental transmission studies, neutralising antibody was detected in 100% of
MCF-recovered cattle but only in a proportion of fatally affected cattle (Plowright,
1965b, 1968). In Rossiter's (1982a) study of A1HV-1 infection in rabbits and cattle,
neutralising antibody was also detected in rabbits shortly before the onset of pyrexia.
However, in experimentally infected cattle neutralising antibody to A1HV-1 was not
detected. These results suggest that in wildebeest and recovered cattle, productive
virus replication - involving expression of late transcripts - has occurred prior to the
virus becoming latent. The presence of neutralising antibody in lower proportions of
fatally infected cattle suggests that in these animals the virus does not express the
late transcripts to which neutralising antibody is directed. This supports the idea that
virus replication is repressed or incomplete in these animals. It should be noted
however, that presence of neutralising antibodies in cattle or rabbits does not protect
the animals from MCF (Barnard, 1984; Mirangi, 1991; Plowright et al, 1975;
Rossiter et al, 1989).
1.2.4.2 Pathogenesis of MCF
The main features of MCF pathology can be summarised as follows:
lymphocyte hyperplasia in lymphoid and non-lymphoid organs, epithelial
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degeneration and vasculitis. In MCF-affected tissue no specific viral cytopathology
is observed (Edington et al, 1979; Rossiter 1985) though cells from such tissue
display infectivity despite little viral antigen having been detected (Rossiter, 1980).
Several hypotheses for the pathogenesis of MCF have been proposed. These
include virus-induced cytopathic effects or virus-induced transformation of infected
cells. Other theories suggest a role for the host immune system such as immune
complex formation, virus-mediated stimulation of autoimmunity, and cell-mediated
immune dysfunction. These hypotheses are reviewed in the following paragraphs.
Virus-induced cytopathic effect is well documented for many viruses (Fields
et al, 1996). Indeed, the isolation of A1HV-1 in vitro depends on the appearance of a
cytopathic effect in cell monolayers. Therefore, it was suggested that the necrotic
lesions seen in MCF could be the result of virus-mediated cytolysis (Liggitt and De
Martini 1980a). Other authors have suggested that virus-induced lymphocyte
transformation is responsible for the lymphoproliferation (Denholm and Westbury
1982; Edington et al, 1979; Heuschele et al, 1985; Hunt and Billups 1979).
However, these hypotheses are not compatible with the lack of viral antigen or the
low numbers of virus-infected cells (1:104) detected in tissue (Bridgen et al, 1992).
Therefore, as virus-mediated cytopathic effects and virus-mediated transformation
are not obvious in MCF pathogenesis the role of the immune system must be
considered.
Immune complex formation is responsible for the pathogenesis of rheumatoid
arthritis, serum sickness and glomerulonephritis (Roitt et al, 1998). The involvement
of such a mechanism might explain the widespread vasculitis typical of MCF
pathology. Patel and Edington (1982) were able to detect deposition of immune
complexes in infected bovine tissue. However, the specificity of the antibodies
involved in these complexes could not be determined. A number of other studies
have failed to detect immune complexes in cattle, rabbit and deer (Liggitt and
DeMartini, 1980a,b; Rossiter, 1980,1981; Mushi and Rurangirwa, 1981c). Once
again, the paucity of viral antigen in MCF-affected tissue indicates that immune
complex-mediated pathogenesis is not likely.
The similarity of lesions in cattle with MCF to lesions seen in contact
hypersensitivity, graft rejection and graft-versus-host disease implicated the
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involvement of the host immune system in MCF pathogenesis. The presence of
lymphoid infiltration in MCF lesions is consistent with this theory (Liggit and
DeMartini, 1980b). However, none of these hypotheses can explain the lymphoid
hyperplasia that occurs prior to tissue destruction and death.
The proliferation of lymphocytes in lymphoid tissues of MCF-affected
animals is generally restricted to the T-cell-dependent areas and the preservation of
tissue architecture in these tissues suggested a hyperplastic rather than a neoplastic
event (Buxton et al, 1984). In experimentally infected rabbits, hyperplasia - which
can be inhibited by cyclosporin-A (Cs-A) in vivo - appears to take place soon after
infection and is accompanied by a relative decrease in the number of B cells (Buxton
et al, 1984). Thus, virus-induced transformation of lymphocytes in MCF pathology
seems unlikely. Evidence for the in vivo involvement of immunopathology in
OvHV-2 infection includes studies of infiltrating lymphocytes in vascular and
epithelial lesions. Immunohistochemistry showed the majority of lymphoid cells at
these sites to be CD2+/CD8+/CD6+ (Ellis et al 1992, Nakajima et al 1992). Most
infiltrating cells had the morphology of large lymphoblastoid cells. Proliferation of
CD8+ T cells was responsible for the typical hyperplasia of MCF seen in lymphoid
organs (Nakajima et al 1992, Schock and Reid, 1996).
Lymphoblastoid cell lines can be generated in vitro with a similar phenotype
to the infiltrating cells observed in vivo. That cell lines can be propagated using
lymphoid cell suspensions from MCF-affected tissue supports the idea that these
cells may play a role in MCF pathogenesis. They have the morphology of large
granular lymphocytes (LGLs) and can transmit MCF to rabbits (Reid et al, 1989).
LGLs generated from OvHV-2 infected animals have the phenotype of
CD2+/CD8+/TCRaP+ T cells (Burrells and Reid, 1991; Cook and Splitter, 1988;
Schock et al, 1998) although CD4+/TCRaP+ and CD47CD87TCRy5+ cell lines have
also been observed. Functionally, these cells displayed major histocompatablilty
complex (MHC)-unrestricted, non-antigen specific cytotoxic activity that is common
to both natural killer (NK) cells and lymphokine activated killer (LAK) cells (Cook
and Splitter, 1988, Reid et al, 1989b). LGL cell lines derived from MCF-affected
animals grow in culture in the presence of exogenous interleukin-2 (IL-2) and/or
feeder cell monolayers. Some of these lymphoblastoid LGL cell lines were able to
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grow in the absence of exogenous IL-2 for longer periods than uninfected control
cells (Reid et al, 1989b). Lymphoblastoid LGL cell lines established from rabbits
experimentally infected with A1HV-1 or OvHV-2 displayed a similar morphology,
phenotype and function (Reid et al, 1983, Schock and Reid, 1996).
Therefore, the hypothesis that best fits the pathology observed was suggested
by Reid and Buxton (1989) who proposed that lymphocyte dysregulation through
inappropriate cytokine stimulation leads to the production of large granular
lymphocytes (LGL) with NK/LAK cell characteristics which ultimately causes tissue
destruction. The target cell for virus infection is thought to be the LGL where viral
DNA, if not virions, has been detected (Bridgen et al, 1989; Bridgen and Reid, 1991;
Baxter et al, 1993). LGL derived cytokines could therefore be responsible for the T
cell proliferation observed in vivo. In support of this hypothesis is the detection in
OvHV-2-infected LGL cells of rnRNA for the cytokines, IL-4, IL-10, INF-y and
TNF-a but not for IL-ip or IL-2 (Schock et al, 1998).
1.2.5 Diagnosis and prevention
1.2.5.1 The development of diagnostic tests for MCF
Historically, firm diagnosis of MCF has only been possible using post¬
mortem histopathological examinations. The wide range and severity of lesions
make diagnosis a difficult task. However, the presence of generalised vasculitis,
cuffing in the CNS, hyperplasia of lymph nodes and lymphoid infiltration of the
kidney, urinary and gall bladder is considered sufficient for a firm diagnosis. This
does not rule out the possibility of misdiagnosis. Theileriosis, trypanosomiasis and
rinderpest are among a number of diseases that have been confused with MCF
(Plowright, 1981; Reid and Buxton 1989).
Virus isolation as a means of diagnosis is only possible for A1HV-1-induced
MCF. Recovery of virus from viable lymphoid or buffy coat cells is possible on co-
culture with permissive cell monolayers. The development of a typical syncitial CPE
in 10 to 20 days is a good indicator but specificity still needs to be confirmed by
indirect immunofluorescence or immunoperoxidase assays (Ferris et al, 1976;
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Rossiter, 1981). However, these tests are dependent on the specificity of the sera
involved, which are from carrier or MCF-susceptible animals.
Diagnosis by indirect immunofluorescence using sera from diseased animals
has been hampered by low titres or non-specificity (Rossiter et al, 1977). The
specificity is tested by reactivity to A1HV-1 antigens expressed in virus-infected
monolayer cells. While this test has been used to diagnose WA-MCF (A1HV-1
infection), the use of the test in SA-MCF is dependent on antigenic relationship
between A1HV-1 and OvHV-2 (Herring et al, 1989). However, antigenic
relationship to other known herpesvimses (particularly BHV-4) has been observed
(Plowright 1967; Reid et al, 1975; Rossiter, 1981, 1983; Rossiter and Jessett 1980;
Rossiter et al, 1977, 1978, 1980) therefore the results of all serological tests using
whole sera from animals with MCF must be interpreted with care. Recently, Li et al
(1994) developed a competitive inhibition enzyme-linked immunosorbent assay (CI-
ELISA) that could be useful for diagnosis of SA-MCF. This test relies on the
inhibition (by the test sera) of a monoclonal antibody with specificity for a
glycoprotein in A1HV-1, which is not cross-reactive with BHV1, BHV2 or BHV4
proteins but is cross-reactive with OvHV-2.
With the emergence of new molecular techniques, the specificity and
sensitivity of diagnostic tests has improved. The molecular characterisation of the
A1HV-1 genome and partial characterisation of OvHV-2 has allowed specific DNA
probes to be developed. In situ hybridisation using an A1HV-1-specific HincUl
fragment encoding the major terminal non-coding repeat sequence allowed the
detection of this virus in tissue and lymphocyte cultures derived from rabbits with
experimental MCF (Bridgen et al, 1992). The sensitivity of this test was thought to
be a hundred fold higher compared to indirect immunofluorescence using whole sera
from animals with MCF. The result nevertheless confirmed previous findings that in
tissues from animals with MCF a very low number of cells were infected with
A1HV-1.
The development of polymerase chain reaction (PCR)-based techniques has
made a major impact on the diagnosis of MCF. This method uses vims specific
DNA sequences to amplify viral DNA and is much quicker than virus isolation. It
has the added advantage of being able to detect and amplify viral sequences that are
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present at very low concentrations in tissue samples. Diagnosis is now possible
during the clinical stage of the disease. PCR-based assays have been developed for
detecting A1HV-1 DNA of open reading frame 21 (ORF21) with homology to the
EBV ORE, BXLF1 (encoding thymidine kinase) and a WC11 clone with homology
to parts of the sequence for EBV major capsid proteins encoded by the open reading
frames, BDLF1 and BcLFl (Hsu et al, 1990b; Katz et al, 1991; Michel, 1993; Tham
et al, 1994). For diagnosis of OvHV-2 infection, DNA sequences homologous to the
140kd and 160kd tegument proteins of EBV and HVS respectively are used for PCR-
based assays (Baxter et al, 1993). The PCR has allowed early detection of OvHV-2
in Indonesian ruminants and should lead to a better understanding of the
epidemiology of MCF in Southeast Asia (Wiyono et al, 1994). The first case of
MCF (caused by OvHV-2) in pigs, verified by PCR, was recently reported (Foken et
al, 1998). The accuracy of PCR as a diagnostic test was confirmed in a field
validation study (Mtiller-Doblies et al, 1998). PCR showed more than 94%
agreement with hisopatholgical diagnosis (which is still regarded as the definitive
test for MCF). CI-EFISA showed a similar degree of specificity but had a much
lower level of sensitivity compared to PCR.
1.2.5.2 Prevention and control of MCF
Many attempts have been made to immunise animals against the MCF viruses
and have concentrated on the development of a protective antibody response.
However, the presence of neutralising antibody (at high titres) does not protect cattle
or rabbits against a challenge with cell-associated virus (Barnard, 1984; Mirangi,
1991; Mirangi and Rossiter 1991; Piercy, 1954; Plowright et al, 1975; Reid and
Rowe, 1973; Rossiter et al 1989). Where immunisation has been successful in
rabbits using live kidney cells from rabbits infected with the cell-free A1HV-1 virus
WC11, protection against the cell-associated A1HV-1 C500-infected rabbit spleen
cells was short-lived (Rossiter, 1982b). It is presumed that in cases where animals
have recovered from MCF, protective immunity must be cell-mediated rather than
humoral (Heuschele et al, 1985; Plowright et al, 1972). No vaccine has yet been
developed for the prevention of MCF. Therefore, the control of MCF still relies on
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the separation of carrier and susceptible species during the lambing/calving season
(Reid and Buxton, 1989).
The inability of infected and diseased animals to eliminate the MCF viruses
may be due to the expression of viral genes that interfere with the host immune
response either directly or indirectly. Viral interference of the host cell responses
will be discussed with respect to other well-studied viruses in the following section.
1.3 Herpesvirus modulation of host cell function
To ensure survival and replication in host cells, viruses must first escape the
normal immune and anti-viral responses of the host.
1.3.1 Antiviral immune responses
The first line of defence against a virus infection is the innate immune
system. On infection, the infected cell produces interferons (IFNa/p/y) and tumour
necrosis factor (TNF), both cytokines with antiviral activity. Anti-viral activity
includes the blocking of protein translation, degradation of viral RNA and induction
of host cell apoptosis or programmed cell death (Billiau 1996; Roitt et al, 1998).
Apoptosis triggered by virus infection can be mediated by the induction of
intracellular proteins such as Bax or via death receptors such as Fas and tumour
necrosis factor receptor-1 (TNFR-1) (Boyd et al, 1995; Sato et al, 1994; Thome et al,
1997). Another effect of interferons, specifically IFNy, is the activation of natural
killer (NK) cells and macrophages and the triggering of the adaptive immune system
(Billiau 1996; Heise and Virgin 1995).
The principle contribution of B cells in the adaptive immune response to
virus infection is the production of virus-specific antibody. Neutralising antibody
can block the binding and entry of free virions into host cells. Antibody, in
conjunction with NK cells, can mediate antibody-dependent cell cytotoxicity
(ADCC) against virus infected cells. This is facilitated by the production of perforin
- a cytolytic protein - released from the cytoplasmic granules of NK cells (Doherty
1993). Antibody can also mediate the activation of the complement system - a series
of proteins that bind to the cell membrane, leading to the formation of the membrane
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attack complex (MAC) and cell lysis. The combination of antibody and complement
can sometimes act to opsonise the virus or virus-infected cell, making phagocytosis
possible (Sissons and Oldstone 1980).
The anti-viral immunity mediated by T cells can be direct and indirect. The
CD4+ T helper (Th) cells have an indirect role by recruiting and activating
macrophages to the site of virus infection by the production of cytokines. For
example, the production of cytokines such as IL-2, IFNy and TNFp produced by
Thl-type cells enhance monocyte activation as well as CD8+ cytotoxic cells (CTLs).
CTLs - major effector cells in anti-viral immunity - recognise virus antigen presented
by major histocompatability complex (MHC-I) on virus-infected cells (Doherty et al,
1992; Ramsay 1993). The regulation of all these responses is controlled by the
cytokine network.
1.3.1.1 Control of the immune response
The cytokine network includes a large group of soluble proteins that regulate
immune and inflammatory responses. They can co-ordinate the clearance of virus by
stimulating effector cells and control their responses to ensure minimal damage to
host cells. Within this group of cytokines are the chemokines that are known for
their proinflammatory and chemoattractant properties. The effects of cytokines and
chemokines are controlled by the expression of different families of cell surface
receptors. For example, IL-2 and IL-15 are stimulators of T cell proliferation. IL-2
is a cytokine produced mainly by T cells while IL-15 is produced by monocytes,
dendritic cells and fibroblasts (Carson et al, 1995; Doherty et al, 1996; Grabstein et
al, 1994; Jonuleit et al, 1997). The response of cells to IL-2 is controlled by the
presence of the IL-2 receptor (IL-2R). This receptor is a heterotrimer consisting of
the a, P and y subunits (Smith, 1988). IL-15 shares many of its properties with IL-2
due to its use of the common subunits IL-2RP and IL-2Ry (Carson et al, 1994; Giri et
al, 1994; Grabstein et al, 1994) . The additional expression of the a subunit of the
IL-15 receptor (IL-15Ra) increases the affinity of the receptor for IL-15 just as the
induction of the IL-2Ra subunit on activated cells increases the affinity of IL-2 for
its receptor (Anderson et al, 1995; Giri et al, 1995a,b; Kondo et al, 1986; Robb,
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1986; Takeshita et al, 1992). Another family of receptors is used by chemokines
including MCP-1 (macrophage chemotactic protein) and IL-8. Chemokine receptors
are G-protein-coupled receptors (GCRs) and have a characteristic structure with
seven transmembrane domains. The specificity of these receptors is determined by
the N-terminal extracellular domain (Murphy, 1994; Gayle et al, 1993).
The specificity of the anti-viral immune response is determined by the
engagement of a virus antigen with the antigen receptors of B cells and T cells via
presentation of antigen by antigen presenting cells (APC). The nature of the immune
response is also controlled by the engagement of cytokine receptors and co-
stimulatory molecules on APCs and T cells such as CD2, CD4, CD8, CD28 and the
IL-2 receptor on T cells (Roitt et al, 1998). The result of the stimulation of these
extracellular proteins is the induction of intracellular proteins that transmit messages
to the nucleus (i.e. signal transduction). These signalling pathways can intersect with
each other creating a complex biochemical network within the cytoplasmic space.
The outcome is the transcription of genes and the generation of an appropriate
response. This process is fundamental to the responses generated in innate and
adaptive immunity (Crabtree and Clipstone, 1994).
The proteins involved in the signalling pathways - i.e. signal transduction
molecules - include kinases (which phosphorylate proteins on tyrosine, serine or
threonine residues), phosphatases (which de-phosphorlate proteins) and several
adaptor molecules (including guanosine triphosphate (GTP)/ guanosine diphosphate
(GDP) exchange factors). The interaction of cell surface receptors with signalling
molecules and the resultant cascade of protein phosphorylation and de-
phosphorylation is the basis of signal transduction (Crabtree and Clipstone, 1994).
For example, p56 Ick - a T cell-specific signalling molecule (belonging to the src
family of tyrosine kinases) - is activated in the early stages of T cell activation via
the T cell receptor. This then leads to the activation of downstream signal
transduction molecules (Fig 1.4). The events following cytokine receptor
engagement is similar though associated with a different family of signal
transduction molecules - i.e. the JAKs (Janus kinases) and STATs (signal transducers
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1.3.2 Immune evasion mechanisms adopted by herpesviruses
Viruses have developed a variety of strategies that enable them to evade the
anti-viral immune responses. The infection and persistence of viruses in a host cell
will sometimes change the behaviour of the infected host cell. In other cases, the
immune environment in which the virus exists can be altered to aid virus survival.
The mechanisms used by the MCF viruses to modulate host cell behaviour are
unclear. Therefore, the following sections will review the mechanisms used by other
herpesviruses focussing on the related gammaherpesviruses herpesvirus saimiri
(HVS) and Epstein-Barr virus (EBV) in particular (summarised in Tablel.3). As for
all gammaherpesviruses, HVS and EBV are both lymphotropic viruses that transform
T cells and B cells respectively and are associated with lymphoproliferative disease
(Masucci and Emberg, 1994; Meinl et al, 1995). Studying the mechanisms
employed by these and other herpesviruses to deregulate host cell function may give
valuable insights into the mechanisms utilised by the MCF viruses.
Cell transformation is a major mechanism by which viruses modulate host
cell behaviour. Many viruses encode proteins that can modulate the growth of an
infected cell, which drives the expansion of host cells and therefore the persistence of
viral genome. Viruses such as Kaposi's sarcoma herpesviruses (KSHV or HHV-8)
(Boshoff and Weiss, 1998), human T cell leukaemia virus (HTLV-1) (Feuer et al,
1993) and EBV (Ring, 1994) exhibit transforming activity. The transforming ability
of EBV has been associated with two groups of proteins: the EBNAs (EBV nuclear
antigens) and the LMPs (latent membrane proteins) (Ring, 1994). Transformation
can be achieved by viral interaction with normal cellular activation pathways (as
exemplified by the HVS proteins, Tip and STP -see next section). Another
mechanism of transformation is virus-induced evasion of host cell apoptosis as
demonstrated in HTLV-1-infected T cells and EBV-infected B cells (Copeland et al,
1994; Gregory et al, 1991). The interaction of Bax (the intracellular protein induced
during apoptosis) with the anti-apoptotic protein Bcl-2 inhibits apoptosis (Sato et al,
1994). Some viruses may inhibit host cell apoptosis by exploiting the anti-apoptotic
activity of Bcl-2. For example, a Bcl-2 homologue is encoded by HHV-8 and
cellular Bcl-2 is induced by LMP-1 of EBV (Cheng et al, 1997; Henderson et al,
1991; Sarid et al, 1997). Viral proteins that inhibit the signaling complex of death
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receptors can also inhibit apoptosis. For example, HHV8 and equine herpesvirus 2
(EHV2) encode proteins with structural homology to death effector domains or
caspase recruitment domains - both important in mediating protein interactions of
signaling molecules associated with death receptors (Bertin et al, 1997; Thome et al,
1997, 1999). Therefore, the presence of a Bcl-2 homologue encoded by ORF A9 of
A1HV-1 might suggest that an anti-apoptotic mechanism may also be important for
virus survival and persistence (Ensser et al, 1997).
Interference with antibody and complement function (one of the earliest host
defence mechanisms against pathogens) allows viruses to evade the host's immune
system. Several viral proteins have been shown to exhibit antibody or complement
binding activity. Examples include the glycoproteins gC, gE and gl of herpes
simplex viruses (HSV-1 and HSV-2), gl of varicella zoster virus (VZV) and protein
ml38 of murine cytomegalovirus (MCMV) (Bell et al, 1990; Hung et al, 1992;
Litwin et al, 1992; Thale et al, 1994). Gammaherpesviruses including HVS have
also been shown to encode proteins with homology to cellular complement
regulatory proteins and will be discussed in the next section. Interestingly, EBV also
inhibits complement activation despite the absence of viral homologues to
complement control proteins (Mold et al, 1988). Therefore, viruses that interfere
with host defence mechanisms at an early stage may have a greater chance of
survival and thence the ability to replicate or establish latency.
The evasion of innate immune responses is clearly important for virus
survival and replication. However, the long-term persistence of viruses within the
host also depends on successful evasion of adaptive, cell-mediated immune
responses. Proteins with major histocompatability complex (MHC) class II - binding
activity have been noted in HVS (ORF 14) and EBV (BZLF2) whilst proteins with
MHC class I homology are present in MCMV (ml44) and HCMV (UL18) (Davis-
Poynter and Farrell, 1996). The herpes simplex virus (HSV) protein, IE12 also binds
to and down-regulates MHC class I expression (York et al, 1994). These viral
proteins may aid immune evasion by inhibiting viral recognition and may be an
immunosuppressive mechanism.
Viruses have been able to bypass cell-mediated immunity by disrupting the
cytokine network by the production of viral proteins that mimic cytokines or viral
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homologues to cytokine receptors and chemokine receptors that block cytokine and
chemokine function respectively. Cytokine homologues have been demonstrated in
the herpesviruses EBV (BCRF1 = IL-10) and EHV-2 (ORF E7 = IL-10) ( Moore et
al, 1990; Telford et al, 1995; Vieira et al, 1991). Cellular IL-10 inhibits the
inflammatory response mediated by macrophages and is involved in the regulation of
helper T cell (Th) responses. IL-10 shifts the immune response towards a Th2
response, which includes enhancement of B cell responses and inhibition of CTL,
and NK responses (normally controlled by Thl cells). Thus, viral IL-10 may aid
virus survival by inhibiting the normal immune responses to virus infection
controlled by Thl-derived cytokines (Moore et al, 1993). Viral cytokine receptor
and chemokine receptor homologues have also been found in poxviruses (McLadden
et al, 1995) and herpesviruses. Examples in herpesviruses include HCMV, MCMV,
human herpesvirus 6 and 7 (HHV-6 and 7), EHV-2, EBV and HHV8 (Cesarman et
al, 1996; Chee et al, 1990; Davis-Poynter et al, 1997; Gompels et al, 1995; Nicholas
1996; Telford et al, 1995). The function of these homologues has not been
determined but it has been speculated that they might play a role in tissue tropism.
This is illustrated by the chemokine receptor homologue in MCMV encoded by ORF
M33. The deletion of this ORF leads to the loss of the ability to replicate in the
salivary gland, a major site of replication and persistence (Davis-Poynter et al, 1997).
Alternatively, viral chemokine receptors may decrease the concentration of
chemokines at the site of infection thereby decreasing chemotaxis of immune
effector cells to the area. Conversely, the expression of viral chemokine receptors on
infected cells may modify the chemotactic nature of the infected cell thus assisting in
the dissemination of the virus to different tissues. The predicted seven
transmembrane structure of the protein encoded by ORF A5 of A1HV-1 is suggestive
of a viral chemokine receptor. However, the function of ORF A5 has yet to be
determined
The co-evolution of viruses with their hosts has generated viral proteins that
can interrupt signalling pathways and alter cell function to benefit virus replication
and persistence. The importance of this mechanism is demonstrated by the range of
viruses that encode protein kinase binding proteins. The polyomavirus middle T
antigen and the human T-cell leukaemia vims (HTLV-1) protein TAX have been
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shown to interact with protein tyrosine kinases (PTKs) (Courtneidge et al, 1991;
Sinclair and Farrell, 1995). The best examples within herpesviruses come from
studies of EBV and HVS. The EBV latency protein LMP2A is constitutively
phosphorylated and associates with the tyrosine kinases, lyn and syk, in B cells. A
reduction in lyn activity was also observed in EBV-transformed cells and LMP-2A
blocked reactivation of the virus (Miller et al, 1994, 1995). Thus, LMP-2A acts as a
factor for the maintenance of latency. The association of altered cellular kinase
activity with virus infection has also been noted in HVS-transformed cells and will
be discussed in more detail in the next section.
1.3.3 Herpesvirus saimiri (HVS) - mediated host cell modulation
The gammaherpesvirus, herpesvirus saimiri (HVS) has attracted attention
from those studying MCF. HVS epidemiology is summarised by Falk et al (1972).
HVS infects the majority of squirrel monkeys without apparent disease. The
transmission of this virus to marmosets induces a lymphoproliferative disease with
similar pathological features to MCF. In addition, the disease cannot be transmitted
between marmosets and the virus infects T cells which can be propagated in vitro as
LGL cell lines. The characteristics of HVS-transformed T cells have some
similarities to LGL cell lines derived from cases of MCF. HVS-transformed cells
have a variable dependency on exogenous IL-2 and a requirement for high cell
densities to achieve optimum growth (Meinl et al, 1995). HVS-transformed T cells
exhibit a hypersensitivity to CD2-mediated stimulation (Mittriicker et al, 1992).
Given such similarities, it is possible to speculate that the diseases induced by HVS
and the MCF viruses could share some common elements of pathogenesis.
Extensive study of HVS shows that this virus uses a wide range of
mechanisms for immune modulation that have also been demonstrated in other
herpesviruses. For example, the HVS proteins encoded by ORE 04 and 15 exhibit
strong homology (up to 69% amino acid identity) to cellular proteins involved in
complement regulation, i.e. CD55 and CD59 respectively (Albrecht and
Fleckenstein, 1992). CD55 (or decay accelerating factor - DAF) inhibits C3
convertase while CD59 inhibits C9 activation and subsequent assembly of the
membrane attack complex (MAC). Both viral proteins show functional as well as
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sequence homology and cells transfected with these proteins were protected from
complement mediated cytolysis (Fodor et al, 1995; Rother et al, 1994).
HVS also encodes a secreted protein in ORF 14 that exhibits MHC II binding
activity and elicits non-specific T cell expansion (Yao et al, 1996) which may lead to
the diversion of the immune system away from virus-specific responses. Other HVS
proteins display homology to Bcl-2 (Nava et al, 1997), to the cytokine IL-17
(Knappe et al, 1998; Rouvier et al, 1993; Yao et al, 1995) and to a chemokine
receptor, IL-8R (Nicholas et al, 1992). HVS also induces the expression of a cellular
homologue to IL-10 in transformed T cells (Knappe et al, 2000).
The transforming ability of HVS was mapped to genes within the left
terminal region of the unique DNA (Jung et al, 1991). The variability of this region
is the basis for the classification of HVS into three subgroups - A, B and C.
Transformation of susceptible monkey T cells can be achieved by all three subgroups
but only subgroup C strains have demonstrated this activity in human T cells
(Biesinger et al, 1992). Two proteins encoded in this area of the HVS genome are
associated with transforming activity. They are the HVS transforming protein (STP)
and the tyrosine kinase interacting protein (Tip) - both are products of a bicistronic
mRNA encoded by ORF 1. Both these proteins are required for transformation of
human T cells (Medveczky et al, 1993). Interestingly, the closely related heipesvirus
ateles also encodes a protein (Tio) with homology to Tip and STP (Albrecht et al,
1999; Albrecht, 2000), which may also explain its ability to infect and transform T
cells.
The characteristics of HVS-transformed cells may be attributed to the affinity
of STP and Tip for Ick as it is involved in T cell receptor, CD2, CD4 and IL-2
receptor-mediated signalling (Biesinger et al, 1990, 1995; Jung et al, 1995a; Lund et
al, 1996). The constitutive activation of, and interaction with, STAT-1 and STAT-3
(Heim, 1996) by Tip is also dependent on Ick and the presence of the Ick-binding
domain on Tip (Lund et al, 1997,1999). Some authors have reported the
upregulation of Ick activity (Guo et al, 1997; Noraz et al, 1998; Wiese et al, 1996).
This would support the role of Tip (in co-operation with STP) as a transformation
factor (Duboise et al, 1998a). The finding that Tip and STP mediate IL-2
independence in HVS-transformed T cells also supports this hypothesis (Lund et al,
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1996; Medveczky et al, 1993). Meanwhile, others have reported the downregulation
of Ick kinase activity (Duboise et al, 1998b; Jung et al, 1995b). If this is the case,
then Tip may act in a similar way to LMP-2A of EBV by blocking virus reactivation
and maintaining latency.
Herpesvirus saimiri transforming protein (STP) is encoded by the two
subgroups A and C. The STP of subgroup C (STP-C488) forms a complex with a
downstream signalling molecule called p21 -ras. Subsequent activation of ras by
STP-C488 is associated with cell transformation (Jung and Desrosiers, 1995).
Meanwhile, the STP of subgroup A (STP-A11) may induce transformation by a
different mechanism. It was shown that interaction with c-src via an SH2 binding
domain allows binding of STP-A11 to Ick and another T cell-specific tyrosine kinase,
fyn (Lee et al, 1997). Interaction with Ick is clearly an important mechanism as other
viruses (HIV and myxomavirus) also modulate /c/r-mediated signalling (Barry et al,
1995; Greenway et al, 1995). Finally, viral enhancement of CD2 mediated
stimulation (e.g. via its ligand CD58 on neighbouring cells) could induce autocrine
growth of transformed cells (Mittrticker et al, 1992) and may explain the requirement
for high cell densities to achieve optimum growth.
These examples illustrate that while the whole sequence of a viral protein
may have little homology to cellular proteins, the presence of small sequence motifs
with homology to cellular binding domains may be enough for viral proteins to
disrupt normal cell functions. The mechanisms of HVS-mediated host cell
modulation have similarities to other herpesviruses including EBV. However,
comparison of the HVS and A1HV-1 genomes illustrates significant differences in
that homologous proteins to HVS transforming proteins, cytokines and complement
regulatory proteins are not found in A1HV-1. Therefore, it is likely that A1HV-1
encodes unique effector proteins that can generate similar functions to that seen in
HVS-transformed cell lines. The viral immunomodulatory proteins mentioned here
are summarised in Table 1.3.
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1.4 Objectives and strategies
In the absence of defined viral virulence proteins, the primary objective of
this project was to investigate how the MCF viruses (A1HV-1 and OvHV-2) interfere
with proliferation and cytotoxicity of large granular lymphocyte (LGL) cell lines
derived from MCF-affected cattle and rabbits.
1.4.1 Specific objectives:
To characterise the effect of virus infection on host cells by comparing
phenotype and functional differences between infected LGL cell lines and control
(uninfected) cells (Chapter 3). This work aimed to build on the previous observation
that IL-2 mRNA was not expressed in OvHV-2-infected cattle cell lines (Schock,
1996). The study will extend these findings by asking whether virus-mediated
dysregulation of the cytokine network or interference with signal transduction
pathways is responsible for the phenotype of the cell lines. In light of the IL-2-
independence of some LGL cell lines and the similarities of MCF viruses to other
gammaherpesviruses, two objectives were proposed.
• Firstly, the work in this study examined the possible role of the cytokine IL-15 in
the maintenance of LGL phenotype and function. IL-15 is functionally similar to
IL-2 and stimulates the proliferation and cytotoxicity of T cells. The ability of
IL-15 to maintain the phenotype of the LGL and its involvement in an autocrine
or paracrine loop was tested by growth response assays, immunocytochemistry
and RT-PCR (Chapter 3).
• Secondly, as viral interference with signal transduction pathways has been
demonstrated in other gammaherpesviruses the work presented here aimed to
determine if MCF virus infection altered the activation of some T cell-specific
protein kinases. An indication of the involvement of signal transduction
pathways in general was tested in pilot studies and investigated the effect of
biochemical inhibitors of signal transduction on IL-2-independent growth. In
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addition, the presence of tyrosine phosphorylated proteins in infected and
uninfected control cells were compared. Specific kinase activity of
immunoprecipitated protein kinases was then assessed by phosphotransferase
assays measuring the kinase-mediated transfer of radioactively labelled
phosphate to a substrate (Chapter 4).
LGL cell lines were obtained from cattle naturally infected with OvHV-2 and rabbits
experimentally infected with A1HV-1 or OvHV-2. In order to determine the effect of
virus proteins on LGL phenotype and function (and to remove stimulus due to IL-2),
the cells in these experiments were cultured in the absence of exogenous IL-2 before
use.
During the course of this study, the genomic DNA sequence of A1HV-1 was
published (Ensser et al, 1997). Prior to this publication, a region of the A1HV-1
genome had been characterised that underwent rearrangement upon passage of the
virus in culture. This rearrangement was associated with loss of virulence (Handley,
1993: Handley et al, 1995). Three proteins encoded in this region were of particular
interest as potential virulence factors. Given this information a further objective was:
• To produce the three putative virulence proteins (encoded in ORF50, A6 and A7)
in an E coli expression system and to produce specific rabbit polyclonal
antibodies (Chapter 5). Using these antibodies the expression of the proteins was
determined (by immunofluorescence) in virus infected bovine turbinate cells and
LGL cell lines. Expression at protein level was compared to expression at the
mRNA level (determined by RT-PCR). The involvement of these proteins in the





2.1 Animals and viruses
2.1.1 Viruses
AIHV-1:
The WC11 strain of AIHV-1, first isolated from blue wildebeest, has been
extensively passaged in fibroblast cultures and can be harvested as a cell-free virus
(Plowright, 1968; Plowright et al, 1960). WC11 is attenuated in terms of its ability
to induce disease in susceptible animals. The C500 strain was first isolated from an
infected ox (Plowright et al, 1975). Throughout short-term passage (up to pass no. 5)
in bovine turbinate (BT) cultures this virus is cell associated and becomes cell-free
after extensive passage. C500 (at low passage) is fully virulent in terms of its ability
to induce disease in susceptible animals while C500 (at high passage) is attenuated.
'Virulence' and 'attenuation' -as defined above- was determined using 104 PFU
(plaque forming units) of low pass C500 or 5 xlO7 TCID5o (50% tissue culture
infective virus dose) of high pass C500 as inoculum in rabbits. Rabbits inoculated
with the stated doses of low pass C500 virus died of MCF while those inoculated
with high pass C500 virus survived without apparent disease. These doses represent
an excess of virus in the high pass C500 inoculum compared to the low pass C500
inoculum thus reducing the possibility that 'attenuation' of high pass C500 was due to
lower vims dose (H. Reid, personal communication).
For infection of rabbits, the virulent C500 strain was used and came in the
form of spleen and/or lymph node cell suspensions from rabbits with A1HV-1-
induced MCF. Cell suspensions were stored in liquid nitrogen in Iscove's
modification of Dulbecco's medium (IMDM) (Gibco BRL, Paisley, UK)
supplemented with 40% foetal bovine serum (FBS) and 10% dimethyl sulphoxide
(DMSO) until required. For the generation of rabbit LGL cell lines, the virulent
C500 strain was maintained by repeated passage in rabbits as pathogenicity is lost on
repeated culture in BT cells. The WC11 and C500 isolates at low passage (pass no 4
or 5) and high passage (pass no. >350) were also used to infect bovine turbinate (BT)
cells. Details for the culture of vims in BT cells or LGL cell lines are described in
Chapter 2.2 ('cell culture').
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OvHV-2:
OvHV-2 has never been isolated as a free virus but viral DNA can be
detected in large granular lymphocyte (LGL) cell lines derived from naturally and
experimentally infected animals (i.e. cattle and rabbits).
Infection of rabbits with OvHV-2 was achieved using lymph-node/ spleen
cell suspensions from rabbits infected with OvHV-2-induced MCF. These cell
suspensions were handled and stored in the same manner as the C500-infected cell
suspensions described above. OvHV-2-infected rabbit LGLs were also generated in
the same manner as A1HV-1-infected cell lines.
2.1.2 Rabbits
Specific pathogen-free 3-12 month old male and female New Zealand white
rabbits were inoculated intravenously with pathogenic A1HV-1 or OvHV-2 in
lymphocytes as described above. The inoculum consisted of approximately 107
spleen or lymph node cells from rabbits with MCF, which contained approximately
104 plaque forming units (infective doses) of virus. The rectal temperature was
recorded each day and the animals killed after 2 days of febrile response (>40°C).
LGL cell lines were established from these rabbits (Table 2.1).
For the preparation of polyclonal antibodies, the rabbits were immunised
intramuscularly with an emulsion of complete then incomplete Freund's adjuvant
(Difco Laboratories, Detroit, MI) mixed with equal parts antigen and administered
four weeks apart. Four weeks later an intravenous boost of antigen with no adjuvant
was given. Serum was tested two weeks later for the presence of specific antibody.
The nature and concentration of antigen and the reactivity of serum are described in
Chapter 5. Animals were killed using CO2 when the serum was collected for
antibody purification (Chapter 2.4.7).
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Selected clinical cases of bovine MCF referred by the Scottish Agricultural
College Veterinary Services and practising veterinary surgeons were transported to
the Moredun Research Institute. After post-mortem examination, affected tissues
were removed aseptically. Single cell suspensions were prepared from spleen,
retropharyngeal, prescapular, prefemoral and mesenteric lymph nodes (Chapter
2.2.3). The established bovine (OvHV-2-infected) MCF LGL cell lines used in this
study (Table 2.1) were derived from these tissues.
2.2 Cell culture
2.2.1 Media
For wash medium, 500ml of sterile Hank's balanced saline solution (HBSS)
was supplemented with 5% (v/v) foetal bovine serum (FBS), 200U/ml penicillin,
200pg/ml streptomycin (Gibco BRL, Paisley, UK) and lOU/ml heparin (Sigma-
Aldrich, Gillingham, UK).
Routine culture medium was Iscove's modified Dulbecco's medium
(IMDM). A 500ml bottle of IMDM was supplemented with 10% (v/v) foetal bovine
serum, 200U/ml penicillin, 200pg/ml streptomycin, lOpM 2-mercaptoethanol and
0.5pg/ml fungizone (Gibco BRL, Paisley, UK). Foetal bovine serum was free of
bovine diarrhoea virus (BVDV) and batch selected to ensure optimum growth of
MCF virus-infected LGL cell lines.
2.2.2 Cell culture conditions
Cells were incubated in 25cm2 flasks (Costar UK Ltd, High Wycombe, UK),
24-well cell culture plates or 96-well flat-bottomed cell culture plates (Costar UK
Ltd, High Wycombe, UK) in a humidified atmosphere of 5% CO2 at 37°C.
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2.2.3 Preparation of control cells
2.2.3.1 Cattle and rabbit peripheral blood mononuclear cells (PBMC)
Cattle PBMCs were prepared from fresh heparinised peripheral blood. The
buffy coat was collected after centrifugation of lOmls whole blood at 1400 x g for 30
minutes. This fraction was then diluted 1:1.5 with sterile phosphate buffered saline
(PBS) and layered onto Lymphoprep (Nycomed, Oslo, Norway) in an equal volume
and centrifuged at 1400 x g for 30 minutes. The interface layer of mononuclear cells
was collected and washed twice in HBSS wash medium. These cells were used
immediately as 'resting' cell controls without further culture. Alternatively, cells
were counted in a haemocytometer and re-suspended in IMDM at a density of 2 x
106 cells/ml. To stimulate the cells, the T cell mitogen concanavalin A (conA) (ICN
Biochemicals, Cleveland, OH) was added at 5pg/ml in IMDM to the cell cultures in
24-well plates. After 72 hours in conA, cells were washed in IMDM and maintained
in IMDM at a density of 5 xl05/ml with 20U/ml human recombinant interleukin-2
(hrIL-2) (Eurocetus UK Ltd, Harefield, UK). The lymphoblasts that developed were
used in experiments as control cells. These cells were also phenotyped by flow
cytometry (as described in Chapter 2.3.1)
Rabbit spleen, mesenteric or popliteal lymph nodes were removed aseptically.
The tissue was chopped finely with scissors and passed through a stainless steel
sieve. After one wash and re-suspension in wash medium (HBSS) the cells were
layered onto 'Lymphoprep', mononuclear cells collected and stimulated with conA as
described above to generate lymphoblasts.
2.2.3.2 Rabbit and mouse adherent cells
For the detection of IL-15 in rabbit and cattle MCF LGL cell lines (Chapter
3) rabbit adherent cells or mouse fibroblast cells (LTK") were chosen as positive
controls.
Rabbit monocytes (contained in the adherent cell population) were isolated
from lung and peritoneal lavage samples. Briefly, crude cell suspensions were
washed in IMDM (without serum) at 4°C and resuspended to a cell density of 106/ml.
Cells (1ml) were plated out on coverslips in a 24-well plate. 10% FBS was added to
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the cultures and the cells were incubated at 37°C with 5% CO2 overnight to allow the
attachment of adherent cells to the coverslips. Non-adherent cells were removed by
2-3 washes in IMDM. The cultures were then stimulated with lOjig/ml bacterial
lipopolysaccharide (LPS) (Sigma Aldrich, Gillingham, UK) for 18-24 hours. The
coverslips were then washed in PBS and fixed in 50: 50 methanol: acetone for 5-10
minutes. Once dried the coverslips were stored at -20°C until ready for use.
Mouse LTK" cells (Spandidos and Wilkie, 1983) were prepared in a similar
fashion. An aliquot of LTK" cells stored in liquid nitrogen were thawed and cultured
at 5 x 106 cells/ml in IMDM + 10% FBS on coverslips and fixed as above.
2.2.4 Maintenance of MCF LGL cell lines
Maintenance of MCF LGL cell lines (which grow in suspension) was based
on methods previously determined by Reid et cil (1989b). All MCF LGL cell lines
were grown in 25cm2 flasks or 24-well plates and maintained in IMDM. Half of the
medium was replaced with fresh medium once a week and if required the cultures
were split (when cell densities reached 2 xl06/ml or more). Cell lines were
maintained in 350U/ml of hrIL-2 (Eurocetus UK Ltd, Harefield, UK) for optimum
growth. Approximately a week prior to use, cells were transferred to medium
containing 20U/ml of hrIL-2 to maximise any viral effect on cell phenotype and
minimise the effect of hrIL-2 on the cells. However, for the IL-15 (Chapter 3) and
kinase (Chapter 4) studies, cell lines were deprived of hrIL-2 to establish short or
medium-term IL-2-independent cell cultures. For these cultures, cells were set up at
1 x 106/ml after washing in culture medium. Half the total culture volume of
medium was replenished with fresh medium approximately once a week. Cultures
were readjusted to 106 cells/ml when required.
2.2.5 Infection of bovine turbinate (BT) cells with AIHV-1
BT cells between pass no. 5-20 were seeded at a density of 105cells/ml in 1ml
IMDM + 10% FCS on coverslips (21 x 6mm) and incubated at 37°C until
monolayers were formed. A 200j.il aliquot containing 2 x 104 BT cells infected with
cell-associated AIHV-1 C500 (low pass) (i.e. pass no. 5) was used to infect the BT
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cell monolayers until 50 - 70% of the monolayer showed cytopathic effect (CPE).
For the infection of BT cell monolayers with cell-free C500 (high pass) (pass no. 340
or higher) a 200pl aliquot of a 1:4 dilution of culture supernatants from an C500-
infected BT cell culture (showing maximum CPE) was added to the monolayers. For
the infection of BT cells the titre of virus in this inoculum is not routinely quantified
in this laboratory as cultures are fixed when similar levels of CPE have been
achieved.
For the infection of BT cells with cell-free WC11 (purified virus), 4mls of a
liquid nitrogen stock of WC11 was added to a 5mls suspension of BT cells (1.5 x 107
cells) in IMDM. The titre of WC11 was between 10"5 - 10"6 TCID5o/ml. The mixture
was incubated and shaken several times at 37°C for 60mins to allow adsorption to
proceed. The suspension was diluted to 105 cells/ml and FCS added to a final
concentration of 10%. These cells were allowed to form monolayers on coverslips as
before until 50-70% CPE was reached.
At this stage, coverslips were harvested and fixed in cold acetone for 5-10
minutes and stored at -20°C with silica gel until required. Once thawed the
coverslips were mounted onto glass slides with a permanent mountant for easy
handling.
2.2.6 Determination of cell growth and viability
50pl samples of cells were mixed with an equal volume of 0.1% (w/v)
nigrosine (Merck Ltd, Lutterworth, UK). Dead cells were determined by the
incorporation of nigrosine into the cells. Live and dead cells were counted in a
haemocytometer. The density of live cells and percentage viability (i.e. number of
live cells / number of live + dead cells) were calculated.
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2.3 Cell phenotype analysis
2.3.1 Flow cytometry (FACS analysis)
FACS (or fluorescence-activated cell sorting) analysis allows the detection of
cell surface antigens using fluorescently-labelled antibodies. The FACScan can
distinguish between cell types according to cell size and density and can measure the
intensity of fluorescent signal from each cell analysed. Furthermore, rapid analysis
of large numbers of cells can be achieved. Therefore, the expression of a particular
antigen within a population of cells can be determined by this method.
Cells were washed and re-suspended in FACS wash buffer (Earls medium
with 2% foetal bovine serum and 0.1% sodium azide) to a density of 5 x 105/ml. In
round-bottomed 96-well plates (Gibco BRL, Paisley, UK), cells were incubated with
50pl of the desired primary antibody (for details see Chapter 3) prepared in FACS
wash buffer for 30 minutes (to 2 hours) on ice. The cells were centrifuged at 250 x g
for 5 minutes and the supernatant removed. The pellets were washed twice in FACS
wash buffer. The fluorescein isothiocynate (FITC) conjugated secondary antibody
(rabbit-anti-mouse 1:50) (Dako Ltd, Ely, UK) was diluted in FACS wash buffer,
added to the cells and mixed thoroughly. This mixture was incubated on ice for 30
minutes in the dark. After a further two washes the cells were fixed in 1%
paraformaldehyde in wash buffer and transferred to FACS tubes (Becton Dickinson,
Mountain View, CA). Analysis was performed on 10000 cells with a Becton
Dickinson FACScan (Mountain View, CA). Lymphocytes and blast cell populations
were distinguished on the basis of the forward scatter/ side scatter profile. The FITC
green fluorescence (FL-1) on a logarithmic scale was plotted against cell numbers.
2.3.2 Immunofluorescence antibody test (IFAT)
IFAT is similar to FACS analysis in that it detects the expression of cellular
antigens using fluorescently labelled antibodies. In this case, the labelling took place
on fixed immobilised cells as opposed to cells in suspension. This technique has an
added advantage to FACS analysis in that sub-cellular localisation of antigens may
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be determined. This technique was used for the detection of viral antigens in MCF
LGL cell lines and in MCF virus-infected BT cells.
Cell suspensions (at a density of 5 xl05/ml) were cytocentrifuged onto slides
and fixed in cold acetone for 5-10 minutes. In a moist box, 50-75pi 1:20 blocking
serum in PBS was added and slides incubated at 37°C for 30 minutes. The type of
blocking serum was determined by the species from which the secondary antibodies
were derived. After two washes in PBS, excess moisture was removed and the same
volume of the desired primary antibody was added (for details on antibodies used see
Chapter 3 and 6). This process was repeated for the FITC-conjugated secondary
antibody (1:40) (Dako Ltd, Ely, UK and SAPU, Carluke, UK). The slides were
mounted with Citifluor (UKC Chem. Lab., Canterbury, UK) and viewed under a UV
microscope.
2.3.3 Determination of cell morphology by Leishman's staining
Cell suspensions (at a density of 5 xl05/ml) were cytocentrifuged onto slides
and cell morphology was revealed by staining the cells with Leishman's stain. For
this, slides were incubated in undiluted Leishman's stain for 2 minutes followed by
an incubation of 10 minutes in Leishman's stain diluted 1:2 with water. After rinsing
in water and once dry the slides were mounted with Coverbond mounting media
(American Scientific Products, McGraw Park, IL.). The cells were then examined by
light microscopy
2.3.4 BLT (benzyloxycarbonyl-L-lysine thiobenzyl) esterase assay
The BLT esterase assay was used to identify cells expressing the cytotoxicity-
associated enzyme, BLT esterase - a tryptase. This assay reveals the presence of the
serine protease (tryptase) in cytoplasmic vesicles or granules. It is detected as a
yellow stain that can be seen in cells by microscopy or measured in lysed cells or
cell-free supematants by absorbance at 412nm.
BLT esterase detection by cytochemistry:
Cytocentrifuge preparations were made from a cell sample of each cell line and cells
were fixed with cold acetone for 5 -10 minutes. The assay was performed by
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incubation of slides in BLT buffer (4.2mg BLT ester in 50ml, 0.2M Tris pH8.1 +
0.02% Fast Blue) at 37°C for 30 minutes. After thorough washing of slides the cells
were counter-stained with haematoxylin for 2mins and observed under a light
microscope. BLT esterase is identified by a yellow stain in the cytoplasmic vesicles
or granules.
BLT esterase quantification in cell lysates:
In the IL-15 dose-response assays (see Chapter 3.2.7), 50pl of culture supernatant
and cell lysate (from 10% of the total population of cells per well) were taken to
measure the BLT esterase content. To each sample, 200pl of 0.3mM BLT ester,
0.3mM dithio-bis-2-nitrobenzoic acid in PBS pH7.2 was added (at saturating
substrate concentration as described by Haig et al, 1996). Following an incubation
of 1 hour at 37°C in 97-well flat-bottomed plates, the reaction was stopped by the
addition of 5pl, 5mM 'Pefabloc' (Boehringer Mannheim, Mannheim, Germany).
BLT esterase levels were quantified by absorbance at 412nm on an ELISA plate
reader.
2.3.5 Immunocytochemistry
Immunocytochemistry was performed on cytocentrifuge preparations of fixed
cells for the detection of IL-15-producing cells (see Chapter 3).
After an initial wash in PBS/0.05%Tween 80 the cells were incubated in 1:50
normal horse serum and normal rabbit serum in PBS/high salt buffer (0.5M NaCl in
PBS) for 30mins at 25°C to block non-specific antibody binding sites. Normal goat
IgG was used as negative control. Cells were incubated for 30 minutes at 25°C in
goat anti-human IL-15 (Santa Cruz Biotechnology, Santa Cruz, CA), specific for a
carboxy terminal peptide of the human IL-15 precursor, diluted in PBS/high salt over
a range of concentrations (for details see Chapter 3.2). Following two 10 minute
washes in PBS/Tween80, the cells were incubated as before in a biotinylated
secondary antibody diluted in PBS/high salt. A Vectastain ABC-alkaline
phosphatase kit and Vector Red substrate (Vector Laboratories, Peterborough, UK)
was used to detect bound antibodies.
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2.4 Protein analysis
2.4.1 Activation of cells, preparation of cell lysates and
immunoprecipitates
5 xlO6 or 107 LGL cells (grown with or without hrIL-2) were washed twice in
serum-free medium (IMDM) then allowed to rest for 5 minutes at 37°C. For
maximal stimulation of T cells different concentrations of concanavalin A (conA) (a
T cell mitogen) ± TPA (a phorbol ester) were added for varying lengths of time at
37°C in lml serum-free medium (for details see Chapter 4). Stimulation was stopped
by rapid removal of medium from the cell pellets and then placing the tubes on ice.
For immunoprecipitations, lml cold lysis buffer (1% Triton X-100 or IGEPAL-
CA630, lOmM Tris pH7.2, 150mM NaCl, ImM activated Na3V04, ImM NaF)
containing protease inhibitors ('Complete™', Boehringer Mannheim, Mannheim,
Gennany) was added to cell pellets and mixed by vortexing for 10 seconds. Cell
lysates to be used for the detection of proteins in whole lysates were lysed in 50-
lOOpl of lysis buffer. The protease inhibitors came in the form of a tablet that is
dissolved in 25mls of lysis buffer prior to use. This tablet contained an mixture of
serine, cysteine and metalloprotease inhibitors (the manufacturers were unwilling to
specify the identity of the inhibitors used in this tablet). After 20 minutes on ice the
samples were vortexed and passed through a 26G needle and returned to ice.
Another 20 minutes later cellular debris was removed from the lysates by
centrifugation at 12000 x g for 15 minutes. Protein concentrations in the 50-1 OOpil
lysates as determined by the 'Pierce' assay (Chapter 2.4.8) were between 10-14mg/ml
and in the lml lysates between l-2mg/ml.
To minimise immunoprecipitation of non-specific proteins, each cell lysate
was cleared by adding an agarose-IgG complex made from lOpl normal whole serum
(from the same species as the precipitating antibody) added to 20pl 'protein A/G-
PLUS-agarose' (Santa Cruz Biotechnology, Santa Cruz, CA). This mixture was
incubated at 4°C for 30minutes and the IgG-agarose complexes removed by
centrifugation at 12000 x g for 30s. Specific proteins were immunoprecipitated from
the cleared lysate using specific antibodies at the concentrations shown in Chapter 4.
After a lhr incubation at 4°C, all primary antibody-antigen complexes were
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precipitated by the addition of 20pl 'protein A/G-PLUS-agarose' (Santa Cruz
Biotechnology, Santa Cruz, CA) for 1 hour or overnight at 4°C with constant
agitation. The resulting protein-agarose complexes were washed three times by
repeated resuspension in lysis buffer and centrifugation at 10000 x g for 30seconds.
Agarose pellets were either boiled in reducing Laemmli sample buffer (for use in
Western blot analysis - Chapter 2.4.4) or used in phosphotransferase assays (Chapter
2.4.5).
2.4.2 Sodium dodecylsulphate - polyacrylamide gel electrophoresis
(SDS-PAGE)
The separation of proteins was performed on the Mini Protean II system
(BIO-RAD, Hemel Hempstead, UK) by the method described by Laemmli (1979).
Briefly, samples (whether whole cell lysates or immunoprecipitated material) were
boiled in reducing Laemmli sample buffer (62.5mM Tris-HCl pH7.8, 10% w/v
sucrose, 2% w/v SDS, 0.001% w/v bromophenol blue, 5% v/v (3-mercaptoethanol
prior to loading onto gels. Depending on the molecular weight of the protein of
interest, proteins were separated on a 10%, 12% or 15% acrylamide gel made in
separating gel buffer (0.375M Tris-HCl pH8.8, 1% w/v SDS, 0.1% v/v TEMED,
0.1% w/v ammonium persulphate (APS)) at 200V for 45-50mins in tank buffer
(25mM Tris, 200mM Glycine, 5mM SDS). The separating gel was overlaid with a
4% acrylamide stacking gel made in stacking gel buffer (0.15M Tris-HCl pH6.8,
0.5% (w/v) SDS, 0.2% (v/v) TEMED, 0.2% (w/v) APS) at all times.
Separation of proteins by Serva Blue-SDS-PAGE:
This method of SDS-PAGE was used for the separation and purification of
recombinant proteins (see Chapter 5). The use of Serva Blue (a dye that binds to
proteins) in the upper tank buffer allows protein bands to be visualised in the gel
during separation and without using harsh fixatives as in Coomassie blue staining
(see Chapter 2.4.3).
Samples in non-reducing Laemmli sample buffer (62.5mM Tris-HCl pH7.8,
10% sucrose, 2% SDS, 0.001% bromophenol blue) were loaded into a single large
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well on a BIORAD Mini Protean II system using a thick comb (1.25mm). Up to
400pl total volume was loaded per gel. The upper tank was filled with cathode
buffer (3.08g/l Tris, 14.4g/l glycine, 0.05% SDS, 24mg/l Serva Blue - Sigma
Aldrich, Gillingham, UK) and the lower tank filled with tank buffer as for a
traditional SDS-PAGE. Molecular weight standards (BioRad, Hemel Hempstead,
UK) were loaded in a small well at the end of the gel to help with identification of
proteins. Once identified, the relevant protein band was excised from the gel and
stored at -70°C until required.
2.4.3 Protein detection in SDS-PAGE gels
Proteins in SDS-PAGE gels were detected by Coomassie brilliant blue
solution (Sigma Aldrich, Gillingham, UK) or silver staining. For Coomassie staining
of proteins, gels were incubated in Coomassie Blue solution for 10 minutes, with
agitation. Non-specific staining was removed by several washes in de-stain (30%
(v/v) methanol, 12% (v/v) acetic acid). For a more sensitive detection method, silver
staining was used. Firstly, the proteins in the gel were fixed with silver stain 1st fix
(50% v/v methanol, 10% v/v acetic acid) for 30 minutes followed by 15 minutes in
silver stain 2nd fix (5% v/v methanol, 7% v/v acetic acid). After a 10 minute wash in
distilled water (DW) the proteins were reduced in dithiotreitol (DTT, 5pg/ml) for 15
minutes and washed again in DW. The gel was stained with 0.1% silver nitrate
solution for 20 minutes and rinsed in DW several times. Proteins were developed in
silver stain developer (0.3M sodium carbonate, 0.02% w/v formaldehyde). To stop
the reaction citric acid powder was added (to a final concentration of 0.1M) to
lOOmls of developer.
2.4.4 Western blot analysis
Proteins were transferred to a nitro-cellulose membrane (Schleicher &
Schuell, Germany) by semi-dry western blot. The gel and membrane were
sandwiched between several sheets of filter paper soaked in transfer buffer (25mM
Tris, 200mM glycine, 5mM SDS) and then placed in the western blot apparatus.
Transfer took place at 70mA per gel for 3 hours. The membrane was blocked with
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5% non-fat milk (Marvel) in wash buffer (WB) (0.5M NaCl, 0.5% (v/v) Tween 80 in
PBS) for 30 minutes to lhour. The membranes were incubated in the desired
primary antibody for 1 hour then HRP-conjugated secondary antibodies (Dako Ltd,
Ely, UK) diluted 1:2000 in wash buffer for 1 hour. Between the blocking, primary
and secondary antibody stages, thorough washing in 20-30mls of wash buffer was
performed for at least 30 minutes with constant agitation. All membranes were given
a brief rinse in PBS prior to detection of HRP by enhanced chemiluminescence -
ECL (Amersham International, Little Chalfont, UK) or TMB stabilised substrate
(Promega UK Ltd, Southampton, UK).
For the detection of primary antibodies via an alkaline phosphatase
amplification system, a 1:2000 dilution of goat anti-mouse IgG conjugated to
alkaline phosphatase (Upstate Biotechnology Inc (UBI), Lake Placid, NY) was
prepared in wash buffer. Membranes were incubated in this mixture for 1 hour.
After a wash in wash buffer for at least 30 minutes followed by several rinses in
PBS, the membrane was developed in alkaline phosphatase substrate solution (1%
nitro-blue tetrazolium (NBT), 1% bromochloroinodyl phosphate (BCIP) - of stock
solution as supplied by UBI - in lOOmM Tris pH 9.5, lOOmM NaCl, 5mM MgCl2) at
room temperature until bands were visible (approximately 10-30 minutes). The
enzyme reaction was terminated by washing the membrane in distilled water.
2.4.5 Determination of protein kinase activity
Phosphotransferase assay for protein kinases (as used in Chapter 4):
Protein kinases were immunoprecipitated as described in Chapter 2.4.1 and
using specific antibodies at the concentrations shown in Chapter 4. The precipitated
samples were washed three times in lysis buffer then twice in kinase buffer (20mM
Tris/HCl pH7.5, lOmM MgCU 5mM MnCh) prior to use in the phosphotransferase
assay.
The activation of kinases was assayed by the transfer of radioactively labelled
phosphate groups in [y-32P]-ATP (Amersham International, Little Chalfont, UK) to
the src kinase substrate, acid-treated enolase (rabbit muscle enolase, Sigma Aldrich,
Gillingham, UK). For acid treatment, the enolase was resuspended to 10pg/p,l in
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enolase buffer (50mM HEPES pH7.0, ImM DTT, ImM MgCb) and incubated on ice
for 30-60 minutes. Prior to use, an equal volume of 50mM acetic acid was added
and the mixture was incubated at 30°C for 5 minutes then neutralised with 20mM
HEPES.
Protein-agarose pellets were resuspended in 25pl kinase buffer containing
25pM ATP, 320pCi/ml [y-32P]-ATP and 400pg/ml acid-treated enolase. The
mixture was incubated at 30°C for 10 minutes. Samples were mixed with reducing
Laemmli sample buffer (62.5mM Tris-HCl pH7.8, 10% sucrose, 2% SDS, 62.5mM
Tris-HCl pH7.8, 10% sucrose, 2% SDS, 0.001% bromophenol blue, 5%
P-mercaptoethanol) for a further 20 minutes at room temperature then boiled for 5
minutes before proteins were separated by SDS-PAGE using 10% or 12%
acrylamide gels (Chapter2.4.2). To detect the molecular weight markers and to
check for protein loading the acrylamide gel was stained with Coomassie brilliant
blue (Chapter 2.4.3). The gel was then dried and exposed to X-ray film for between
2-16 hours, depending on the incorporation of isotope. Kinase activity was detected
as a band of y-32P phosphorylated substrate (enolase) at 48kDa. To quantify the
incorporation of y-32P into enolase, enolase bands were excised from the gel and
radioactivity measured by P-scintillation counting on a Tri-Carb liquid scintillation
analyzer (Packard, Meriden, CT.) Incorporation of radioisotope into enolase was
calculated for each sample as follows:
c.p.m. (enolase + kinase) - c.p.m. (enolase without IP kinase)
[note: IP = immunoprecipitated, c.p.m. = counts per minute]
2.4.6 Electroelution of recombinant proteins
Recombinant proteins separated by Coomassie Blue SDS-PAGE (see Chapter
2.4.3) can be collected from acrylamide gels by application of a current through the
excised protein bands. First, gels containing the excised protein band were roughly
chopped and placed in the cathode (-ve/ upper) chamber of a BIORAD electroelution
unit. Both chambers and the tank unit were filled with tank buffer (25mM Tris,
200mM Glycine, 5mM SDS). A current of 50mA was applied for approximately 30
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minutes or until all the blue dye (protein) had moved from the upper to the lower
chamber. The electroeluted material was collected, washed in Vivaspin
concentrators (with a lOkDa cut-off membrane) (Vivascience, Lincoln, UK) with
PBS and stored at 4°C.
2.4.7 Affinity purification of rabbit polyclonal sera on a protein A-
sepharose column
Whole serum was purified on a protein A-sepharose column by FPLC (fast
TVI
performance liquid chromatography) (Pharmacia ' ).
The serum was first diluted 1:2 in PBS followed by filtration through a
0.45pm filter. A small 3-5ml column of protein A- sepharose was packed and
washed thoroughly with equilibration buffer (50mM Tris, 150mM NaCl, 0.02%
azide, pH8.4). Several bed volumes of elution buffer (lOOmM glycine, 150mM
NaCl, 0.02% azide, pH3) and equilibration buffer were passed over the column to
remove any material bound to the column. After a final wash in equilibration buffer,
0.5-lml of filtered serum was loaded onto the column. The flow through (unbound
proteins) was collected. At this stage the O.D.280 was monitored for all fractions
collected to detect proteins. The column was washed through with equilibration
buffer until the O.D.280 returned to baseline and all unbound proteins were eluted.
IgG bound to the column was removed using elution buffer passed through the
column at a rate of lml/min. Eluted samples were detected by the rise in O.D.280, the
relevant fractions collected and immediately neutralised with 1M Tris, pHlO.
Samples were either tested for reactivity against the original antigen or aliquoted and
stored (in PBS/0.05% azide, pH7.5) at -20°C for future use. Finally, the column was
cleaned and washed with several cycles of equilibration and elution buffer followed
by a final wash in PBS/0.02% azide, pH7.5. This column was stored at 4°C until
required.
2.4.8 Determination of protein concentration by the 'Pierce BCA assay'
The reaction of protein with copper ions and bicinchoninic acid (BCA) - the
two reagents in this assay- produces a change in colour that can be measured by
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absorbance at 540nm (Smith et al, 1985). The method used was as described in the
manufacturer's protocol (Pierce, Rockford, IL). Briefly, lOpl of the test sample was
placed in duplicate wells of a 96-well flat-bottomed plate. Bovine serum albumin
(BSA) was also placed in duplicate wells and prepared in the same buffer as the test
sample over a concentration range of 0.05 - 2.0 mg/ml. To each well 200pl of the
Pierce reaction mix (one part 4% w/v CuSCC in 50 parts BCA solution) was added
and mixed thoroughly. The plate was wrapped in film and incubated at 37°C for 30
minutes. Colour change was detected by absorbance at 540nm. The standard curve
of BSA concentration against OD540 was used to determine the concentration of the
test sample.
2.5 Molecular biology techniques
2.5.1 Preparation of total cellular RNA
Cells from control and MCF virus-infected cell cultures were pelleted and the
medium was removed. The cell pellets (containing up to 107 cells) were
homogenised in 5ml of RNA extraction buffer (23.6g of guanidine isothiocyanate
(GTC), 0.36ml (3-mercaptoethanol, 5ml of 250mM sodium citrate pH7, 2.5ml of 10%
w/v N-lauroylsarcosine, 47ml of water) using the technique described by Chirgwin et
al (1979). Half a milliliter of 2M sodium acetate pH 4.8 were added followed by
5ml of water-saturated phenol and 1ml of chloroform: isoamyl alcohol (24:1) and the
mixture shaken vigorously for 5 minutes. After 10 minutes on ice, the solution was
centrifuged at 12000 x g for 30 minutes at 4°C. The aqueous phase containing the
RNA was removed and the RNA precipitated by the addition of 5ml of isopropanol.
The precipitate was pelleted and dissolved in 0.5ml RNA extraction buffer. 0.5ml of
isopropanol was added and the mixture was incubated at -70°C for 30 minutes. The
resulting precipitate was then pelleted, washed in 70% ethanol and resuspended in
100 pi of autoclaved water.
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Quantification of RNA:
Nucleic acid was quantified by use of a spectrophotometer. DNA and RNA
have characteristic UV spectra, the peak of absorbance is at 260 nm, while the
absorbance at 280mn is a measure of the amount of contaminating protein which is
present (Sambrook et al 1989). The absorbance at 260nm gives a measure of the
concentration of the nucleic acid sample. An absorbance of 1 ODU260 corresponds to
a concentration of 40 pg/ml for RNA. The ratio OD260/OD280 is approximately 2.0
for pure RNA samples.
2.5.2 Analysis of gene expression by reverse transcription polymerase
chain reaction (RT-PCR)
First strand cDNA was prepared from total cellular RNA using Expand1 M
reverse transcriptase (Boehringer Mannheim, Mannheim, Germany). Specific
sequences within the cDNA were then amplified using the polymerase chain
reaction.
2.5.2.1 cDNA synthesis
Total cellular RNA (5 pg) and 2 pi (lpg) of primer (random hexamers -
Promega UK Ltd, Southampton, UK) was placed in a tube and made up to a total
volume of 10 pi with sterile distilled water. To remove the secondary structure and
allow annealing of the primer to cellular RNA the mixture was heated to 65°C for 10
minutes then allowed to cool on ice. The following were then added in the order
indicated, 4pl of 5x Expand™ RT buffer (250mM TRIS-HC1, 25mM MgCl2,
200mM KC1, 2.5% Tween 20, pH 8.3250mM TRIS-HC1, 25mM MgCl2, 200mM
KC1, 2.5% Tween 20, pH 8.3), 2pl lOOmM DTT, 2pl lOmM dNTPs, 0.5 pi of RNase
inhibitor (Promega UK Ltd, Southampton, UK) and lpl (50 units) of Expand™
reverse transcriptase (RT) - a final volume of 20pl. The mixture was carefully mixed
and incubated for 10 minutes at 30°C followed by 45 minutes at 42°C. The reaction
was stopped by placing on ice. The sample was then ready for PCR amplification or
stored at -20°C for later use.
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2.5.2.2 Polymerase chain reaction (PCR)
PCR amplification was performed using the Expand1 M long template PCR
system (Boehringer Mannheim, Mannheim, Germany). The reaction was set up in a
total volume of 50 pi as follows, 3pi cDNA from the 20pl RT reaction, 5pl lOx PCR
buffer (Boehringer PCR buffer 3 containing 22.5mM MgCh and detergents, pH9.2),
lpl of each primer at 2pM, 2.5pl lOmM dNTPs, 37pl water and 0.75pl Taq DNA
polymerase mix (Boehringer Mannheim, Mannheim, Germany). 30 pi of mineral oil
was added and the tubes placed in a Hybaid Omnigene thermal cycler.
PCR reactions involved one cycle of denaturation at 93°C for 2 minutes. A
further 10 cycles consisted of denaturation at 93°C for 10 seconds, followed by 30
seconds at an annealing temperature calculated to be 10°C below the melting
temperature (Tm) of the two oligonucleotide primers, followed by 5 minutes
elongation at 68°C. The next 15 cycles involved the same conditions for
denaturation and annealing. For higher yields, the elongation step was increased by
20 seconds for each subsequent cycle. A final cycle with a prolonged elongation step
of 7 minutes was performed.
Eight microliter samples of the amplified products were analysed on agarose
gels and their identity confirmed by digestion at internal restriction sites or by
Southern blot and hybridisation to specific probes.
2.5.2.3 Agarose gel electrophoresis of PCR products
DNA fragments resulting from PCR amplification were analysed by
conventional agarose gel electrophoresis. Agarose concentration was 1 % w/v and
gel dimensions were either 10x7 cms or 20x20 cms. Electrophoresis buffer was TBE
(45mM Tris/borate, ImM EDTA pH7.3) and gels were run at 75 volts for one hour
(10x7cm gels) or at 15V overnight (20x20cm gels). Ethidium bromide was added to
a final concentration of 0.5pg/ml and the DNA fragments were visualised by their
fluorescence under UV illumination. A permanent record was obtained by
photographing the gels on heat sensitive paper (Mitsubishi video copy processor,
UVP). The size of the DNA fragments was determined by comparison with known
standards (lkb ladder - Promega UK Ltd, Southampton, UK).
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2.5.2.4 Southern blot analysis
After electrophoresis in agarose gels, DNA was transferred to Hybond-N
membranes (Amersham International, Little Chalfont, UK), using a modification of
the crush blot method of Smith and Summers (1980). The DNA was denatured in
0.5 M NaOH/1.5 M NaCl for 30 minutes. The gel was transferred to a 1M
ammonium acetate/0.02M NaOH solution. After 1 hour, the gel was removed and a
piece of Hybond-N, cut slightly bigger than the gel, was placed on top of the gel.
Three pieces of 3MM filter paper were cut to the same size as the gel, soaked in the
ammonium acetate and placed on top of the membrane. A 10 cm thickness of paper
towel was positioned on top of the filter paper and finally a weight was placed on top
of the towels. The blot was left overnight for the DNA transfer to take place by
capillary action. The next day, the membrane was air-dried and the DNA fixed to the
Hybond membrane in a Hybaid UV cross-linker at 70,000 joules/cm2.
Hybridisation of labelled internal probe for IL-15 to immobilised DNA:
An internal IL-15 cDNA probe representing residues 231-270 based on the
sequence of bovine IL-15 was labelled with digoxygenin (DIG). DIG labelling and
subsequent hybridisation followed the manufacturer's protocol (Boehringer
Mannheim, Mannheim, Germany). The hybridisation fluid was 5xSSC (750mM
NaCl, 75mM sodium citrate) containing 0.1% w/v blocking reagent (Boehringer
Mannheim) and 0.02% SDS. Following hybridisation, the membranes were washed
to remove unbound probe. The membranes were washed at high stringency with
O.lxSSC and 0.1% SDS at 65°C.
Detection of bound DIG labelled probe for IL-15:
DIG labelled probe that had hybridised to an immobilised target was detected
immunochemically using a commercial kit (Boehringer Mannheim, Mannheim,
Germany). Non-specific binding was blocked by incubating the membrane for 30
minutes in Tris buffered saline (TBS) (lOOmM Tris/HCl, 150mM NaCl) containing
0.5% (w/v) blocking reagent (Boehringer Mannheim). The membranes were then
transferred to TBS containing a 1:5000 v/v dilution of an anti-DIG alkaline
phosphatase conjugate for 60 minutes. Unbound conjugate was removed by two 15
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minute washes in TBS. The filters were then equilibrated in lOOmM Tris/HCl,
150mM NaCl, 50mM MgCl2, pH 9.5. The enzyme substrates were then added, 45pl
NTB (75 mg/ml nitroblue tetrazolium salt in dimethylformamide) and 35pl X-
phosphate (50mg/ml in 5-bromo-4-chloro-3-indolyl phosphate toludinium salt in
dimethylformamide). The filters were left in the dark for a few hours to allow the
purple colour to develop fully. The reaction was stopped by washing in Tris/EDTA
(TE) buffer (lOmM Tris pH 7.5, ImM EDTA).
2.5.3 Expression of recombinant AIHV-1 proteins in E. coli
2.5.3.1 Amplification of AIHV-1 ORF 50, A6 and A7 and ligation into pTrXFus.
For the expression of AIHV-1 proteins in E.coli (see Chapter 5) the
ThioFusion™ Expression System (Invitrogen, Groningen, Netherlands) was used.
The vector pTrXFus contains the following restriction sites - Kpn I, Srna I, BarnH I,
Xba I, Acc I, Sal I, Pst I. The primers used are detailed in Chapter 5.
In order to ligate the PCR products to the pTrXFus vector DNA and the insert
DNA were first digested with two restriction enzymes (see Chapter 5). The
restriction enzymes were purchased from Boehringer Mannheim (Mannheim,
Germany) and used with the accompanying buffers following the manufacturer's
instructions. The final concentration of each enzyme was 5units/pg of DNA, which
represents an excess of enzyme. The enzymes made up 10% of the total reaction
volume to remove any damaging effects of glycerol on enzyme activity. Reaction
volume was adjusted to 20 pi and digestions were incubated at 37°C for lhr.
Approximately lOOng of vector or insert DNA was used for each reaction. The
digests were extracted using phenol/chloroform and precipitated using ethanol. The
digested DNA was then resuspended in O.lx TE buffer (lOmM Tris pH 7.5, ImM
EDTA) to a concentration of lOOng/pl.
Ligation of DNA was performed using T4 DNA ligase. The enzyme
catalyses the formation of a phosphodiester bond between a 5' phosphate group and a
3' hydroxyl group resulting in the covalent linking of two DNA molecules that have
compatible ends produced by restriction enzyme digestion. Ligation reactions were
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set up in 20 pi total volume containing lOOng of vector, insert DNA at an insert :
vector ratio of 4 : 1, 2 pi of 1 Ox DNA ligase buffer (660mM Tris/HCl, 50mM MgCL,
lOmM DTT, lOmM ATP, pH 7.5) and 2 units of T4 ligase (Boehringer Mannheim,
Mannheim, Germany). Reactions were incubated at 37°C for 2 hours or at 12°C
overnight.
2.5.3.2 Preparation of competent E. coli
E. coli, strain JM109, (Yannitch-Perron et al 1985) were streaked on LB
plates and incubated overnight at 37° C. A single colony was picked and used to
inoculate 100 ml of LB broth. The bacteria were allowed to grow to an OD600 of 0.5
to 0.6 when the cells were transferred to pre-chilled tubes and incubated on ice for 10
min. The bacteria were then centrifuged in a Beckman rotor J2-21 at 4000 x g for 10
min. The media was decanted and the cells resuspended in ice cold 0.1M CaCh and
then placed on ice for 30 min. The bacteria were pelleted again at 4000 x g for 10
min and then resuspended in a volume of ice cold 0.1MCaCl2 containing 15% (w/v)
glycerol corresponding to 1/ 50 of the original volume of medium. The bacteria
could then be used directly or stored at -70° C. E. coli, strain G1724 (Invitrogen,
Groningen, Netherlands) was prepared in a similar manner but was grown on RM
plates or broth. Table 2.2 shows the recipes for media used for the growth and
induction of E.coli in recombinant protein expression.
2.5.3.3 Transformation of competent E. coli with plasmid DNA
The E. coli strain JM109 was used as a standard strain for the expression of
high yields of recombinant proteins. The G1724 strain was supplied with the vector
pTrXFus. This expression system is induced by the addition of tryptophan and was
chosen for its ability to express high yields of soluble proteins.
A 50pl aliquot of the frozen stock of competent bacterial cells (G1724 for
thioredoxin recombinants and JM109 for GST recombinants) was thawed on ice.
The ligation reaction (approximately 50ng of DNA) was added and the mixture held
on ice for 30 minutes, after which it was heat-shocked at 42°C for 2 minutes. The
transformed G1724 cells were spread on low tryptophan RMG-agar (Invitrogen,
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Groningen, Netherlands) plates containing 100p,g/ml ampicillin and 0.5% glucose
then incubated at 30°C, overnight. The low tryptophan agar inhibits induction of
protein expression. The trans formed JM109 cells were spread on LB plates
containing 50pg/ml ampicillin and incubated at 37°C overnight.
2.5.3.4 Selection and growth of ampicillin resistant colonies
One ampicillin resistant colony was inoculated into 1ml RM medium
(Invitrogen) (for G1724 cells) or LB-broth (for JM109 cells) containing lOOpg/ml or
50pg/ml ampicillin respectively. G1724 cells were incubated at 30°C as growth of
G1724/pTrX transformed bacteria at >30oC leads to uncontrolled expression, which
may cause plasmid rearrangements and deletions. Transformed JM109 cells were
grown at the standard temperature of 37°C. Cells were incubated overnight with
constant agitation.
Table 2.2: Media used for growth and induction of E. coli
Medium Recipe
LB Broth 1% (w/v) Tryptone, 0.5% (w/v) yeast extract, 0.5% (w/v) NaCl.
L-agar As LB plus 15g/l Difco agar.
RM Media 16.7mM Na2HP04, 22mM KH2P04, 8.5mM NaCl, 18.7mM
NH4C1, ImM MgCl2, 0.2% (w/v) Casamino acids.
RMG-agar As RM plus 2% Casamino acids, ImM MgCl2, 1.5% agar.
Induction Media As RM plus 0.5% glucose.
All media were sterilised by autoclaving for 15 minutes at 1.05kg/cm . Ampicillin
was added to the media after autoclaving. Reagents were supplied by Invitrogen,
Groningen, Netherlands.
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2.5.3.5 Induction of protein synthesis
50pl of the overnight culture of G1724 cells were added to lOmls of
induction medium (Invitrogen) containing lOOpg/ml ampicillin and 0.5% glucose.
Similarly, JM109 cells were added to lOmls of L-broth containing 100pg/ml
ampicillin. Again, G1724 cells were incubated at 30°C while JM109 cells were
grown at 37oC, with agitation, for approximately 3 hours, until OD600 of 0.3 - 0.5
was reached. Thioredoxin fusion proteins were induced by addition of lOOpg/ml
(final concentration) tryptophan while GST fusion proteins were induced by the
addition of 100p,g/ml (final concentration) IPTG (isopropyl-l-thio-P-D-galactoside).
Incubation at 37°C proceeded for 4 hours. Once induction was complete cells were
centrifuged and lysed for collection of proteins. Alternatively, cell pellets were
stored at -20°C until required.
2.5.3.6 Harvesting recombinant fusion proteins from E. coli
Cell pellets were resuspended in lml 20mM Tris pH8/ 2.5mM EDTA. To
this, 100p.g/ml lysozyme, 0.1% Triton X-100 and 5pg/ml leupeptin (a protease
inhibitor) was added and the mixture incubated at 30°C for 30 minutes. MgCl2 was
then added to a final concentration of 8mM. DNA and RNA were removed from the
lysate by the addition of 50U DNasel (Boehringer Mannheim, Mannheim, Germany)
and RNase to a final concentration of 10p.g/ml then allowed to incubate on ice for 30
minutes. Soluble and insoluble proteins were separated by centrifugation at 13000 x
g for 10 minutes. The insoluble pellet was resuspended in lOOpl reducing Laemmli
sample buffer (62.5mM Tris-HCl pH7.8, 10% sucrose, 2% SDS, 0.001%
bromophenol blue, 5% p-mercaptoethanol). An equal volume of 2x reducing
Laemmli sample buffer was added to 10pl of the supernatant containing the soluble
proteins. A total of 20pl supernatant samples and lOpl pellet samples were analysed
by SDS-PAGE (see Chapter 2.4.2) and the gel stained with Coomassie blue to detect
the presence of recombinant proteins. Recombinant proteins were identified by
Western blotting analysis (see Chapter 2.4.4) using an anti-thioredoxin (Invitrogen,
Groningen, Netherlands) or an anti-GST antibody (Amersham, Little Chalfont, UK).
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2.6 Statistical Analysis
Data generated for Figs 3.6 and 3.7 were analysed by analysis of variance (ANOVA)
using the data analysis software, 'Minitab'. ANOVA was felt to be the most
appropriate method of statistical analysis and is very similar to the Student's t-test.
ANOVA has the advantage over the Student's t-test in that the risk of spurious results
arising from multiple testing is removed. This outweighed any potential problem
with the use of ANOVA - the most serious of these being the assumption of constant
variance in all subgroups within the analysis. However, any heterogeneity of
variance would be unlikely to affect the results of these analyses seriously.
2.7 Frequently used reagents
Coomassie blue de-stain







30% (v/v) methanol, 12% (v/v) acetic acid
660mM Tris/HCl, 50mM MgCB, lOmM DTT,
lOmM ATP, pH 7.5
lOOmM glycine, 150mM NaCl, 0.02% azide, pH3
50mM Tris, 150mM NaCl, 0.02% azide, pH8.4
250mM TRIS-HC1, 25mM MgCl2, 200mM KC1,
2.5% Tween 20, pH 8.3
62.5mM Tris-HCl pH7.8, 10% sucrose, 2% SDS,
0.001% bromophenol blue ± 5%
P-mercaptoethanol
1% Triton X-100 or IGEPAL-CA630, lOmM Tris
pH7.2, 150mM NaCl, ImM activated Na2V04*,
ImM NaF
150mM NaCl, 200mM KC1, lOmM Na2HP04,
2mM KH2P04
♦
For the maximal inhibition of protein tyrosine phosphatases by Na2V04, the stock
solution needs to be activated prior to use. The initial solution was adjusted to
pHlO.O (and appears yellow) then boiled until it turns colourless. These steps were
repeated until the solution remains colourless at pHlO.O. This procedure
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0.5M NaCl in PBS
23.6g of guanidine isothiocyanate (GIT), 0.36ml [3-
mercaptoethanol, 5ml of 250mM sodium citrate
pH7, 2.5ml of 10% w/v N-lauroylsarcosine, 47ml
water
0.375M Tris-HCl pH8.8, 1% SDS, 0.1% (w/v)
TEMED, 0.1% (w/v) ammonium persulphate (APS)
50% (v/v) methanol, 10% (v/v) acetic acid
5% (v/v) methanol, 7% (v/v) acetic acid
0.3M sodium carbonate, 0.02% (w/v) formaldehyde
750mM NaCl, 75mM sodium citrate
0.15M Tris-HCl pH6.8, 0.5% (w/v) SDS, 0.2%
(v/v) TEMED, 0.2% (w/v) APS
25mM Tris, 200mM Glycine, 5mM SDS
45mM Tris/borate, ImM EDTA pH7.3
lOOmM Tris/HCl, 150mM NaCl
lOmM Tris pH 7.5, ImM EDTA
50mM Tris, 40mM Glycine, ImM SDS
0.5M NaCl, 0.5% (v/v) Tween 80 in PBS
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Chapter 3
Phenotypic characterisation of MCF virus-infected
LGL cell lines: response to IL-15
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3.1 Introduction
Lymphocyte cell lines have been generated in tissue culture from the tissues
of animals naturally and experimentally infected with MCF viruses. These cell lines
can be maintained for months or even years and display the morphology of large
granular lymphocytes (LGLs) (Fig 3.1). Previous phenotypic analyses of these cell
lines demonstrated that they exhibited a T cell or NK cell phenotype. In addition,
these LGLs were shown to have cytotoxic activity towards a variety of primary and
established monolayer cell cultures. This cytotoxicity was non-MHC restricted and
non-antigen specific (Burrells and Reid 1991; Cook and Splitter, 1988; Reid et al,
1983, 1989; Schock and Reid, 1996; Schock et al, 1998). Furthermore, it was shown
that high cell densities and occasionally feeder monolayer cells (fibroblasts) were
also important for the maintenance of the LGLs in tissue culture (Reid et al, 1989).
For optimum growth, exogenous IL-2 was routinely added to cultures. These cells
were described as lymphokine activated killer (LAK) cells and expressed IL-2Ra
(Cook and Splitter, 1988; Schock et al, 1998). However, LGLs could also be
maintained in the absence of exogenous IL-2 for days, weeks and sometimes months.
Interestingly, OvHV-2-infected bovine LGLs did not express IL-2 mRNA even after
stimulation with concanavalin A (conA) (Schock et al, 1998) and LGL culture
supernatants did not display detectable levels of IL-2 activity (Schock, 1996). This is
in contrast with normal uninfected T cells that produce IL-2 when activated (Meuer
et al, 1984, Schock et al, 1998). Schock's study (1998) did however show that
bovine OvHV-2-infected LGL cell lines express mRNA for the cytokines IL-4, IL-
10, IFN-y and TNF-a but not IL-lp or IL-2. These observations raise the possibility
that endogenous growth factors other than IL-2 may maintain LGL cell survival for a
limited period of time.
Since Schock's study (1998), the cytokine IL-15 has been described as a T
cell growth factor. This cytokine was of interest to the present study as it has similar
actions to IL-2 and can induce the expression of IL-2Ra (Kumaki et al, 1996). In the
mouse and man, IL-15 promotes the proliferation of T cells and NK cells and of
relevance to the pathogenesis of MCF, induces CTL and LAK activity (Armitage et
al, 1995; Carson et al, 1994; Gamero et al, 1995; Giri et al, 1994, 1995b; Grabstein
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et al, 1994). Unlike IL-2, which is produced by T cells, IL-15 is predominantly
produced by accessory cells, including monocytes (Carson et al, 1995; Doherty et al,
1996), dendritic cells (Jonuleit et al, 1997), fibroblasts and a variety of other non-
lymphoid tissues (Grabstein et al, 1994). While T cells are not normally a source of
IL-15, transcripts of the cytokine have been detected in HTLV-1-transformed T cell
lines (Azimi et al, 1998). Induction of IL-15 expression by peripheral blood
mononuclear cells (PBMC) in human herpesviruses 6 and 7 (HHV-6 and HHV-7) -
infected individuals (Atedzoe et al, 1997; Flamand et al, 1996) has also been
reported. These observations prompted the question of whether MCF-virus infection
can also upregulate IL-15 expression in LGL cells and thus explain the IL-2
independent phenotype observed in LGL cell lines.
In this study, MCF virus-infected LGL cell lines established from naturally
infected cattle and experimentally infected rabbits were characterised in a series of
phenotypic assays and compared to control uninfected lymphoblasts. In particular,
the hypothesis that MCF virus-induced IL-15 mediates the lymphoproliferation and
cytotoxic activity of the LGLs was tested. The objectives of this study were as
follows:
1. To test the whether IL-15 acts as a growth factor for the LGLs.
2. To test whether IL-15 maintains or enhances the cytotoxic phenotype of the LGL
cell lines.
3. To test the production of IL-15 in LGL cell lines.
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Fig3.1: An OvHV-2 infected cattle cell line (BJ1035) showing the
morphology of large granular lymphocytes (LGLs).
Morphology of A) BJ1035 and B) bovine lymphoblasts (controls)
revealed by Leishman's staining - see chapter 3.2.2. Note the large
kidney-shaped nuclei, large cytoplasm and vacuoles/granules in A)
compared to morphology of B).
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3.2 Materials and methods
3.2.1 Cells
LGL cell lines:
BJ1035, BJ1044, BJ1104 and BJ1196 were bovine LGL cell lines derived from
natural cases of OvHV-2-induced MCF. These bovine cell lines did not survive the
course of this study due to difficulty in resurrecting the cells from liquid nitrogen
following a move to new laboratories. Therefore, new cell lines had to be
established to allow more data to be generated. These cell lines (BJ1857, BJ1859
and BJ1860) were generated from rabbits experimentally infected with OvHV-2
(BJ1857) or A1HV-1 (BJ1859, BJ1860). The rabbit cell lines BJ1001 and BJ1263
(both infected with A1HV-1) stored in liquid nitrogen were successfully resurrected
and included in these studies. Infection protocols for the LGL cell lines were as
described in Chapter 2.
Control cells:
Fresh PBMCs or conA-stimulated lymphoblasts were used as control cells. These
cells were collected from uninfected rabbit or bovine blood or lymph nodes and the
lymphoblasts were generated as described in Chapter 2.
3.2.2 Analysis of cell phenotype
Morphological analysis:
Cytocentrifuge preparations at a density of 5 x 105 cells / ml were prepared from cell
suspensions and the morphology of the LGL cell lines and the control lymphocytes
was revealed by staining of cells with Leishman's stain (Chapter 2.3.3).
FACS analysis:
All LGL cell lines and control PBMCs (bovine and rabbit) were phenotyped by
FACScan analysis (see Chapter 2.3.1) using murine monoclonal antibodies against
CD2, CD3, CD4, CD5, CD8, WC1 (expressed on y8 T cells), CD21 and CD45
(Table 3.1 and 3.2). For the characterisation of bovine cells, where bovine antigen-
specific antibodies were not available, ovine / bovine cross-reactive antibodies were
used. For the characterisation of rabbit lymphocytes, mouse monoclonal antibodies
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specific for rabbit cell surface antigens were used. It should be noted that these were
only available for a limited range of surface markers. Murine monoclonal antibodies
(of different IgG isotypes) to border disease virus (a gift from G. Entrican, Moredun
Research Institute) were used as antibody isotype controls.
BLT esterase cytochemistry and quantitation:
Cytotoxic enzyme activity over a range of IL-15 concentrations was measured by
BLT (benzyloxycarbonyl-L-lysine thiobenzyl) esterase activity. BLT esterase is a
serine protease (tryptase) induced in cytotoxic cells (Griffiths and Mueller, 1991;
Haig et al, 1996). The activity of BLT esterase is measured by an assay that relies on
an enzyme-substrate reaction between BLT esterase and BLT. The reaction
produces a yellow product that can be visualised in cells by light microscopy or
quantified by absorbance at 412nm. The BLT esterase assay was performed on
cytocentrifuge preparations, cell lysate samples (to measure intracellular enzyme)
and culture supernatant samples (to measure secreted enzyme) as described in
Chapter 2.3.4.
3.2.3 Detection of virus-specific proteins in LGL cell lines
The immunofluorescence antibody test (IFAT) was used to demonstrate the
presence of virus proteins in OvHV-2-infected cell lines and their absence in control
uninfected lymphoblasts. Cytocentrifuge preparations of LGL and control cells were
prepared as previously described (Chapter 3.2.2). Serum antibodies from a cow
('Jezebel') that survived OvHV-2 infection recognise undefined OvHV-2 proteins and
are useful as a probe for OvHV-2 infection of cells (Milne and Reid, 1990).
'Jezebel' serum was added to slides at 1:10 or 1:20 dilution in PBS for 30mins at
37°C following a blocking stage with 1:20 nonnal horse serum. Bovine serum from
a MCF-negative cow was used as a negative antibody control. After each incubation
stage the slides were washed 2 x lOmins in PBS. The anti-sheep FITC conjugate
was added at 1:50 dilution to all the slides and incubated as before.
The presence of virus proteins in A1HV-1-infected LGLs was demonstrated
by RT-PCR detection of a protein first defined by Handley (1993) as a potential
virulence factor for A1HV-1 and more recently defined as the protein encoded by
ORF50 (Ensser et al, 1997; H. Wright, personal communication). The amino acid
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sequence encoded by ORF50 has homology to the EBV R transactivator protein
produced as an immediate early gene product (Ensser et al, 1997). The details
regarding these experiments and the role of this protein in the virus life cycle are not
discussed in this Chapter but will be presented in Chapters 5 and 6.
3.2.4 Cell survival assays in the absence of exogenous cytokines
The bovine OvHV-2-infected MCF cell lines BJ1035, BJ1044 and control
bovine conA activated lymphoblasts were washed twice in IMDM to remove any
residual IL-2. Cells were then seeded at 2, 1, 0.5 or 0.25 xl06/ml IMDM, plated out
in 48-well plates at 1ml per well and incubated in a humidified atmosphere of 5%
CO2 at 37°C. Viable cell numbers were determined by nigrosine exclusion (Chapter
2.2.6) and performed every 24hrs for 4 days or longer. Cytocentrifuge samples were
also taken for the detection of BLT esterase in these cells (Chapter 3.2.2).
In addition, viable cell numbers in LGL and control cells cultured in rhIL-2-
free medium for 3 days were recorded on at least three separate occasions prior to
use in signal transduction experiments (Chapter 4).
3.2.5 Cytokine response assays
Human recombinant (hr) IL-2 expressed in E.coli (>98% purity, specific
activity 18 x 106 units/mg) was purchased from Eurocetus UK Ltd (Harefield, UK).
Human recombinant IL-15 expressed in E.coli (>98% pure, specific activity > 2 x
106 units/mg) was purchased from Peprotech EC Ltd (London, UK). After a
thorough wash in IMDM cells were set up in 48-well plates at a density of 0.5 x
106/ml in duplicate or triplicate wells (using 500pl per well). IL-2 or IL-15 was
added to each well in a range of concentrations and cells incubated under standard
conditions (see Chapter 2.2.2). Cell growth was measured as changes in viable cell
counts (measured by nigrosine exclusion - Chapter 2.2.6) after time in culture.
Based on preliminary experiments, cell growth was recorded for IL-2 and IL-15 after
3 days and 6 days in culture. 50pl volumes of lysates containing 10% of total cell
population per well (lysed in water) were taken for determination of BLT esterase
activity in cell lysates. 50pl volumes of neat culture supernatant were taken for the
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determination of BLT esterase activity secreted by cells into the culture supernatant
(see Chapter 3.2.2).
Table 3.1: Mouse monoclonal antibodies used in FACS analysis of
bovine cells.
Specificity Clone Ig Isotype Source Reference
boCD2 CC42 IgGl IAH Davis and Splitter, 1991
boCD4 CC8 IgG2a IAH Bensaid and Hadam, 1991
bo/ovCD5 CC17 IgGl IAH Howard and Leibold, 1991
bo/ovCD8 CC63 IgG2a IAH MacHugh and Sopp, 1991
boWCl CC15 IgG2a IAH Morrison and Davis, 1991
boCD21 CC21 IgGl IAH Naessens and Howard, 1991
boCD45 CC1 IgGl IAH Bembridge et al, 1993
IAH = Institute of Animal Health (Compton, UK); bo = bovine-specific; ov = ovine-
specific; WC1 = workshop cluster 1. WC1 is expressed on yS T cell receptor4" (TCR)
cells. CD21 is expressed on B cells. CD45 (also known as leukocyte common
antigen - LCA) was included as a positive control as it is present on all lymphocytes.
Table 3.2: Mouse monoclonal antibodies used in FACS analysis of
rabbit cells.
Specificity Clone Ig Isotype Source Reference
rbt.CD4 KEN-4 IgG2a Research Kotani et al, 1993
Diagnostics
rbt.CD5 KEN-5 IgGl Serotec Kotani et al, 1993
rbt.CD8 12C7 IgGl Serotec Civin et al, 1984
rbt.IgM NRBM IgGl Serotec Idogawa et al, 1997
Antibodies were obtained from Research Diagnostics Inc., Flanders, USA or Serotec
Ltd, Oxford, UK. rbt = rabbit-specific. KEN5 detects antigen on rabbit T cells. IgM
is expressed on B cells.
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3.2.6 Immunocytochemical detection of IL-15
Normal rabbit monocytes or adherent cells from peritoneal lavage and spleen
cell suspensions were grown on coverslips as a putative source of IL-15-expressing
positive controls. As fibroblasts are known to express IL-15, the mouse fibroblast
cell line LTK" (Spandidos and Wilkie 1983) was also grown on coverslips and
included as a positive control. The cells were stimulated for 24h with 10pg/ml
lipopolysaccharide (LPS from S. minnesota - Sigma Aldrich, Gillingham, UK) to
induce IL-15 production. MCF virus-infected LGLs were stimulated overnight (or
not) with lOpg/mlConA+lOng/mlTPA and cytospins prepared. Cells were fixed in
cold acetone.
After an initial wash in PBS/0.05%Tween 80 the slides were blocked in 1:50
normal horse serum and normal rabbit serum in PBS/high salt (0.5M NaCl in PBS)
for 30mins at 25°C. Normal goat IgG (at 1,5 and lOpg/ml) was used as negative
control. Goat anti-human IL-15 (L-20) (Santa Cruz Biotechnology, Santa Cruz,
USA), specific for a carboxy terminal peptide of the human IL-15 precursor, was
diluted in PBS/high salt to 1, 5 and lOpg/ml and incubation proceeded for 30
minutess at 25°C. Following 2x10 minute washes in PBS/Tween80 the biotinylated
horse anti-goat IgG antibody (2pg/ml) was added and incubated as before. A
Vectastain ABC-alkaline phosphatase kit and Vector Red substrate (Vector
Laboratories, Peterborough, UK) was used to detect bound antibodies.
3.2.7 Detection of IL-15 by western blot
Cell lysates were prepared using a 1% IGEPAL-CA630 lysis buffer (1%
IGEPAL-CA630, lOmM Tris pH7.2, 150mM NaCl, ImM activated NaaVCL, ImM
NaF) from rabbit MCF cell lines BJ1857 (infected with OvHV-2), BJ1859 and
BJ1860 (infected with A1HV-1). Uninfected, conA-stimulated lymphoblasts derived
from rabbit lymph nodes were used as controls. Cells were washed in IMDM to
remove rhIL-2 then given further stimulation (or not) with lOpg/ml conA and
lOng/ml TPA for 18 hours prior to lysis. Cell lysate from approximately 106 cells
was loaded into a well of a 15% acrylamide gel. Recombinant human IL-15
(Peprotec EC Ltd, London, UK) was loaded into two wells at lOOng or 200ng per
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well. Electrophoresis and western blots were performed as before (Chapter 2.4.2 and
2.4.4). Anti-IL-15 (Santa Cruz Biotechnology, Santa Cruz, USA) was used at
lpg/ml to probe the nitrocellulose membrane. The cell lysates were also
concentrated four-fold in Vivaspin concentrators (with a lOkDa membrane)
(Vivascience, Lincoln, UK) and analysed in the same manner.
3.2.8 Detection of IL-15mRNA in rabbit MCF cell lines
RT-PCR and Southern blots were used to detect whether or not LGL cell
lines transcribe IL-15 mRNA. The IL-15 primers and probes used in this study were
based on the bovine IL-15 sequence, as the rabbit IL-15 has not been sequenced
(Table 3.3). RT-PCR and Southern blots were performed by the method described in
Chapters 2.5.1 and 2.5.2. This was performed on RNA samples from the rabbit
A1HV-1 -infected LGL lines, BJ1001, BJ1263, BJ1857, BJ1860 and rabbit OvHV-2-
infected cell line BJ1265. Control cells were uninfected lymphoblasts isolated from
rabbit spleen or lymph nodes. Cells were either taken from culture with exogenous
IL-2, without exogenous IL-2 or stimulated with lOpg.ml conA and 5ng/ml TPA.
In a preliminary study, an oligonucleotide sequence specific for the 231 -
270bp region of bovine IL-15 was used as an internal probe to detect and identify the
products of the RT-PCR reaction in the rabbit AlHV-l-infected LGL cell line,
BJ1001.
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Table 3.3: Primers used for the detection of IL-15 by RT-PCR and
Southern blot.
Specificity Function Sequence Tm Product
Size
IL-15 5' primer CATATTTGAGAAGTACTTCCATCCAG 72°C 469bp
3' primer TGTGCAAATGTTCATCAACACTCC 64°C
internal GCACTGCATCGCTGTTACTTTGCAATTGGGAT 114°C
probe GAGCATCA
GAPDH 5' primer CCTTCATTGACCTCAACTACAT 56°C 380bp
3' primer CCAAAGTTGTCATGGATGACC 58°C
The primers used for IL-15 detection cover the 17-485bp region of the bovine IL-15
sequence. The internal probe covers the 231-270bp region of the same sequence.
GAPDH — glyceraldchydc-3-phosphate dehydrogenase - used as a control to measure
equal loading of mRNA in RT-PCRs. Tm = melting temperature
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3.3 Results
3.3.1 Phenotypic analysis of MCF LGL cell lines
The OvHV-2-infected cattle LGL cell lines BJ1035, BJ1044, BJ1104, and
BJ1196 were phenotyped by FACS analysis. Rabbit LGL cell lines from three
infected rabbits were also phenotyped. These rabbits were infected with A1HV-1
(two rabbits) or OvHV-2 (two rabbits). One of the rabbits infected with OvHV-2
died without developing a febrile reaction. The reason for this was not established.
From the remaining rabbits, three cell lines (one per rabbit) were generated - BJ1857,
BJ1859 and BJ1860 (see Chapter 2.1.2). BJ1857 was infected with OvHV-2 while
BJ1859 and BJ1860 were infected with A1HV-1. The results presented here are
representative of at least three separate analyses.
The phenotypic analysis of the cattle cell lines showed that the majority
(>96%) of the LGLs in each cell line was CD2+ (summarised in Table 3.4). None of
the LGL cell lines contained CD4+ cells but all cell lines contained variable
percentages of CD8+ cells, except BJ1035, which was CD4~CD8". A proportion
ranging from 5% to 16% of the cells in BJ1104 and 1044 respectively (both OvFIV-
2-infected) expressed the WC1 antigen specific to y5TCR+ cells. The majority
(>96%) of cells in lines BJ1035 and BJ1044 were CD5+ and CD2+.
The phenotype of the rabbit cell lines was determined using the limited
number of anti-rabbit CD antibodies available. The results (see Table 3.5) show that
none of the cell lines expressed surface IgM. Of the two established rabbit cell lines
(i.e. > 3 years old) the majority (>99%) of BJ1263 cells expressed CD5. At least
50% of cells in BJ1263 expressed the CD8 marker. Cells in BJ1001 expressed
neither CD5 nor CD8. Only small proportions of cells in the cell lines BJ1263 and
BJ1001 expressed the CD4 marker. The phenotype of the LGL cultures BJ1857,
BJ1859 and BJ1860 stabilised after 5 months in culture. The presence of CD5+ cells
was observed in 50% of cells in BJ1859. Neither BJ1857 nor BJ1860 cells expressed
CD5. The proportion of cells expressing CD8 varied between each cell line. None
of these cell lines expressed CD4.
All antibodies used in this study reacted against antigens expressed on control
PBMCs. Some sample FACS profiles are illustrated in Fig 3.2.
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Table 3.4: Detection of cell surface markers on bovine OvHV-2-infected
LGL cell lines.












BJ1035 20months 98 <1 98 <1 <1 <1 96
BJ1104* 27months <1 <1 rid 93 5 4 99
BJ1044 19months 96 <1 96 56 16 <1 87
BJ1196 4months 98 <1 nd 52 <1 nd nd
Values represent % of total live cell population staining positively with antibody, nd
= not determined. *performed by J. McCallum.
Table 3.5: Detection of cell surface markers on rabbit MCF cell lines.
Cell Line Period in
Culture
CD4 (%) CD5 (%) CD8 (%) slgM (%)
BJ1001 59months 8 <1 <1 <1
BJ1263 40months 2 99 50 <1
BJ1857 5 months <1 <1 12 <1
BJ1859 12months <1 50 50 <1
BJ1860 12months <1 <1 45 <1
BJ1001 and BJ1263 are established cell lines from A1HV-1 -infected rabbits. BJ1857
is a cell line derived from an OvHV-2-infected rabbit. BJ1859 and BJ1860 are both
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Fig 3.2: Sample FACS profile for bovine conA-stimulated
lymphoblasts (continues on next page).
1) FITC conjugate alone. 2) anti-CD2. 3) anti-CD4. 4) anti-CD8.
5) anti-CD5. 6)anti-WC1. 7)anti-CD21. 8) anti-CD45.
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Fig 3.2 (continued): Sample FACS profile for bovine LGL cell line
BJ1035.
9) FITC conjugate alone. 10)anti-CD2. 11)anti-CD4. 12)anti-CD8.
13) anti-CD5. 14)anti-WC1. 15)ant-CD21. 16) anti-CD45.





Fig 3.2 (continued): Sample FACS profile for rabbit mononuclear
cells from lymph nodes.
18) FITC conjugate alone. 19)anti-CD4. 20) anti-CD8. 21)anti-CD5.
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Fig 3.2 (continued): Sample FACS profile for rabbit LGL cell line
BJ1859. (Analysis made after 5 months in culture).
24) FITC conjugate alone. 25) anti-CD4. 26) anti-CD8. 27) anti-CD5.
28) anti-lgM. 29) anti-border disease virus (control). M1 = marker gate
for positive cells.
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3.3.2 OvHV-2 convalescent bovine serum detects viral antigens in the
nucleus of LGL cell lines
In order to confirm the virus infection of the OvHV-2-infected cell lines the
OvHV-2 convalescent bovine serum ('Jezebel' serum) was used in an indirect
fluorescent antibody test to detect viral antigen. Over 90% of cells in BJ1035 and
BJ1265 (derived from a rabbit infected with OvHV-2) were positive for viral
antigen(s) in nuclei of LGL cells (Fig. 3.3b). A qualitative difference in staining was
observed when an uninfected bovine control serum was used on BJ1035. Some non¬
specific cytoplasmic staining was seen in BJ1035 using this control serum but no
nuclear staining was present (Fig 3.3a). In control uninfected conA-stimulated
lymphoblast cells nuclear staining was not detected using either the 'Jezebel' or the
control serum.
Virus infection of the A1HV-1-infected cell lines (BJ1859 and BJ1860) was
confirmed by the presence of mRNA for the viral protein encoded in ORF50. These
results are presented and discussed in Chapter 6.
Fig. 3.3: Punctate nuclear staining detected by IFAT using a convalescent
bovine serum (photographs were taken using equal exposures).
A) Bovine LGL cell line BJ1035 incubated with bovine control serum.
B) BJ1035 incubated with 1: 20 'Jezebel' serum.
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3.3.3 Growth of LGL cell lines in the absence of exogenous IL-2
The growth of LGL cell lines was tested and compared to growth of
uninfected conA-stimulated lymphoblasts in the absence of rhIL-2 over 4 days. The
cells were set up in these cultures at different initial cell densities to determine if this
might also have an effect on survival. The data shown in Fig 3.4 represent those
from duplicate wells as cells were in limited supply at the time of this experiment.
Therefore, the following trends were recorded although no statistical analysis was
performed.
Both OvFIV-2 infected bovine cell lines (BJ1035 and BJ1044) cultured in
medium alone could survive without exogenous IL-2 for at least a week (and up to
46 days in one instance with BJ1035 if medium was refreshed and cultures were split
when cell densities reached over 2 x 106/ml). This survival was characterised by a
small initial decline in viable cell numbers followed by a recovery of viable cell
numbers three to four days after culture. In contrast, the control uninfected con-A-
stimulated lymphoblasts tended to decline from day 0 of culture without exogenous
IL-2. Any survival of control cells was short-lived and could not be maintained at
over 50% viability for as long as the LGL cell lines. The greatest difference in the
number of viable cells between the LGL cell lines (BJ1035 and BJ1044) controls
occurred after 4 days in culture (Fig 3.4a-c, e-g), except when the initial density was
2 x 106 cells/ml (Fig 3.4d, h). The viable cell numbers in the LGL lines after 4 days
in culture also exceeded the initial population at day 0 and the cells maintained at
least 50% viability during this time. The recovery of cell numbers over four days
appears to be dependent on initial cell density where an initial density of 1 x 106/ml
gave the greatest difference in viable cell numbers between LGL cell lines and
controls after four days in culture (Fig 3.4c, g). For this reason, 106 cells/ml was the
chosen cell density for the inhibition and the signal transduction studies (Chapter 4).
The survival of rabbit LGL cell lines in the absence of hrIL-2 has been
observed for 5 to 10 days. This period of survival exceeds that of control uninfected
rabbit lymphoblasts, which decline in numbers and viability (to less than 70% viable)
after 30 hours without hrIL-2.
In a series of subsequent analyses, the viable cell count following 3 days in
culture without exogenous IL-2 was recorded for LGL and control cells set up at an
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initial density of 106 cells/ml prior to use in signal transduction assays (Chapter 4).
These data, generated from at least three different experiments, are shown in Fig 3.4i
and confirms the trend observed for the time-course assay described above. Hence,
at an initial density of 106 cells/ml LGLs survive, while control cells die in the
absence of exogenous IL-2 for 3 days (in this instance).
3.3.4 LGL cell lines show cytotoxic granular morphology in the
presence and absence of IL-2
The BLT esterase assay determines the presence of the enzyme in
cytoplasmic granules. Its expression is associated with functionally cytotoxic cells
(Griffiths and Mueller 1991; Haig et al, 1996). In the presence of recombinant
human IL-2, OvHV-2-infected bovine LGL cell lines BJ1035, BJ1044 and rabbit
OvHV-2-infected LGL cell line BJ1265 grown in culture have cytoplasmic granules
containing BLT esterase (observed as a yellow stain within the granules - Fig.3.5b).
While the majority of BJ1265 cells expressed BLT esterase, the intensity of staining
was lower than that observed in BJ1035. This staining was detected in LGL cell
lines in the absence of IL-2. In one case - BJ1035 cultured in the absence of
exogenous IL-2 for 1 month - cells still maintained good LGL morphology with
cytoplasmic granules that were positive for BLT esterase.
Less than 1% of uninfected, conA-stimulated lymphoblast cells were positive
for BLT esterase. The levels of BLT esterase were very low by comparison to
BJ1035 cells although cytoplasmic granules could be seen (Fig. 3.5a). After a short
period in culture without exogenous IL-2, the few remaining live cells showed lower
















































































































BovBI BJ1035 RbtBI BJ1859 BJ1860
Fig 3.4i: IL-2 independent growth and survival of LGL cell lines in
culture.
Cells (set up at an initial density of 106 cells/ml) were cultured in the absence
of exogenous IL-2 for 3 days. Mean viable cell counts and standard error of
the mean (s.e.m.) for repeated experiments are shown above.
BJ1035 (n=5); bovine OvHV-2+ LGL cell line
BJ1859 (n=4), BJ1860 (n=3); rabbit AIHV-1+ LGL cell lines
BovBI (n=3); bovine conA-stimulated control cells
RbtBI (n=4); rabbit conA-stimulated control cells












Fig. 3.5: Expression of BLT esterase in cytoplasmic granules
/vacuoles of LGL cell lines compared to control uninfected
cells.
A) Control, uninfected, conA-stimulated bovine lymphoblasts.
B) Bovine OHvV-2-infected cell line, BJ1035. The yellow stain
indicates the presence of BLT esterase.
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3.3.5 LGL cell lines respond to human recombinant interleukin 15
LGL cell lines and control cells were tested for their response to human
recombinant IL-15. Cell growth and expression of secreted or intracellular (stored)
BLT esterase per culture were recorded. Response to IL-2 was also measured for
comparison. Uninfected, conA-activated lymphoblasts were used as control cells.
The following data from bovine LGL cell lines are representative of two separate
experiments.
The established OvHV-2-infected bovine cell line BJ1035 and control cells
showed a dose-dependent proliferative response to IL-15 (0.01 to lOOng/ml) and IL-
2 (1 to 50U/ml) (Fig 3.6a, b). While the addition of both IL-2 (at 20U/ml) and IL-15
(0.1, 1.0 and lOng/ml) increased the growth response of both control and BJ1035
cells when compared to the response with IL-15 alone, this increase was not
significant (data not shown). A similar response was observed in the A1HV-1-
infected rabbit cell lines BJ1859 and BJ1860 and in rabbit control cells on addition
of IL-15 (0.1 to lOOng/ml) and IL-2 (1 to 400U/ml) (Fig 3.7a, b). The addition of IL-
2 at 50U/ml along with different concentrations of IL-15 (0.1, 1.0, 10 and 50ng/ml)
to the culture medium significantly increased the growth response of BJ1859 and
BJ1860 when compared to IL-15 alone (p < 0.02).
In the OvFIV-2-infected LGL cell line BJ1035 and control cells the levels of
BLT esterase in culture supernatants was unaffected by the dose of cytokine added.
However, there was a dose-dependent rise in the intracellular BLT esterase activity
in the total population of BJ1035 cells per culture with increasing concentrations of
IL-2 and IL-15 (Fig 3.6c, d). The uninfected controls expressed lower levels of
intracellular BLT esterase compared to BJ1035 (p < 0.0007) and were less sensitive
to IL2 or IL-15 mediated enhancement of BLT esterase activity. However, at IL-15
concentrations of lOOng/ml, the BLT esterase stored in the total population of
BJ1035 cells per culture had declined from peak levels and intracellular BLT levels
in control and BJ1035 cell cultures were comparable (Fig 3.7c). Rabbit LGLs and
control cells also showed similar patterns in BLT esterase expression in response to
IL-2 and IL-15. The intracellular levels of BLT esterase in rabbit control cell
cultures were comparable to rabbit LGL cultures only when using lOOng/ml IL-15 in
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the culture medium (Fig 3.7d, f)- Otherwise, levels of intracellular BLT esterase in
A1HV-1 -infected rabbit LGL cell cultures were higher than in control cells (p <0.01)
and showed an IL-2 and IL-15 dose-dependent increase (Fig 3.7c-f). A combination
of IL-2 at 50U/ml and IL-15 at different concentrations (0.1, 1.0, 10, 50 ng/ml) did
not produce a significant increase in intracellular BLT esterase levels when
compared with IL-15 alone (data not shown). BLT esterase levels in all rabbit cell
culture supernatants were not affected by the addition of IL-2 or IL-15 into the
culture medium.
Therefore, these experiments demonstrate the ability of IL-2 and IL-15 to
stimulate the proliferative response of the LGL cell lines tested here. In addition,
both IL-2 and IL-15 are capable of stimulating and /or maintaining the production of
the BLT esterase cytotoxic enzyme in LGL cell cultures. In contrast, only high
concentrations of IL-15 induced the production of cytotoxic enzymes in control cells.
This could indicate that the dose response observed in LGL cell lines represents the
maintenance of BLT esterase production while the dose-response of control cells
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Fig 3.6: Dose-dependent growth and BLT esterase activity in the bovine
OvHV-2-infected LGL cell line, BJ1035.
Cells and supernatants were harvested after 6 days in culture with the
respective cytokines. BLT esterase activity of cell supernates (sn) and
lysates (lys) represent secreted and stored enzyme respectively. Stored
enzyme data represent activity present in 10% of the total population of cells
per culture. Analysis of enzyme activity was as described in Chapter 2
(materials and methods). Error bars indicate standard error of the mean
(s.e.m.). (Statistical analysis performed by ANOVA).
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Fig 3.7: Dose-dependent growth and BLT esterase activity in the rabbit
AIHV-1-infected LGL cell lines, BJ1859 and BJ1860.
Cells and supernatants were harvested after 6 days in culture with the
respective cytokines.
a-b) Growth of LGL cells and control cells in hrlL-2 or hrlL-15. BJ1859+ and
BJ1960+ represent data where 50U/ml hrlL-2 with different concentrations of
hrlL-15 were added to the cultures.
c-f) (see following page for d-f). BLT esterase activity of cell supernates (sn)
and lysates (lys) represent secreted and stored enzyme respectively. Stored
enzyme data represent activity present in 10% of the total population of cells
per culture. Analysis of enzyme activity was as described in Chapter 2
(materials and methods). Error bars indicate standard error of the mean
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3.3.6 IL-15 expression by MCF virus-infected LGLs
An immunocytochemical assay performed with the anti-IL-15 antibody
(described in Chapter 3.2.6) did not detect any IL-15 in the positive control cells,
rabbit monocytes and mouse LTK" cells. Western blotting analysis confirmed that
this antibody recognised purified recombinant human IL-15 but did not detect any
IL-15 in lysates prepared from the rabbit A1HV-1-infected LGL cell lines BJ1859,
BJ1860 or the rabbit OvHV-2 infected cell line BJ1857 (Fig 3.8).
3.3.7 Expression of IL-15 messenger RNA in LGL cell lines
A previous study (C. Rensche, personal communication) by RT-PCR and Southern
blotting using an internal primer as a probe (Table 3.1) showed expression of IL-15
mRNA in the rabbit A1HV-1-infected LGL cell line, BJ1001 (Fig 3.9). This present
study repeated and extended the previous investigation of IL-15 expression by RT-
PCR in a variety of rabbit LGL cell lines (Table 3.5). IL-15 mRNA was not
detectable in any of the cell lines, including BJ1001 (Fig 3.10).
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A) 2 3 4 5
2 3 4 5
Fig3.8: Western blot analysis of the reactivity of an IL-15-specific
antibody (clone L-20) to rhlL-15 and LGL cell lysates.
A) Lane 1: rhlL-15 (100ng). Lane 2: BJ1857 (rabbit OvHV-2+) (not
stimulated). Lane 3: BJ1857 (stimulated with conA/TPA, 24hrs).
Lane 4: BJ1859 (rabbit AIHV-1 +)(not stimulated). Lane 5: BJ1859
(stimulated).
B) Lane 1: rhlL-15 (200ng). Lane 2 - BJ1860 (rabbit AIHV-1+) (not
stimulated). Lane 3: BJ1860 (stimulated). Lane 4: uninfected rabbit









IL-15 RT-PCR IL-15 Southern Blot
Fig 3.9: IL-15 PCR and Southern Blot.
M = markers; L = rabbit AIHV-1+ cell line, BJ1001; B = uninfected rabbit
lymphoblasts; G = GAPDH. Primer used in Southern blot was specific for
the 231-270bp region of the bovine IL-15 sequence.
103
Table 3.6: Cells used in detection of IL-15 by RT-PCR.







7 Rabbit lymphoblast Uninfected
(from lymph nodes)





12 Rabbit lymphoblast Uninfected
(from lymph nodes)
13 Rabbit lymphoblast + Uninfected
(from lymph nodes)
14 Rabbit lymphoblast Uninfected
(from lymph nodes)





Sample numbers refer to those indicated in Fig 3.10. - = cells cultured without IL-2
(for a minimum of 24 hours). + = cells stimulated with lOpg/ml conA + 5ng/ml
TPA. All other cells were cultured in the presence of hrIL-2. All LGL cell lines









11 12 13 14 15 M 16 17 18
Fig3.10: IL-15 RT-PCR of rabbit LGL cell lines and control uninfected
lymphoblasts from rabbit spleen and lymph nodes.
Samples are as indicated in Table 3.5. The expected PCR product size for
GAPDH = 380bp and IL-15 = 469bp.
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3.4 Discussion
3.4.1 Phenotypic and functional analysis
The results confirmed findings from other studies (Cook and Splitter, 1988;
Burrells and Reid, 1991; Reid et al, 1989; Schock et al, 1998) and showed that cell
lines established from MCF-affected rabbits infected with A1HV-1 and cattle
infected with OvHV-2, have the morphology of large granular lymphocytes (LGLs)
and proliferate in the absence of exogenous cytokines for longer periods than control
cells. The expression of serine proteases such as BLT esterase (a tryptase) has been
associated with cytotoxic activity in T and NK cells following target cell-mediated
stimulation (Griffiths and Mueller, 1991). However, the presence of IL-2 in in vitro
cultures can also induce the expression of serine proteases (Liu et al, 1989).
Therefore, the expression of BLT esterase in LGL cells cultured without exogenous
IL-2 indicates that LGL cells have the phenotype of constitutively activated cytotoxic
cells. The cytotoxic activity of the LGL cells on target cells was not demonstrated in
this study. The chromium release assay where LGLs are exposed to 51Cr-labelled
target cells would need to be performed to demonstrate the cytotoxic activity of these
LGL cells. However previous studies using 5ICr-release assays have demonstrated
the cytotoxic activity of LGL cells derived from tissues of MCF affected animals
(Reid et al, 1985). In addition, the occasional use of feeder cell monolayers (which
are rapidly destroyed by LGL cells) in the routine culture of the LGL cell lines used
in the current study support the idea that these LGLs are functionally cytotoxic. In
culture supernatants, the level of BLT esterase detected was not influenced by the
dose of cytokine. This could suggest that a steady state between secretion and
breakdown of BLT esterase is occurring.
On the basis of the presence of the cell surface antigens CD2, CD4, CD8,
CD5 and CD6, previous studies identified the cells in cell lines derived from MCF-
affected animals as T cells (Burrells and Reid, 1991; Schock et al, 1998).
Experimentally infected rabbit LGL cell lines have also been phenotyped in a similar
fashion (Reid et al, 1983; Schock and Reid 1996). In the present phenotypic
analyses, the surface antigen phenotype (with respect to lymphocyte-specific
markers) of all of the cells in rabbit and cattle LGL cell lines could not be established
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using the available antibodies. However, in some cattle LGL cell lines (BJ1035 and
BJ1044) the expression of both CD2 and CD5 on almost 100% of cells and the
absence of CD21 expression suggested a T cell phenotype. Thus, in the cell lines
BJ1035 and BJ1044 the possibility that CD5 expression is due to the presence of B
cells is eliminated. In other LGL cell lines tested where 100% of cells do not express
CD2 and CD5 (or where expression of these markers could not be established), the
absence of CD21 or surface IgM suggests that these cell lines also do not contain B
cells. In some cases, the expression of CD5 at low levels along with CD2 and CD8
expression could describe the cell surface phenotype of NK cells, aP T cells or yS T
cells (Meeusen et al, 1988; Howard and Naessens 1993). Clearly, more information
is required to phenotype these LGL cell lines further. For example, the co-
expression of these antigens on LGL cells has not been determined but would be
helpful for the identification of LGL cell phenotype. An analysis of CD2 expression
in rabbit LGL cell lines should be studied once a rabbit CD2-specific antibody
becomes available. The detection of CD3 (which forms part of the T cell receptor
complex not found on NK cells) was attempted using two antibodies reactive to
cattle and rabbit CD3 respectively (Davis et al, 1993; Jones et al, 1993). Attempts to
phenotype cattle and rabbit LGL cells using the CD3-specific antibodies gave
inconclusive results despite having positive reactivity against PBMCs. Therefore,
the expression of the definitive T-cell specific marker CD3 should be re-evaluated
(by using different antibodies if possible or by RT-PCR) to confirm (or not) a T cell
phenotype. This would enable the identification of these CD2+ cells as T cells rather
than NK cells that can also express CD2 (Perussia et al, 1983).
The phenotypic analysis of LGL cells is complicated by the occurrence of
phenotypic drift over time in culture. For example, in the present study the OvHV-2-
infected cell line BJ1104 did not express CD2. In a previous analysis of this cell
line, this marker was expressed (Schock et al, 1998). A disparity between the past
and present analysis of the cell lines BJ1035 and BJ1044 was also observed (Schock
et al, 1998). Phenotypic drift was also observed in the rabbit LGL cell lines. This
was demonstrated by the enrichment of CD8 expressing cells and loss of CD4
expressing cells in rabbit LGL cell lines during the first few months of culture. This
phenomenon has been described previously where short-term cultures from A1HV-1-
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infected rabbits were shown to contain significantly fewer CD4+ cells and more
CD8+ cells than cultures from an uninfected animal (Schock and Reid, 1996). The
phenotypic drift of the LGL cell lines after short periods in culture may reflect the
adaptation of the cultures to conditions in vitro despite the presence of virus. In
addition, it is possible that these short-term cultures represent a mixture of uninfected
lymphocytes activated in response to infection of other cells as well as the virus
infected LGLs that eventually become established cell lines. Thus, established LGLs
may be a better reflection of the cells involved in pathogenesis than early cell
cultures. At the other extreme, LGL cell lines established in vitro for years show
some disparities between different phenotypic analyses. This may suggest that long-
term culture influences the expression of cell surface antigens or that there is a
genuine shift in phenotype due to expression of viral genes. Alternatively, the
emergence of different populations of cells over time may reflect the fact that the
LGL cell lines are not cloned cell lines. However, it is not clear in this study whether
the differences in the phenotypic analyses is due to the emergence of a different
population of cells or due to changes in expression of specific markers on the same
cells. Difficulties in defining a constant cell surface phenotype has been encountered
in the past (Schock, 1996). This may simply indicate that like other herpesviruses,
the MCF viruses have the ability to infect more than one cell type.
In conclusion, there are important features common to all LGL cell lines
irrespective of cell surface phenotype:
1) The majority of MCF virus-infected cells exhibit the morphology of large granular
lymphocytes after approximately one month in culture
2) LGL cell lines are not B cells
3) LGL cell lines have a cytotoxic phenotype (most cells are BLT esterase+), which
supports the results showing that a proportion of these cells express surface antigens
of T cells or NK cells
4) LGL cell lines express virus genes or transcripts
5) Irrespective of phenotype and whatever the reasons for phenotypic drift LGL cell
lines maintain their ability to cause MCF in susceptible rabbits when used as an
inoculum.
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3.4.2 Growth characteristics of LGL cell lines in culture: the role of IL-15
The lack of requirement for exogenous IL-2 by LGL cell lines over a limited
period of time is comparable to the growth characteristics of some HVS-transformed
T cells (Meinl et al, 1995). HVS-transformed cell lines require high cell densities for
optimum growth. This was also a characteristic of LGL cell lines in this study.
Moreover, survival in IL-2 deficient medium was cell density-dependent. These
characteristics suggest firstly that the LGL cell lines, due to MCF virus infection,
may secrete a growth factor(s) into the medium that acts in an autocrine fashion.
This is also supported by the fact that the LGL cultures cannot be maintained if all of
the culture medium is changed during passage. Secondly, these characteristics also
suggest that cell to cell contact may be an important factor for cell survival. In the
case of HVS-transformed T cells, stimulation through the interaction of CD2 with its
ligand CD58 is thought to be important for continuous growth of these cells in
culture (Mittriicker et al, 1992). The stimulation of LGL cells through direct cell to
cell contact may induce the activated phenotype observed in these cells. The vims-
mediated production of cytokines by LGLs could be facilitated through the
interaction of surface molecules such as CD2 on LGL cells. Indeed, even in the
absence of direct cell to cell contact the close proximity of cells to each other may be
sufficient to maintain the cycle of virus-induced cytokine stimulation of LGL cells.
The finding that survival of LGL cell lines without exogenous IL-2 exceeds that of
control uninfected cells has been exploited in these experiments to reveal
characteristics of LGL phenotype and function associated with virus infection of
these cells.
Despite the ability to grow in culture without exogenous IL-2, previous
studies have shown that bovine OvHV-2-infected LGL cell lines do not transcribe
IL-2. However, IL-2Ra is present on the cell surface and the cells respond to IL-2
(Shock et al, 1998). The complete removal of LGL culture supernatant during
routine passage of these cells is detrimental to optimum LGL growth. Partial
characterisation of cytokines expressed by bovine OvHV-2-infected LGL cells
demonstrated the presence of IL-4, IL-10, IFN-y and TNF-a but not IL-2 or IL-ip
mRNA (Schock et al, 1998). Therefore, these or other undefined cytokines in
culture supernatant may support the growth and survival of LGL cells in the absence
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of exogenous IL-2. The presence of growth factors in LGL supernatants have been
tested by their ability to stimulate uninfected PBMCs (Schock, 1996). The results of
these studies showed the existence of low levels of stimulatory activity in LGL
culture supernatants. However, it is difficult to determine whether this was due to
low levels of growth factor secretion by LGLs or due to growth factor sequestration
on receptors in LGL cultures. The evidence in the present study suggesting the
recovery of LGL cell numbers following a few days in culture in the absence of
exogenous hrIL-2 would indicate that LGLs do produce their own growth factors.
Of the cytokines known to be transcribed by LGLs, none were likely candidates for
allowing IL-2-independent growth. Therefore, the virus-induced production of IL-15
by LGL cells was suggested as a mechanism for survival in culture in the absence of
exogenous and endogenous IL-2.
The shared effects of IL-2 and IL-15 are mediated by the use of a common
cytokine receptor - the IL-2RPy (Grabstein et al, 1994; Carson et al, 1994; Giri et al,
1994). The IL-2Rpy along with IL-2Ra form the three components of the IL-2
receptor (Smith, 1988). The IL-2RP and y chains mediate signal transduction
through non-receptor tyrosine kinases (NRPTKs) (Miyazaki and Taniguchi, 1996;
Siegel et al, 1987). Cell activation induces the expression of the IL-2Ra (Cantrell
and Smith, 1983; Koyasu et al, 1991; Uchiyama et al, 1981). The association of the
IL-2Ra with the Py chains mediates high affinity binding (Kd = 10"n M) of IL-2 to
this receptor complex (Kondo et al, 1986; Robb, 1986; Takeshita et al, 1992). IL-15
uses the IL-2RPy for low affinity binding and intracellular signalling (Carson et al,
1994; Giri et al, 1994). Alternatively, the response of cells to IL-15 can be mediated
through the binding of IL-15 to its high affinity (Kd = 10"11 M) receptor, IL-15Ra in
association with IL-2RPy on lymphoid cells (Giri et al, 1995a.b; Anderson et al,
1995). The expression of the IL-15Ra has been detected in T cell, B cell and
macrophage cell lines and NK cells as well as in non-lymphoid tissue (Giri et al,
1995b).
The results of the present study suggests that hrIL-15 stimulates LGL cell
proliferation and maintains or enhances BLT esterase expression. IL-15 also
stimulated the proliferation and at high concentrations enhanced the expression of
BLT esterase in control uninfected lymphoblasts. The elevation of BLT esterase
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activity in control cells at high IL-15 concentrations could suggest the presence of a
small proportion of cytotoxic cells within the control lymphoblast population in
which BLT esterase is induced. The proliferative response of LGL cells and control
cells to IL-15 suggests that these cells express a functional receptor for IL-15. The
results also indicate that IL-15 could replace IL-2 as has been demonstrated in adult
T cell leukaemia cell lines (Yamada et al, 1998). In this case, the response to IL-15
was mediated by the expression of IL-15Ra. Whether the binding of IL-15 on LGL
cells takes place through the low affinity IL-2RPy or the high affinity IL-15Roc/IL-
2R(3y complex is not known. The receptor usage by either control or LGL cells was
not determined as the important finding in this study was that virus-infected LGL
cells express higher levels of BLT esterase than uninfected cells and that IL-15
enhances BLT expression in LGL cells but not in uninfected cells. Therefore, the
implication is that the MCF viruses infect cells capable of cytotoxicity or that vims
infection itself may enhance the cytotoxic ability of infected and uninfected
bystander lymphocytes in vivo.
The induction of cellular IL-15 by the T cell transforming virus HTLV-1
through Tax-1 (a viral transactivating protein) (Azimi et al, 1998) has been observed.
As viral homologues of IL-15 have not been observed in the genomic sequence of
A1HV-1 (Ensser et al, 1997) any IL-15 produced in LGL cells must be of cellular
origin. RT-PCR detection of IL-15 in rabbit LGL cell lines and controls was
unsuccessful. This was probably due to use of primers based on the bovine IL-15
sequence, as the sequence for rabbit IL-15 is not available. This may have
consequences for the specificity of the primers for rabbit IL-15 and thus explain the
problems in detecting the IL-15 transcript in rabbit cells. An initial analysis
(Christine Rensche, personal communication) showed a positive result on one
occasion. The inability to repeat this may be due to transient expression of IL-15
(giving a negative result) or may be due to the presence of contaminating cells (in
Rensche's study) that can produce IL-15 (giving a positive result). However,
comparison of the bovine IL-15 sequence chosen for the generation of primers with
that of human, mouse, rat and pig IL-15 shows a high degree of homology to each
other (Fig 3.11). The failure of the anti- human IL-15 antibody to detect IL-15 in
rabbit control and LGL cell lysates may be due to the lack of sensitivity of the
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western blot or the lack of antibody reactivity with rabbit IL-15. Analysis of bovine
LGLs for IL-15 mRNA or protein was not done as bovine LGLs were not available
at the time as attempts to resurrect these cells from liquid nitrogen had failed. This
could be explained by the reactivation of virus replication in LGLs or simply due to
cell death on return to culture. The detection of IL-15 protein in tissues from MCF
virus-infected animals using anti-IL-15 antibodies was attempted but the results were
inconclusive due to problems with non-specific antibody reactivity. Due to time
restrictions, the detection of IL-15 in bovine control tissues was not attempted. This
has since been achieved. In conclusion, given the inability to find a suitable IL-15-
producing uninfected rabbit positive control the question of IL-15 expression in
rabbit LGL cells remains unanswered.
Further work with other anti-IL-15 antibodies may be useful and RT-PCR or
in situ mRNA hybridisation analysis on bovine LGL cell lines may be informative.
The detection of IL-15 mRNA by RT-PCR in bovine LGLs is currently being
investigated. Any future attempts to detect IL-15 mRNA in rabbit LGLs could

















Fig 3.11: Sequence alignment of bovine IL-15 primers to IL-15
sequences from other species.
'*' Indicate sites of sequence identity between species. Scale indicates
nucleotide position with respect to the start codon (ATG). BOV = bovine;
HUM = human; MUS = mouse; RAT = rat; PIG = pig.
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Chapter 4
Signal transduction in MCF virus-infected cell lines
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4.1 Introduction
In the previous chapter, MCF virus-infected cells were demonstrated to have
the morphology of large granular lymphocytes; have the ability to survive and grow
in the absence of exogenous cytokines for longer periods of time than uninfected
cells; constitutively express the cytotoxicity-associated enzyme BLT esterase;
display a phenotype most closely resembling T cells or NK cells and respond to IL-
15. Some of these characteristics are similar to those observed in HVS-transformed
cell lines (Meinl et al, 1995). The mechanism for T cell dysfunction following HVS
infection involves viral interference with T cell signalling molecules. For instance,
the transforming protein Tip interacts with the T cell-associated signal transduction
molecule, Ick - a src kinase (Biesinger et al, 1995; Jung et al, 1995a; Lund et al,
1996). This kinase is involved in T cell signalling via the T cell receptor (TCR), the
IL-2 receptor and other surface molecules such as CD2 and CD4 (Crabtree and
Clipstone, 1994). The HVS transforming proteins known as STPs also bind to ras
(which is involved in signalling downstream of Ick) (Jung and Desrosiers, 1995) and
fyn (another src kinase involved in the early stages of the signalling pathway) via
interaction with c-src (Lee et al, 1997). Similarly, the EBV proteins LMP-1 and 2A
block the transduction of signals from the B cell receptor (BCR) by binding the
kinases lyn and syk (Miller et al, 1995) or by binding signalling molecules normally
associated with the TNF receptor (Izumi and Keiff, 1997; Mosialos et al, 1995).
Therefore, these two gammaherpesviruses have evolved mechanisms that target
lymphocyte src kinases and other downstream signalling molecules in order to
control virus life cycle and pathogenicity. In this chapter, the possibility that the
MCF viruses express proteins that interfere with lymphocyte signalling is explored.
This form of virus-host interaction could explain the proliferative and constitutively
cytotoxic phenotype of the LGL cell lines. Given this background an analysis of T
cell-associated kinases (eg Ick, fyn and ZAP-70) in MCF virus-infected cell lines is
therefore appropriate.
The strategy adopted for this study was to compare the phenotype of MCF
virus-infected cattle and rabbit LGLs with uninfected 'resting' or activated
lymphocytes from the respective species. The objective was to determine whether
115
infected LGLs had altered signalling pathways compared to uninfected control
lymphocytes. This objective was approached from two directions. First, the indirect
approach used biochemical inhibitors of signal transduction pathways to define
general pathways utilised by the LGLs. The specific inhibitors used and their mode
of action will be discussed in more detail over the course of this chapter. The second
approach was to target specific signalling molecules based on the outcome of the
inhibitor studies. To do this, signalling molecules were isolated from cell lysates by
immunoprecipitation. The state of activation of the precipitated kinases can then be
assessed (either by the presence of phosphorylated tyrosine residues or by testing the
ability of the kinase to transfer radioactive phosphate onto a known substrate). The
presence of tyrosine kinases (such as Ick and fyn and ZAP-70) were also assessed by
examining the presence of tyrosine phosphorylated proteins in whole cell lysates. In
these studies, the activating effect on the LGLs of exogenous IL-2 could mask any
virus-induced effect within the cells. For this reason, LGL cell lines were deprived
of exogenous IL-2 for at least 30 hours before analysis of signalling molecules and
pathways.
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4.2 Materials and Methods
4.2.1 Inhibitors
Rapamycin (Calbiochem-Novabiochem, San Diego, CA) - an inhibitor of S6
kinase - and genistein (TCS Biologicals, Botolph Claydon, UK) - a general tyrosine
kinase inhibitor - were diluted in DMSO before use. Cyclosporin A (Sandoz,
Sandimmun, Switzerland) - an inhibitor of the Ca2+/calcineurin pathway - and
sodium orthovanadate (Sigma Aldrich, Gillingham, UK) - a phosphatase inhibitor -
were diluted in water.
Experimental protocol:
OvHV-2-infected LGL cell lines (BJ1035, BJ1104) were grown in hrIL-2-deficient
medium for 3-4 days then transferred to 96-well plates at a density of 106 cells/ml
(lOOpl per well). The rabbit AlHV-l-infected cell line BJ1859 was also set up at 106
cells/ml in 96-well plates following culture for 2-3days in hrIL-2-deficient medium.
The inhibitors were added to each well at a range of concentrations (see results). As
a carrier control, DMSO alone was added to a well at the maximum concentration
used in each inhibitor study. The growth response of the IL-2-independent cell lines
to the addition of inhibitors was measured as numbers of viable cells (determined by
nigrosine exclusion) per ml of culture. Data were collected over three days in
culture.
4.2.2 Cell proliferation assay using 3H-thymidine
Antibodies that cross-link the T cell receptor and activate rabbit and bovine T
cells are not available. Therefore, the T cell mitogen conA was used in this study.
To test the proliferative response of LGL and control cells to different concentrations
of mitogen the 3H-thymidine incorporation assay was used. lOOpl aliquots of cells at
a density of 2 x 106 cells/ml IMDM were cultured in 96-well plates for two days.
The cells were then incubated with 50ml of 3H-thymidine (0.5pCi/well) for a further
18 hours. Cells were harvested onto membranes and 3H-thymidine incorporation
measured in a p-scintillation counter (Tri-carb 2500 TR, Packard, Meriden, USA).
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4.2.3 Stimulation of lymphocyte signalling molecules and preparation of
cell lysates
The bovine OvHV-2-infected LGL cell line BJ1035 and the rabbit A1HV-1-
infected cell lines BJ1859 and BJ1860 were used in this study. The bovine LGL cell
line BJ1035 was cultured for 48 hours to 22 days in the absence of exogenous IL-2.
Samples were taken at various points during this period of IL-2-deficient culture.
The rabbit LGL cell lines were also taken from culture between 48 and 96 hours after
deprivation of exogenous IL-2. Cell viability at this stage was >70%. Control rabbit
and bovine PBMC or conA-activated lymphoblasts were also deprived of exogenous
IL-2 for up to 30 hours. After this point, cell viability in control cell cultures
dropped below 70%. The maintenance of IL-2-independent cultures is described in
Chapter 2.2.4.
IL-2-deprived control and LGL cells were stimulated using 1 Opg/ml conA for
0, 3, 5, 10 and/or 30 minutes at 37°C in serum-free medium. The dose of conA was
determined by dose-response experiments using the phosphotransferase assay
(Chapter 2.4.5). The preparation of cell lysates following stimulation of cells
proceeded as described in Chapter 2.4.1. Cell lysates were used in western blot
analysis or in subsequent immunoprecipitation protocols (see below).
4.2.4 Immunoprecipitation (IP) of signal transduction molecules
Signal transduction molecules were immunoprecipitated from cell lysates
using specific antibodies at the concentrations indicated (Table 4.1) and as described
in Chapter 2.4.1. Immunoprecipitated samples were prepared for western blotting or
phosphotransferase assays as described in Chapter 2.
4.2.5 SDS-PAGE and western blot analysis
Whole cell lysates or immunoprecipitates from cell lysates were prepared for
SDS-PAGE as described in Chapter 2.4.2 and analysed by western blot (Chapter
2.4.4). For the detection of phosphotyrosine in proteins, nitrocellulose membranes
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were incubated in 4G10 antibody (diluted 1:1000 in wash buffer (0.5M NaCl, 0.5%
(v/v) Tween 80 in PBS). Lck and fyn were detected using the same antibodies as
described for immunoprecipitation and used at a concentration of 1:1000 in wash
buffer.
4.2.6 Determination of Ick and fyn activity by in vitro phosphotransferase
assay
Immunoprecipitation of Ick and fyn were performed as described in Chapter
2.4.1 using the antibodies in Table 4.1. The activity of these kinases was determined
in the phosphotransferase assay as described in Chapter 2.4.5.


























All antibodies (except 4G10) were purchased from Santa Cruz Biotechnology, Santa
Cruz, CA. 4G10 was purchased from Upstate Biotechnology, Lake Placid, NY. All
antibodies were used at a final concentration of l-2pg/ml.
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4.3 Results
4.3.1 Signal transduction inhibitor studies: effect on cell growth
To determine the ability of biochemical inhibitors of signal transduction
pathways to inhibit the growth response of IL-2-independent cells these chemicals
were added to culture medium and cell growth observed over 3-4 days. These
experiments were designed around inhibitor concentrations demonstrated to affect T
cell lines as reported in previous studies (Baldari and Telford, 1994; Gajewski et al,
1995; Luo et al, 1993). It should be noted at this point that the interpretation of
results from these experiments were made with the knowledge that appropriate
control cells could not be included in this study. As this experiment measures the
ability of inhibitors to reverse the IL-2-independent phenotype of LGL cells, the
appropriate control cells would need to be constitutively activated lymphoblasts with
T/NK cell phenotype and the ability to survive IL-2 deprivation. As these control
cells were not available, the results of these experiments were used merely to
indicate possible trends in LGL signalling. The data from these experiments
represent single observations. Since then some of these experiments have been
repeated using triplicate wells and are indicated by error bars - which represent
standard error of the mean (see Fig 4.1).
The cell lines BJ1035, BJ1104 (bovine OvHV-2 infected cells) and BJ1859
(rabbit A1HV-1 infected cells) were cultured without IL-2 for 2-3 days prior to
addition of inhibitors. In the absence of inhibitors, IL-2 independent survival was
maintained for a further 3 days. The growth response of these cells on addition of an
inhibitor differed according to the inhibitor used. Cyclosporin A (CsA) showed a
dose-dependent inhibitory effect on IL-2 independent cell growth in BJ1035 after 3
days in culture with CsA (Fig 4.1a). Sodium orthovanadate had a small inhibitory
effect on cell growth in BJ1035 following 3 days of culture with lOOpM NasVCL
(Fig 4.1b). The inhibition of S6 kinase using rapamycin (which blocks the entry of
resting T cells into the cell cycle) did not inhibit the growth of BJ1035 or BJ1104 in
IL-2-deficient medium (Fig 4.1c). Addition of genistein at lOOpM to BJ1035
cultures (Fig 4.Id) inhibited cell survival and growth over 3 days (p<0.01, compared
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with medium control values). A similar response was noted in BJ1859 (rabbit,
AlHV-l-infected) cultures using genistein at 10pM and lOOpM (p<0.01) (Fig 4.Id).
The response of BJ1104 to genistein followed the same trend as that observed in
BJ1035 and BJ1859 although statistical analysis was not performed as the BJ1104
data represents single observations.
4.3.2 Mitogen stimulation of LGL and control cells
The proliferative response of LGLs and control cells (deprived of exogenous
IL-2 for approximately 30 hours) to conA ± TPA stimulation was assessed by 3H-
thymidine incorporation over three days and the results shown in Table 4.2. The
results show that mitogen induces proliferation of bovine and rabbit control
lymphoblasts. However, both rabbit and bovine LGL cells (deprived of exogenous
IL-2 for 2 and 4 days respectively) showed poor (if any) proliferative responses to
mitogen. The use of TPA in addition to conA did not alter the response observed
with conA alone.
4.3.3 Analysis of tyrosine phosphorylated proteins in total cell lysates
The role of protein-tyrosine kinase signaling molecules in MCF virus
infection was suggested by the response of LGL cell lines to genistein. To determine
whether MCF-virus infection was associated with differences between control and
LGL cell lines the presence of tyrosine phosphorylated proteins in cell lysates of IL-
2-deprived cultures (with and without 5 and 10 minutes of stimulation with conA)
was investigated. During this period of stimulation, the non-receptor tyrosine
kinases (NRPTKs) such as Ick and fyn are likely to be activated and phosphorylated.
The presence of tyrosine phosphorylated proteins was assessed by western blot using
the phosphotyrosine-specific antibody, 4G10. Fresh peripheral blood mononuclear
cells (PBMCs) or conA-stimulated lymphoblasts were used as controls. The data
shown represents the best two of three repeated experiments.
In unstimulated rabbit A1HV-1-infected LGL cell lines BJ1859 and BJ1860
tyrosine-phosphorylated proteins of approximately 90, 70, 55-59, 48, 38 and 21 kDa
were detected (Fig 4.2a) and was observed in repeated 4G10 western blots (Fig
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4.2b). After 5 minutes stimulation with conA changes in the intensity of some bands
were observed, though this was not consistent in repeat analyses. ConA-stimulated
control rabbit lymphoblasts expressed a similar set of phosphorylated tyrosine bands
as those observed in the unstimulated rabbit LGL cell lines. These same bands
appeared at low levels in the unstimulated rabbit lymphoblast cell lysates.
Stimulated bovine control PBMCs or lymphoblasts and unstimulated bovine
OvHV-2-infected cell line BJ1035 expressed tyrosine-phosphorylated proteins of
approximately 90, 70, 55-59, 48, 38, and 21 kDa (Fig4.2c, d). Unstimulated control
lymphoblasts expressed low levels of tyrosine-phosphorylated proteins compared to
stimulated control cells. Tyrosine-phosphorylated proteins were not detectable in
unstimulated PBMCs. After stimulation, BJ1035 exhibited changes in the intensity
of some bands while others appeared unchanged. The changes in band intensity
following stimulation were also observed in a repeated analysis (Fig4.2d). However,




Fig 4.1: Growth response of LGL cell lines to signal transduction
inhibitors.
Cell lines BJ1035, BJ1104 (bovine, OvHV-2-infected) and BJ1859 (rabbit,
AIHV-1-infected) were seeded at a density of 106 cells/ml (1 OOjal per well) at
day 0. Viable cell counts were performed after 3 days of culture in the
following inhibitors: a) CsA = cyclosporin A, b) Na3V04 = sodium
orthovanadate, c) rapamycin and d) genistein. med. control = medium only.
Error bars indicate mean ± sem for triplicate wells. Where error bars are
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Fig 4.2: Phosphotyrosine proteins in LGL and control lysates.
4G10 anti-phosphotyrosine western blot of lysates from unstimulated (-) cells
or cells stimulated for 5 (5) or 10 (10) minutes with 10pig/ml conA and
separated by SDS-PAGE. The best two of three repeated experiments are
shown.
A and B) Control rabbit conA-stimulated lymphoblasts (L/blasts) and the
AIHV-1-infected LGLs, BJ1859 and BJ1860.
C and D) Control bovine peripheral blood mononuclear cells (PBMC), control
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4.3.4 Detection of src kinases in LGLs
Western blot analysis of the whole cell lysates of rabbit or bovine LGL cells
and control cells with antibodies to src kinases and the syk kinase ZAP-70 identified
only two antibodies - anti-fan and anti-Ick that reacted with the p55 and p56/59kDa
proteins respectively. ZAP-70 could not be detected. The cells were stimulated (or
not) with 10pg/ml of conA for 5 and 30 minutes. The concentration of conA was
optimised by dose-repsonse experiments using the phosphotransferase assay.
Activity of Ick and fyn kinases was assessed by phosphotransferase assay.
This assay measures the amount of radioactive [y-32P]-ATP incorporated into a src
32kinase substrate (enolase) by a precipitated kinase. The level of [y- P]-ATP
incorporated into enolase was evaluated by autoradiography and by P-scintillation
counting. In earlier experiments, only P-scintillation counts were collected. The
activity of Ick and fyn were assessed in the rabbit A1HV-1-infected cell lines BJ1859
and BJ1860 and the bovine OvHV-2-infected cell line BJ1035. The data shown
represents of the best two of three repeated experiments.
In control rabbit lymphoblasts and the A1HV-1-infected cell lines BJ1859 and
BJ1860, immunoprecipitated fyn kinase was activated and phosphorylated the
substrate, enolase (Fig 4.3). In control cells, the degree offyn activation in 'rested'
unstimulated cells was low but increased to high levels following a 5 minute
stimulation with conA (Fig 4.3a, d, e). The level of activity observed after 5 minutes
stimulation declined after 30minutes stimulation. In contrast, the fyn kinases in
BJ1859 and BJ1860 were equally activated with and without conA stimulation (Fig
4.3a, d, e).
In 'rested' unstimulated bovine control lymphoblasts, fyn exhibited very low
levels of activation. Fyn was maximally activated following stimulation of control
cells with conA for 5 minutes. This activity declined after 30 minutes of stimulation
(Fig 4.4a). However, OvHV-2 infected BJ1035 cells exhibited similar levels of fyn
activation with or without conA stimulation (Fig 4.4a, d, e). Fig 4.3b, c and Fig 4.4b,
c show that for each of the cell types there was equal loading of enolase and
immunoprecipitated fyn was used in the analysis of enolase phosphorylation by
autoradiography.
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In control rabbit PBMCs after stimulation with conA; rabbit control
lymphoblasts after stimulation with conA and A1HV-1 infected rabbit LGL cell lines
BJ1859, BJ1860 either before or after conA stimulation Ick kinase was activated and
phosphorylated enolase (Fig 4.5). In contrast to the control cells, the LGL cell lines
BJ1859 and BJ1860 exhibited a high level of Ick activation in the absence of conA
that did not increase after conA stimulation of the cells. In unstimulated bovine
control lymphoblasts, Ick phosphorylation of enolase substrate was low and
maximally active after 5 minutes stimulation compared to 30 minutes stimulation
with conA. In contrast, Ick was highly active in unstimulated bovine OvHV-2 cell
line BJ1035 and this activity was not increased by conA stimulation of the cells (Fig
4.6). In all experiments, control samples containing enolase and [y-32P]-ATP but
without immunoprecipitated kinases did not show any detectable phosphorylation of
enolase (Fig 4.5a and 4.6a). For each of the cell types there was an approximately
equal loading of enolase and immunoprecipitated Ick (Fig 4.5b, c and 4.6b, c). In Fig
4.5b the loading of enolase in the gel with samples of BJ1859 and BJ1860 is not
shown as the quality of the stained gel was poor on two occasions.
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Fig 4.3: Fyn kinase activation in AIHV-1-infected rabbit LGLs (BJ1859
and BJ1860) and control rabbit cells.
A. Autoradiograph of SDS-PAGE gel showing enolase phosphorylation by
fyn kinase immunoprecipitated (IP) from LGLs and control lymphoblasts
either unstimulated (-) or stimulated with conA (lOpg/ml) for 5 minutes
(5) or 30 minutes (30).
B. Coomassie blue stained gel. Control for protein loading of enolase in
each lane.
C. Western blot (anti-fyn) control for equal loading of IP fyn.
D. Quantitation of enolase phosphorylation by p-scintillation counts per
minute (cpm) of enolase bands excised from the SDS-PAGE gels shown
above. C = control lymphoblasts; 59 = BJ1859; 60 = BJ1860. Cells were
unstimulated (0) or stimulated with conA for 5 or 30 minutes.
E. Quantitation of enolase phosphorylation by p-scintillation cpm from a
separate experiment where enolase bands were excised from gels
without autoradiography (thus no images of gels are available). PBMC =
peripheral blood mononuclear cells. Cells were unstimulated (0) or
stimulated with conA for 5 or 30 minutes.
These data represent the best two of three repeated experiments.
Note: cpm shown in D and E were not taken at the same time in relation to
the start of the assay therefore the radioactivity in these samples will have
been at different stages of decay. For this reason, the results above must be
compared within a group rather than between groups. In these gels, lysates
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Fig 4.4: Fyn kinase activation in the OvHV-2-infected bovine LGL,
BJ1035 and control bovine cells.
A. Autoradiograph of SDS-PAGE gel showing enolase phosphorylation by
fyn kinase immunoprecipitated (IP) from LGLs and control lymphoblasts
either unstimulated (-) or stimulated with conA (10f.ig/ml) for 5 minutes
(5) or 30 minutes (30).
B. Coomassie blue stained gel. Control for protein loading of enolase in
each lane.
C. Western blot (anti-fyn) control for equal loading of IP fyn.
D. Quantitation of enolase phosphorylation by p-scintillation counts per
minute (cpm) of enolase bands excised from the SDS-PAGE gels shown
above. C = control lymphoblasts; 35 = BJ1035. Cells were unstimulated
(0) or stimulated with conA for 5 or 30 minutes.
E. Quantitation of enolase phosphorylation by p-scintillation cpm from a
separate experiment where enolase bands were excised from gels
without autoradiography (thus no images of gels are available). PBMC =
peripheral blood mononuclear cells. 35 = BJ1035. Cells were
unstimulated (0) or stimulated with conA for 5 or 30 minutes.
These data represent the best two of three repeated experiments.
Note: cpm shown in D and E were not taken at the same time in relation to
the start of the assay therefore the radioactivity in these samples will have
been at different stages of decay. For this reason, the results above must be
compared within a group rather than between groups. In these gels, lysates
from 8 x 106 cell equivalents were loaded per lane.
132
Control 1035



















o m O O o
CJ O w ^ m o
Cj co co i/o
m
I.iii
















Fig 4.5: Lck kinase activation in AIHV-1-infected rabbit LGLs (BJ1859
and BJ1860) and control rabbit cells.
A. Autoradiograph of SDS-PAGE gel showing enolase phosphorylation by
Ick kinase immunoprecipitated (IP) from LGLs and control lymphoblasts/
peripheral blood mononuclear cells (PBMC) either unstimulated (-) or
stimulated with conA (10pg/ml) for 5 minutes (5).
B. Coomassie blue stained gel. Control for protein loading of enolase in
each lane.
C. Western blot (anti-/c/c) control for equal loading of IP Ick.
D. Quantitation of enolase phosphorylation by (3-scintillation counts per
minute (cpm) of enolase bands excised from the SDS-PAGE gels shown
above. L/blast = control lymphoblasts; PBMC = peripheral blood
mononuclear cells; 59 = BJ1859; 60 = BJ1860. Cells were unstimulated
(0) or stimulated with conA for 5 minutes.
E. Quantitation of enolase phosphorylation by (3-scintillation cpm from a
separate experiment where enolase bands were excised from gels
without autoradiography (thus no images of gels are available). PBMC =
peripheral blood mononuclear cells. Cells were unstimulated (0) or
stimulated with conA for 5 minutes.
These data represent the best two of three repeated experiments.
Note: cpm shown in D and E were not taken at the same time in relation to
the start of the assay therefore the radioactivity in these samples will have
been at different stages of decay. For this reason, the results above must be
compared within a group rather than between groups.
In these gels, lysates from 8 x 106 cell equivalents were loaded per lane.
Coomassie blue stain for enolase loading for the BJ1859 and BJ1860
samples (B) was of poor quality and is therefore not shown.
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Fig 4.6: Lck kinase activation in the OvHV-2-infected bovine LGL,
BJ1035 and control bovine lymphoblasts.
A. Autoradiograph of SDS-PAGE gel showing enolase phosphorylation by
Ick kinase immunoprecipitated (IP) from LGLs and control lymphoblasts
either unstimulated (-) or stimulated with conA (10pg/ml) for 5 minutes
(5) or 30 minutes (30).
B. Coomassie blue stained gel. Control for protein loading of enolase in
each lane.
C. Western blot (anti-/c/c) control for equal loading of IP Ick.
D. Quantitation of enolase phosphorylation by p-scintillation counts per
minute (cpm) of enolase bands excised from the SDS-PAGE gels shown
above. C = control lymphoblasts; 35 = BJ1035. Cells were unstimulated
(0) or stimulated with conA for 5 or 30 minutes.
E. Quantitation of enolase phosphorylation by p-scintillation cpm from a
separate experiment where enolase bands were excised from gels
without autoradiography (thus no images of gels are available). PBMC =
peripheral blood mononuclear cells.
These data represent the best two of three repeated experiments.
Note: cpm shown in D and E were not taken at the same time in relation to
the start of the assay therefore the radioactivity in these samples will have
been at different stages of decay. For this reason, the results above must be
compared within a group rather than between groups. In these gels, lysates
from 8 x 106 cell equivalents were loaded per lane.
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4.4.1 Inhibitor studies suggest involvement of early signalling events of
T cell activation in LGL cells
Several characteristics of LGL cell lines from MCF-affected animals have
been used to differentiate them from uninfected control cells. The ability of LGLs to
survive or grow in the absence of exogenous cytokines for longer periods than
control cells and the LGL's constitutive cytotoxic activity are two such
characteristics and may be dependent on viral gene products interfering with
signalling molecules. As viral genes or proteins were not available at the time of this
study, the characteristics of these cell lines could not be attributed to a specific virus-
host protein-protein interaction. Thus, the inhibitor study allowed for a more general
investigation of signalling mechanisms that might be responsible for the phenotype
of LGL cells cultured in the absence of exogenous IL-2.
Cyclosporin A binds an intracellular protein called cyclophillin A. This
complex then binds and inactivates calcineurin (a phosphatase). This protein is
involved in the Ca2+/calcineurin pathway that mediates cytokine production and
proliferation of T cells (McKeon, 1991). The effect of CsA in inhibiting the
lymphoproliferative response in OvHV-2 infected rabbits has been demonstrated
(Buxton et al, 1984). This immunosuppressant has also been shown to inhibit the
growth of bovine OvHV-2-infected cell lines in a time and dose-dependent manner
(Schock, 1996). The results presented here follows the trend observed in previous
studies which implicates the involvement of T cell or NK cell signalling molecules in
exogenous lL-2-independent LGL growth. Phosphatases such as calcineurin and
CD45 are involved in T cell signal transduction pathways following TCR or cytokine
receptor engagement (Amrein and Sefton, 1988; Crabtree and Clipstone 1994;
Koretzky et al, 1990). The involvement of phosphatases in LGL factor-independent
growth is suggested by the effect of high concentrations of sodium orthovanadate on
bovine OvHV-2-infected cell line BJ1035. Rapamycin inhibits signal transduction
pathways through the IL-2 and other cytokine receptors (Chung et al, 1992).
However, inhibition of IL-2-independent growth by rapamycin was not observed in
the two LGL cell lines tested. This would appear to suggest that IL-2 receptor
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mediated signalling is not critical for IL-2 independent growth. The effect of
genistein on growth of cell lines tested here was the most significant and implicates
tyrosine kinases as mediators of IL-2-independent LGL growth.
It should be noted that the results of studies using CsA, sodium orthovanadate
or rapamycin were not conclusive due to lack of replicate samples. This was due to
the limited supply of cells as a consequence of the death of cell lines during the
course of this study combined with the failure to resuscitate fresh cell lines from
frozen stocks. Subsequent to this study, the effect of rapamycin and genistein on the
cell lines BJ1035 and BJ1859 were repeated using triplicate samples and included in
Fig 4.1. Statistical analysis was performed on these new data (and indicated by the
presence of error bars). At present, any conclusions made from these data remain
tentative and are further complicated by the difficulty in distinguishing between
inhibition of signalling pathways and toxicity due to these chemicals as both
phenomena are measured by cell death. However, this study has proved useful in
suggesting potential areas of LGL growth control that should be investigated in more
detail.
4.4.2 Targeting specific signalling molecules
Non-receptor tyrosine kinases found in T cells (Ick, fyn and ZAP-70) are
located near the cell membrane and are the first signalling molecules activated on
engagement of the T cell receptor (TCR) complex and other cell surface molecules
such as CD2 and CD4 (Crabtree and Clipstone, 1994). On activation, these
signalling molecules become phosphorylated on tyrosine residues. ConA (a T cell
mitogen) and TPA (a phorbol ester) stimulate polyclonal T cell proliferation through
receptors rich in mannose residues including the TCR complex and by the activation
of protein kinase C respectively.
While conA-activated lymphoblasts serve well as uninfected controls with a
T cell phenotype, it was often difficult to obtain a fully rested population even after
an overnight deprivation of exogenous cytokines. Using fresh PBMCs as 'resting'
controls was useful for assessing the state of activation of MCF-derived cell lines.
The results suggested that MCF virus infection of LGLs is associated with the
constitutive activation of Ick and fyn tyrosine kinases. There were more similarities
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than differences in the pattern of tyrosine phosphorylation between control
lymphoblasts and LGL cell lines after stimulation as measured by the 4G10 antibody
western blot. This suggested that tyrosine kinases were activated following
stimulation of both control and LGL cells. The important observation was that in the
absence of stimulation tyrosine phosphorylated proteins were detected in LGL cells
but not PBMCs. This may suggest that LGL cells are constitutively active in the
absence of exogenous IL-2. However, the identity of the phosphorylated proteins
has not been determined. Antibodies specific for human, mouse and rat ZAP-70 did
not react convincingly with any proteins in the rabbit or bovine cell lysates.
However Ick and fyn were revealed using antibodies specific for human, mouse and
rat Ick and fyn in western blots of cell lysates at 56/59kDa and 55kDa respectively.
An indication of constitutively active kinase activity in the LGLs emerged
from the phosphotransferase assays of immunoprecipitated Ick and fyn. Using
enolase as a substrate for the precipitated kinases, the phosphotransferase assays
indicated that Ick and fyn were constitutively activated in both rabbit and bovine LGL
cells compared to control 'resting' cells. The fact that conA stimulation did not
substantially alter the level of Ick and fyn activation in the LGL cells suggest that
these kinases are maximally activated in these cells. Previous studies showed that
OvHV-2-infected LGL cell lines exhibit low levels of proliferation in response to
conA stimulation (Schock, 1996). This result was confirmed in the cell lines
examined in this study and extended the results to AlHV-l-infected rabbit LGL cells.
Therefore, the lack of enhanced proliferation of LGL cells to conA (or conA + TPA)
stimulation may be explained by the inability of Ick and fyn kinase activity to be
stimulated further by these mitogens. An alternative explanation for the relative lack
of responsiveness of LGLs to conA compared to control cells could be due to lack of
expression of conA receptors in the LGL cell lines. However, the aggregation of
LGL cells and control cells in the presence of conA indicates the binding of this
mitogen to the cells (data not shown). The data presented here confirms the
preliminary observations from inhibitor studies suggesting the involvement of
tyrosine kinases in LGL cell lines. Moreover, this study is the first description of the
responsiveness of rabbit A1HV-1-infected LGLs to conA.
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The constitutive activation of Ick and fyn in LGL cell lines suggested by this
study warranted a more thorough investigation of the downstream consequences of
MCF virus infection. Further investigation of the MAPKs (mitogen-activated protein
kinases) erkl and erk2, which are activated following stimulation through various
membrane receptors (Pelech and Sanghera, 1992), was performed following the
completion of the present study. The results showed that MAPKs were constitutively
activated in MCF virus-infected LGL cell lines (Swa et al, in press).
In conclusion, an association between MCF virus infection of LGL cells and
the constitutive activation of Ick, fyn and MAPK has been suggested. This may point
to the possibility that virus could interact directly or indirectly with Ick, fyn and
MAPK. However, it should be noted that this has not been shown. However given
more recent understanding of the molecular biology of A1HV-1 (Ensser et al, 1997)
subsequent to this study, the search for viral proteins that interact with signalling
molecules is currently being undertaken.
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Chapter 5
Expression of recombinant AIHV-1 proteins (ORF50,




In Chapter 3, the results demonstrated that MCF virus infection of LGL cells
was associated with an altered phenotype. In addition, interference with Ick and fyn
kinase signalling pathways was also associated with MCF virus infection (Chapter
4). However, the involvement of specific virus proteins in the generation of the LGL
phenotype and function has not been established. The following chapters describe
specific virus proteins associated with virulence, which may be important in MCF
pathogenesis and describe experiments to test whether these proteins could account
for the ability of LGLs to cause disease in rabbits.
Until recently, only limited sequence data was available on the A1HV-1
genome and to an even lesser extent on OvHV-2. However, the A1HV-1 C500
genome had been characterised by restriction enzyme analysis (Handley et al, 1995).
A1HV-1 C500 exists in two forms - the cell-associated virulent form and the cell-free
attenuated form. The second form of C500 is generated upon serial passage in
culture (Plowright, 1986). Handley et al demonstrated differences in the restriction
enzyme profiles between virulent and attenuated forms of C500. These differences
were encompassed in three fragments. These fragments were cloned and sequenced.
When sequenced, these three clones (of approximately 3.5kbp each) were found to
share 2kbp of DNA. The differences in nucleotide sequence between these clones
were thought to be due to rearrangements in the viral genome during the transition
from virulence to attenuation. However, more recent results indicate that the
rearrangements that occur at the right terminal end of the attenuated C500 genome
are different from that published by Handley et al (1995) (H.Wright, personal
communication). The new data is consistent with the translocation of a fragment of
DNA from the middle of the virulent C500 genome to the right terminal end of the
attenuated genome. Any proteins deleted or altered during the rearrangements were
potential virulence factors with a role in viral pathogenesis. Protein translation of the
DNA clone encompassing the middle of the virulent C500 genome revealed three
ORFs. These were denoted ORFs 50, A6 and A7 respectively in Ensser's analysis of
the complete genomic sequence for A1HV-1 C500 (Ensser et al, 1997).
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One of the distinctive characteristics of LGLs is that they have the ability to
cause MCF when inoculated into rabbits. This would suggest the presence of a
productive and virulent virus in the LGLs. The study of virulence-associated
proteins is therefore important due to their potential role in pathogenesis and their
expression in LGLs could explain the ability of such cell lines to induce MCF when
used as an inoculum in rabbits.
In this chapter, the expression of ORF50, A6 and A7 as bacterial recombinant
proteins and the production of rabbit polyclonal antisera specific for them is
described. These reagents were then used to detect the presence of ORF50, A6 and
A7 at the protein level in virus-infected cells (Chapter 6). The expression of
recombinant proteins in E. coli is a common method of expressing foreign proteins
and is used for production of high yields. The cloned genes were inserted into the
vector, pTrXFus, that contained an ampicillin resistance gene to aid selection of
transformed E. coli and the bacteriophage X promoter (Pi) to drive expression, which
is induced by tryptophan (Mieschendahl et al, 1986). This expression system uses
thioredoxin (TrX) as the peptide fusion partner and was chosen for its ability to
express high levels of soluble fusion proteins (Flolmgren, 1985; La Vallie et al,
1992). This fusion partner was also useful as a means of identification of the
recombinant proteins in the absence of virus protein-specific antisera as monoclonal
antibodies to TrX were available. These recombinant fusion proteins were then used
as antigens to raise specific polyclonal antisera in rabbits. The generation of a
glutathione S-transferase (GST)-recombinant ORF50 product and specific antisera
following purification of the antigen by electroelution was previously achieved by R.
Ireri at Moredun (Ireri, 1999). In this study, similar methods were used to produce,
purify and test the reagents specific for the products of ORFA6 and A7. The further
purification by affinity chromatography of the antisera to the products of ORF50, A6
and A7 is also described.
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5.2 Materials and Methods
5.2.1 Expression of recombinant AIHV-1 proteins in E. coli
The DNA encoding ORF50, A6 and A7 were amplified by PCR, inserted into
the vector pTrXFus and expression induced in E coli as described in Chapter 2.5.3
using the primers shown in Table 5.1. Recombinant thioredoxin fusion proteins were
harvested from E. coli by lysis as described in Chapter 2.5.3. Recombinant proteins
in the E. coli supernatant and pellet material were identified using an anti-thioredoxin
antibody in a Western blotting analysis (Chapter 2.4.4). For the purposes of clarity,
these recombinant proteins will be described in the text as ORF50-TrX, ORFA6-TrX
and ORFA7-TrX.
5.2.2 Purification of recombinant proteins by electroelution
200pl of crude E. coli supernatant was prepared in the same volume of 2x
Laemmli sample buffer (62.5mM Tris-HCl pH7.8, 10% sucrose, 2% SDS, 0.001%
bromophenol blue, 5% p-mercaptoethanol). Meanwhile, insoluble proteins in the
pellet fraction (resulting from 20mls of induced broth - see Chapter 2.5.3) were
resuspended in 200pl of lx Laemmli sample buffer. Proteins were visualised during
separation by Coomassie Blue SDS-PAGE (see Chapter 2.4.3). Recombinant
ORFA6 and A7 bands were excised from the gel according to their molecular
weight.
Gels containing the excised protein band were roughly chopped and proteins
removed by electroelution as described in Chapter 2.4.6. The electroeluted material
was collected and concentrated in Vivaspin concentrators (with a lOkDa cut-off
membrane) (Vivascience, Lincoln, UK) with PBS to a final volume of 500pl. This
material was stored at 4°C while aliquots were taken to assess the purity and
concentration of the material.
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Table 5.1: Primers used for the production of DNA sequences for
ORF50, A6 and A7 of AIHV-1 for recombinant protein synthesis.


























Primers for ORF50 DNA were generated prior to the publication of the full AIHV-1
sequence by Ensser (1997) and covers the ORF50 DNA sequence from 73571bp -
74919bp (thus 746bp smaller than the sequence for ORF50 published by Ensser).
The primers for ORFA6 DNA cover the sequence from 75213bp - 75860bp.
Similarly, ORFA7 primers cover 76554bp - 77312bp. [Tm = melting temperature].
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5.2.3 Testing the purity and concentration of electroeluted material
A 20jal aliquot of the electroeluted material was separated by SDS-PAGE and
analysed by western blot with an anti-thioredoxin antibody (diluted 1: 5000).
Aliquots of purified ORFA6-TrX were placed alongside samples of bovine serum
albumin (BSA) at different concentrations (between 0.05 - 25mg/ml) on an SDS-
PAGE gel. Proteins were visualised by silver staining (see Chapter 2.4.3) and the
concentration of the electroeluted sample was calculated on a BIORAD densitometer
using BSA as standards. The concentration of purified insoluble ORFA7-TrX was
estimated by the size of the band in a Coomassie stained SDS-PAGE gel.
5.2.4 Production of polyclonal rabbit antibodies against recombinant
AIHV-1 proteins
For the preparation of polyclonal antibodies, two rabbits were immunised
with the electroeluted ORFA6-TrX or ORFA7-TrX as described in Chapter 2.1.2.
The antigens used were prepared as follows. ORFA6-TrX from 2mls of crude E. coli
supernatant was electroeluted and the material was concentrated to a final volume of
1.5ml. The protein concentration was determined as described above. This material
was divided between the two rabbits for each set of inoculations. Similarly, the
equivalent of 3 pellets of ORFA7-TrX/E'. coli insoluble protein were purified by
electroelution and divided between two rabbits for each set of inoculations.
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5.2.5 Affinity purification of polyclonal sera on a protein A-sepharose
column
Once reactivity of sera from inoculated rabbits to the respective recombinant
proteins had been confirmed by western blot (see below) the rabbits were bled.
Blood was allowed to clot and serum was collected by centrifugation at 900 x g for
10 minutes. The serum was further purified on a protein A-sepharose column by
FPLC to produce an IgG fraction, which was detected by a shift in absorbance at
280nm (see Chapter 2.4.7).
Samples were either tested for reactivity against the original antigen or
aliquoted and stored (in PBS/0.05% azide) at -20°C for future use.
5.2.6 Testing for reactivity of antisera by SDS-PAGE and western blot
To test the reactivity of sera, recombinant proteins (in reducing Laemmli
sample buffer) were loaded in one large well (using a 0.5mm comb) of a BIORAD
Mini Protean II system and transferred to nitrocellulose (see Chapter 2.4.4). Strips of
this nitrocellulose were then blotted with each fraction of purified sera and the 'flow
through' (unbound protein) fraction at two dilutions (1:100 and 1:500). Anti-
thioredoxin was included as a positive control (and used at 1:5000). Western blots
were developed with TMB stabilised substrate for HRP (Promega, Southampton,
UK) or with ECL reagents (Amersham International, Little Chalfont, UK).
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5.3 Results
5.3.1 Thioredoxin recombinant proteins encoded by ORF50, A6 and A7
of AIHV-1 have variable solubility
All the recombinant proteins appeared as the dominant protein in the E. coli
lysate. This was determined by Coomassie staining following separation of the
soluble and insoluble fractions in a reducing gel. However, only the ORFA6-TrX
appeared in the soluble fraction of the E.coli lysate. The proteins ORF50-TrX and
ORFA7-TrX appeared in the insoluble fraction of the E coli lysate (Fig 5.1).
Western blot with anti-thioredoxin antibody confirmed these dominant bands
to be thioredoxin recombinant proteins. ORF50-TrX, ORFA6-TrX and ORFA7-TrX
have a molecular weight of 70-75kDa, 40kDa and 40-45kDa respectively (Fig 5.2).
5.3.2 Recombinant proteins ORFA6-TrX and ORFA7-TrX can be
successfully purified by electroelution for inoculating rabbits
In order to purify recombinant proteins for use as an inoculum for raising
antibodies in rabbits, electroelution of these proteins from Coomassie Blue-SDS-
PAGE gels was performed. Recombinant proteins in these gels were identified by
their respective molecular weights established in the previous section (5.3.1).
The electroeluted material from the ORFA6-TrX Coomassie Blue gel
contained a thioiedoxin piolein of 40kDa (Fig 5.3a). This protein was the doriiiiiant
protein in the purified material. The concentration of the pooled sample was
approximately 100p.g/ml (using known concentrations of BSA to give a standard
curve - Fig 5.3c). This equates to approximately 7.5pg recombinant protein /ml
bacterial culture. The thioredoxin recombinant ORFA7-TrX was successfully
purified in a similar way (Fig 5.3b) and its identity confirmed by the presence of a
protein of the predicted molecular weight that was detectable by western blot with
anti-thioredoxin. The concentration of electroeluted ORFA7-TrX was estimated to
be approximately 100pg/ml by the intensity of the protein band following staining
with Coomassie blue.
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Fig 5.2: Western blot analysis of recombinant proteins in E. coli
lysates using an anti-thioredoxin antibody (diluted 1: 5000).
G1724 = E.coli, uninduced (control); 50/ G1724 = E.coli + ORF50-TrX
protein; A6/ G1724 = E.coli + ORFA6-TrX protein; A7/ G1724 = E.coli
+ ORFA7-TrX protein; TrX/ G1724 = E.coli + thioredoxin (control).
SN = soluble fraction of lysate; P = insoluble pellet fraction of the
lysate. Molecular weight markers (kDa) are indicated to the left of
each blot. Recombinant proteins are indicated by arrows.
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7 0RFA6-TrX















Fig 5.3: Electroeluted samples of 0RFA6 and 0RFA7 - thioredoxin fusion
proteins.
A) Western blot analysis of electroeluted ORFA6-TrX using an anti-thioredoxin
antibody detected by TMB substrate reaction. R = reduced NR = non-reduced.
B) Coomassie Blue stain of electroeluted ORFA7-TrX.
C) Silver stain of electroeluted ORFA6-TrX indicated by arrow (lanes 1-3: batch
1-3, lane 4: pooled sample) and different concentrations of BSA (lanes 5-9: 0.05,
0.5, 2.5, 5.0, 25mg/ml).
Molecular weight markers (kDa) are indicated to the left of each blot or gel.
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5.3.3 Polyclonal antisera react with the respective recombinant protein
5.3.3.1 Antisera specific for ORF50-GST fusion protein reacts with ORF50-
TrX
Further purification on a protein-A sepharose column of whole serum from a
rabbit (#28) inoculated with ORF50-GST recombinant protein was performed. The
shift in absorbance at 280nm indicated the presence purified IgG in the eluted
fractions. A total of five lml fractions were eluted from the column using 0.5ml of
crude serum - hence the serum was diluted by a factor of ten. These eluted fractions
were able to detect ORF50-TrX along with a number of other E. coli proteins by
western blot (after a further dilution of 1:100 and 1:500). The IgG fractions were
reactive against reduced and non-reduced ORF 50-TrX. No proteins were detected
using the 'flow through' fraction which contains antibodies and proteins not bound to
the protein-A sepharose column (Fig 5.4).
5.3.3.2 Rabbits generate a lower antibody response to ORFA6-TrX
recombinant protein
Rabbits (#88 and #89) inoculated with ORFA6-TrX protein did not appear to
produce as much IgG as rabbit #28 as the shift in absorbance at 280nm was not as
large as that seen with eluted IgG fractions from rabbit #28. Using 0.5mls of crude
serum from rabbit #88 and #89, four 2ml IgG fractions and three 2ml IgG fractions
respectively were eluted from protein-A sepharose (resulting in a total serum dilution
of 1:16 and 1:12). A further dilution of 1:100 and 1:500 was made for western blot
analysis against the ORFA6-TrX fusion protein. All eluted fractions tested from
rabbit #88 (Fig 5.5a) but not rabbit #89 (data not shown) were reactive to reduced
and non-reduced ORFA6-TrX. The 'flow through' fraction in both cases was
negative for reactive antibodies. However, whole sera from both rabbits were able to
detect ORFA6-TrX (Fig 5.5b).
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Fig 5.4: Western blot analysis of purified (IgG) anti-ORF50 antiserum
against ORF50-TrX recombinant protein.
Fraction #1-#5 = purified IgG eluted from a protein-A sepharose column.
'Flow through' = antibodies/proteins from whole sera that did not bind to
affinity column. Recombinant protein is indicated by the arrow. Molecular
weight markers (kDa) are indicated to the left of the blot.
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Fig 5.5: Western blot analysis of anti-ORFA6 antiserum reactivity
against recombinant ORFA6-TrX.
A) IgG fractions (#1 - #4) and unbound antibodies/proteins ('Flow through')
produced during purification of ORFA6-TrX antisera using a protein-A
sepharose column.
B) Whole ORFA6-TrX antisera from rabbit #88 and #89.
Recombinant proteins are indicated by arrows. Molecular weight markers






Fig 5.6: Western blot analysis of purified (IgG) anti-ORFA7 antiserum
against recombinant ORFA7-TrX.
Lane 1: G1724 pellet (control) = insoluble fraction of an E. coli lysate.
Lanes 2-3: A7/ G1724 pellet = insoluble fraction of an E. coli + ORFA7-TrX
lysate. Recombinant proteins are indicated by arrows. Molecular weight
markers (kDa) are indicated to the left of the blots.
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5.3.3.3 Pooled fractions of IgG to ORFA7-TrX are more reactive to the
recombinant protein than single fractions alone
Using whole sera from rabbit #159 and #160 (inoculated with ORFA7-TrX),
a shift in absorbance at 280nm was detected in the eluted IgG fractions from a
protein-A sepharose column. A larger shift in absorbance was observed in the eluted
IgG fractions from rabbit #160 than from rabbit #159. This suggested that the IgG
response of rabbit #160 to full length ORFA7-TrX was greater than that produced by
rabbit #159. From an original volume of 0.5ml whole serum four 2ml fractions were
eluted from the protein-A sepharose column for each rabbit (a total serum dilution of
1:16). Western blot reactivity of these sera at 1:100 and 1:500 against ORFA7-TrX
was patchy with fraction 2 and 3 producing the strongest response (data not shown).
Western blots using pooled fractions of IgG to ORFA7-TrX (from rabbit #160)
followed by ECL development showed reactivity to ORFA7-TrX and a smaller but
equally abundant E. coli protein (Fig 5.6). The IgG fractions were reactive against
reduced and non-reduced ORE A7-TrX. Normal rabbit serum in all cases was not
reactive against any of the recombinant proteins.
5.3.3.4 Purification of terminal sera from rabbits #28, #88 and #160
While the protein A-sepharose column was successful in purifying IgG
fractions from whole sera, the yield (as assessed by shift in O.D.280) was not always
high. In order to ensure the optimal binding of IgG a new protein-A sepharose
column was packed before proceeding with the final purification of terminal sera.
This resulted in high levels of IgG binding for all three sera (of which purification of
sera to ORFA6-TrX is shown in Fig 5.7). The fractions collected were pooled
(giving a total volume of 5ml for each serum) then concentrated in PBS to the
original volume of 0.5ml. Using the Pierce assay the IgG levels in rabbit #28, #88






Fig 5.7: Antiserum to ORFA6-TrX purified on a protein A-sepharose column.
IgG fractions were eluted from the column using a glycine elution buffer and
detected by a shift in absorbance at 280nm.
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5.4 Discussion
The production of proteins encoded by ORF50, A6 and A7 produced as TrX
fusion proteins was successful although some degradation of the fusion proteins was
observed despite the presence of leupeptin and EDTA (both protease inhibitors) in
the lysis buffer. This could be improved by addition of other protease inhibitors or
by reducing the induction period. The induction period of 4 hours was chosen as a
compromise between the recommended 2-7 hours (ThioFusion™ Expression System
Manual, Invitrogen) to limit degradation while allowing time for higher yields. For
the purpose of use as an immunogen, the level of expression and degradation were
acceptable following this period of induction. Had there been problems with
expression a more thorough investigation of optimum induction periods would have
been carried out.
The use of electroelution as opposed to affinity purification allowed for the
selection of only the full-length fusion protein, eliminating any degradation products.
In addition, the use of affinity purification requires the use of soluble proteins. As
ORFA7-TrX was insoluble further solubilisation and refolding procedures would
have to be performed prior to affinity purification. The uncertainty of regaining the
native tertiary structure by these procedures made electroelution the method of
choice for purification of proteins for use as an inoculum for immunising rabbits to
raise antisera. Other strategies to increase the expression of soluble proteins could be
investigated further (e.g. lowering the temperature during induction, use of different
strains of E. coli or different vectors). Following the publication of the full sequence
of A1HV-1, ORFA7 was predicted encode a putative glycoprotein (Ensser et al,
1997). The absence of post-translational protein glycosylation in E. coli would have
produced an ORFA7-TrX recombinant protein without the normal glycosyation
found in native ORFA7 product. The lack of glycosylation may also explain the
insolubility of ORFA7-TrX. The purification of ORFA6-TrX and ORF A7-TrX by
electroelution gave a high yield. The protein concentration was determined by
densitometry of silver stained gels using (bovine serum albumin) BSA to create a
standard graph. In this instance, protein concentration was not determined by the
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colorimetric Pierce assay as the electroeluted proteins had been stained with Serva
blue and would have given false absorbance readings in the Pierce assay.
The antisera produced were reactive to the recombinant protein of interest
although cross-reactivity to other E. coli proteins was also present. Each eluted IgG
fraction of sera from rabbits inoculated with recombinant protein was tested
individually with the initial intention to keep only the fractions with the lowest non¬
specific reactivity. However, after the final purification all fractions were pooled to
maximise the titre of specific IgG and thus increase the chances of reactivity to
native proteins in infected cells. If necessary, it would have been possible to purify
these IgG fractions even further on affinity columns coupled to each recombinant
protein.
In the next chapter, these polyclonal antibodies will be used to study the
expression of ORF50, A6 and A7 at the protein level in LGL cell lines and in A1HV-
1-infected bovine turbinate monolayers.
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Chapter 6
Detection of ORF50, A6 and A7 products in MCF
virus-infected bovine turbinate cells and LGL cell
lines using specific antisera
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6.1 Introduction
In the previous chapter three recombinant proteins translated from three open
reading frames encoded in a region of A1HV-1 C500 that undergoes rearrangement
after passage in culture (Handley et al, 1995) were expressed and specific antibodies
raised to these proteins. The low-passage cell-associated and virulent form of C500
contains the ORFs 50, A6 and A7. These genes were located in the middle of the
genome at approximately 72-76kbp. After extensive passage, C500 becomes cell-
free and attenuated. In the attenuated virus a block of the A1HV-1 genome
containing ORF50 appears to be translocated to the right hand end of the genome
next to the terminal repeats and inverted with respect to transcriptional direction.
During this translocation, the promoter region of ORF50 is lost (H. Wright, personal
communications). This block of translocated genome also contained a truncated
version of ORFA6, which was found adjacent to a truncated version of ORFA10 (H.
Wright, personal communication) (Fig 6.1). The proteins encoded in ORF50, A6
and A7 were of interest as the rearrangements described at the right hand end of the
A1HV-1 genome were associated with loss of virulence. It is proposed that these
three proteins may be important in the switch from virulence to attenuation.
The antisera to the recombinant proteins ORF50-TrX, ORFA6-TrX and
ORFA7-TrX recognised the respective recombinant proteins described in Chapter 5.
In this chapter, the expression of the natural proteins encoded by ORF50, A6 and A7
was investigated in virus-infected bovine turbinate cells to test the ability of the sera
to recognise native viral protein. To determine whether these potential virulence
factors are associated with the ability of LGL cell lines to cause disease in rabbits the
expression of ORF50, A6 and A7 was also investigated in these cells. Protein was
detected by indirect fluorescent antibody tests (IFAT) using the anti-sera produced in
Chapter 5. RT- PCR using primers for the genes encoding these proteins were also
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6.2 Materials and Methods
6.2.1 Sera used for the detection of AIHV-1 proteins
Terminal sera from rabbits inoculated with recombinant proteins described in
Chapter 5 were used in these studies. Both whole serum and purified IgG fractions
were used.
6.2.2 MCF virus-infected cells used for the detection of AIHV-1 proteins
by I FAT
Bovine turbinate (BT) cells grown on coverslips were infected with fully
virulent cell-associated AIHV-1 C500 (pass no. 4-5 i.e. Tow pass'), attenuated cell-
free AIHV-1 C500 (pass no.>350 i.e. 'high pass') or the attenuated cell-free AIHV-1
WC11. The coverslips were mounted on microscope slides and fixed in ice cold
acetone. See Chapter 2.2.5 for a detailed protocol.
Rabbit LGL cell lines infected with OvHV-2 (BJ1857) or AIHV-1 (BJ926,
BJ1859 and BJ1860) were resuspended in PBS to a density of 5 x 105 cells/ml. From
these suspensions, cytocentrifuge preparations were fixed in acetone as above.
6.2.3 Detection of ORF50, A6 and A7 protein in MCF virus-infected cells
by I FAT
Detection of AIHV-1 proteins was performed by indirect
immunocytochemistry as described in Chapter 2.3.2. Normal horse serum (Gibco
BRL, Paisley, UK) was used as a blocking serum for the secondary antibody (a
donkey anti-rabbit polyclonal - SAPU, Carluke, UK). Normal rabbit serum was used
as a negative control. For the positive control, terminal serum from a rabbit infected
with A1FIV-1 C500 (BJ652) was purified on a protein A-sepharose column (see
Chapter 2.4.7) to produce a pooled IgG fraction.
Fixed cells were incubated in normal horse serum (NHS) diluted 1: 50 in PBS
for 30 minutes at 37°C. Primary sera to the recombinant proteins were diluted 1:20
in PBS and the slides incubated as before. The control sera were applied at the same
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dilution. The secondary FITC (fluorescein isothiocyanate) anti-rabbit conjugate was
applied at a 1:50 dilution and incubated under the same conditions. Washing with
PBS was performed after each incubation stage as described in Chapter 2.3.2. Slides
were mounted and viewed under a UV microscope.
6.2.4 Detection of ORF50, A6 and A7 mRNA in MCF virus-infected cells
The detection of mRNA was performed by RT-PCR using the primers for
ORF50, A6 and A7 indicated in Table 6.1 and by the method described in Chapters
2.5.1 and 2.5.2. BT cells used for this study were infected with A1HV-1 WC11 or
C500 (low or high passage). Uninfected BT cells were included as negative controls.
LGL cell lines used for this study were BJ1859, BJ1860 or BJ1263 (all rabbit A1HV-
1-infected cells).
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Table 6.1: Primers used for the detection of ORF50, A6 and A7 mRNA of
AIHV-1.
Specificity Function Sequence Tm Product
Size
ORF50 5' primer TTCTATTGTCCACTGCCTCATCTC 72°C 503bp
3' primer TGACTGTGGTTCACTTGCTTCCAG 72°C
ORFA6 5' primer CCCATTTCAGCATTTAGCCCTCTG 72°C 541bp
3' primer TTGGGTCCTCTCACTACTAGCTTG 72°C
ORFA7 5' primer CAATTGGCAACCTAACCTTTCCCC 72°C 535bp
3' primer AAATCCTCTTGGCCACACAGACAG 72°C
GAPDH 5' primer CCTTCATTGACCTCAACTACAT 62°C 380bp
3' primer CCAAAGTTGTCATGGATGACC 62°C
The primers for ORF50, A6 and A7 covered nucleotide positions 73405 - 73907,
75259 - 75800 and 76722 - 77256 respectively. The numbering is based on the
published AIHV-1 sequence (Ensser et al, 1997). Tm = melting temperature.
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6.3 Results
6.3.1 Expression of ORF50, A6 and A7 protein in AIHV-1-infected bovine
turbinate (BT) cultures
Using whole rabbit polyclonal serum, ORF50 and A6 protein could be
detected in BT cultures. Serum to ORF50 protein detected protein that was localised
to the nucleus of virus-infected cells showing CPE. This staining was brightest in
BT cells infected with low pass C500 and distributed mainly in the large multi¬
nucleate syncitia (Fig 6.2a). In high pass C500-infected BT cell cultures, round
refractile cells showed positive staining (Fig 6.2b). Positive staining in WC11-
infected BT cells was also found in areas of round refractile cells (Fig 6.2c). The use
of purified IgG to ORF50 protein gave similar results (Fig 6.2e-g). Staining with
whole sera or purified IgG to ORFA6 protein was also localised to the nucleus of
cells showing CPE and similar differences between strains of AIHV-1 were observed
(Fig 6.2i-k, m-o). Specific staining was not observed using the serum to ORFA7
protein in whole or purified form.
Using BJ652 serum (from a rabbit infected with AIHV-1 C500), the majority
of staining in infected BTs was localised to the nucleus and reminiscent of the
staining seen with sera to ORF50 and A6 proteins. The distribution of positive cells
was limited to areas of CPE and was again reminiscent of staining observed using
sera to ORF50 and A6 proteins (Fig 6.2q-s). In addition, some cytoplasmic staining
was observed using the BJ652 serum.
Neither the BJ652 serum nor the sera to ORF50 and A6 proteins could detect
any staining in uninfected BTs other than low levels of non-specific cytoplasmic
staining (Fig 6.2d, h, 1, p, t). The normal rabbit serum controls were negative in all
cases (Fig6.2u-x).
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Fig 6.2: Determination of ORF50 and ORFA6 protein expression in AIHV-1
infected BT cells (continues on next page). Magnification, x200. Photographs
were taken using equal exposures.
A) Whole ORF50 serum against BT cells infected with AIHV-1 C500 (low pass)
B) Whole ORF50 serum against BT cells infected with AIHV-1 C500 (high pass)
C) Whole ORF50 serum against BT cells infected with AIHV-1 WC11
D) Whole ORF50 serum against uninfected BT cells
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Fig 6.2 (continued): Determination of ORF50 and ORFA6 protein expression in
AIHV-1 infected BT cells. Magnification, x200. Photographs were taken using
equal exposures.
E) Purified ORF50 serum against BT cells infected with C500 (low pass)
F) Purified ORF50 serum against BT cells infected with C500 (high pass)
G) Purified ORF50 serum against BT cells infected with WC11
H) Purified ORF50 serum against uninfected BT cells
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Fig 6.2 (continued): Determination of ORF50 and ORFA6 protein expression in
AIHV-1 infected BT cells Magnification, x200. Photographs were taken using
equal exposures.
I) Whole ORFA6 serum against BT cells infected with AIHV-1 C500 (low pass)
J) Whole ORFA6 serum against BT cells infected with AIHV-1 C500 (high pass)
K) Whole ORFA6 serum against BT cells infected with AIHV-1 WC11
L) Whole ORFA6 serum against uninfected BT cells
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Fig 6.2 (continued): Determination of ORF50 and ORFA6 protein expression in
AIHV-1 infected BT cells. Magnification, x200 (except O). Photographs were
taken using equal exposures.
M) Purified ORFA6 serum against BT cells infected with C500 (low pass)
N) Purified ORFA6 serum against BT cells infected with C500 (high pass)
O) Purified ORFA6 serum against BT cells infected with WC11 (x400)
P) Purified ORFA6 serum against uninfected BT cells
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Fig 6.2 (continued): Determination of ORF50 and ORFA6 protein expression in
AIHV-1 infected BT cells (positive control serum). Magnification, x200.
Photographs were taken using equal exposures.
Q) Purified BJ625 serum against BT cells infected with AIHV-1 C500 (low pass)
R) Purified BJ625 serum against BT cells infected with AIHV-1 C500 (high pass)
S) Purified BJ625 serum against BT cells infected with AIHV-1 WC11
T) Purified BJ625 serum against uninfected BT cells
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Fig 6.2 (continued): Determination of ORF50 and ORFA6 protein expression in
AIHV-1 infected BT cells (negative control serum). Magnification, x200.
Photographs were taken using equal exposures.
U) Normal rabbit serum against BT cells infected with AIHV-1 C500 (low pass)
V) Normal rabbit serum against BT cells infected with AIHV-1 C500 (high pass)
W) Normal rabbit serum against BT cells infected with AIHV-1 WC11
X) Normal rabbit serum against uninfected BT cells
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6.3.2 Expression of ORF50, A6 and A7 protein in rabbit LGL cell lines
After repeated experiments on cell lines BJ1857, 1859 and 1860 the results
were inconclusive with only BJ1859 showing some positive staining on one occasion
using the sera against ORF50-GST.
6.3.3 Expression of ORF50, A6 and A7 mRNA in MCF virus-infected
cells
Parallel experiments were undertaken using A1HV-1 infected bovine
turbinate cells where expression of ORF50, A6 and A7 transcripts was detected by
RT-PCR using the primers indicated in Table 6.1. As in the IFAT experiments,
bovine turbinate cells were harvested once 50-70% of cells showed signs of CPE.
However, despite the use of DNase the detection of mRNA was hampered by the
presence of excess viral DNA making interpretation of results difficult.
However, a PCR using the same primers on total DNA showed the presence
of the genes ORF50, A6 and A7 in both low and high pass C500 (Fig 6.3). In the
WC11 isolate the genes ORF50 and A6 but not A7 were detected (Fig 6.3).
Uninfected BTs were negative in all cases.
The experiment was also repeated on A1HV-1 -infected rabbit LGL cell lines
(BJ1859, BJ1860 and BJ1263). Messenger RNA from ORF50, A6 and A7 was
detected in BJ1859 (Fig 6.4a). Lower levels of ORF50, A6 and A7 mRNA was also
detected in the other cell lines tested (BJ1860 and BJ1263). As a negative control,
PCR was performed on the same RNA samples as above without reverse
transcriptase and showed that viral DNA was not present. GAPDH mRNA was
detected in equal quantities in all cells used (Fig 6.4b).
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Fig 6.3: Detection of DNA encoding ORF50, A6 and A7 by PCR in AIHV-
1-infected BT cells.
Primers used for these PCR reactions are described in Table 6.1.
- = Uninfected BT cells. + = Purified AIHV-1 DNA. L = BTs infected with low
pass C500. H = BTs infected with high pass C500. W = BTs infected with





Fig 6.4: Expression of mRNA from ORF50, A6 and A7 in rabbit cells.
A) M = molecular weight markers. L = LGL (BJ1859, AIHV-1+). B = uninfected
lymphoblasts. V = purified AIHV-1.
B) BJ1859 and BJ1860 (LGLs infected with AIHV-1). M = markers.
- = unstimulated. + = stimulated with 10pg/ml con A + 5ng/ml TPA.
GAPDH = glyceraldehyde-3-phosphate dehydrogenase. Size of DNA (kbp) are
indicated to the left of gels.
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6.4 Discussion
6.4.1 Expression of ORF50, A6 and A7 in infected BT cells
The results presented here show that in virus-infected BT (fibroblast) cells the
different strains of C500 produce different forms of CPE. In low pass (virulent)
C500-infected BT cells, CPE is characterised by presence of syncitia. In contrast,
attenuated high pass C500 and WCll-infected BT cells showed CPE in the form of
round refractile cells. This pattern of CPE is consistent with previous observations
of CPE in A1HV-1-infected fibroblast cells (Ferris et al, 1976; Harkness and Jessett,
1981). However, proof of A1HV-1-infection in the previous studies required
supporting evidence showing A1HV-1 protein expression in infected fibroblast cells
by the use of specific sera. This was demonstrated in the present study by the use of
antisera to the proteins encoded in ORF50, A6 and by the use of serum from a rabbit
infected with A1HV-1 (strain C500, low pass).
The results shown here demonstrated the ability of antisera to ORF50-TrX
and ORFA6-TrX to detect native viral antigens in infected BT cells. Whether the
failure of the antisera to the ORFA7 product to detect viral antigen reflects a genuine
lack of expression in BT cells or merely low-affinity antibody binding is not known.
Alternatively, the difficulty in detecting ORFA7 at protein level may reflect the
limited sensitivity of immunocytochemistry compared to RT-PCR. This would have
been addressed by RT-PCR analysis of ORF50, A6 and A7 rnRNA expression in
infected BT cells. However, the analysis in virus-infected BT cells was hampered by
the presence of excess amounts of viral DNA despite treating samples with DNase.
The results obtained by the less sensitive method of rnRNA detection, the northern
blot, were inconclusive. However, the detection of PCR products for ORF50, A6
and A7 from DNA samples of BT cells infected with low and high pass C500
demonstrated that none of these genes as defined by the primers were deleted
following extensive passage. The absence of a PCR fragment for ORFA7 in WC11
may indicate that this region of the A1HV-1 genome has a high degree of
susceptibility to genetic alterations. This is supported by evidence that the
neighbouring ORF (A8) is also truncated in WC11 (Ireri, 1999).
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From the rearrangements thought to occur at the right hand end of A1HV-1
genome following attenuation (H. Wright, personal communication, Fig 6.1) the
expected results of the present study might have been the loss of ORF50 and A6
expression upon attenuation. In addition, ORFA7 does not appear to be affected by
the predicted rearrangements and could theoretically be expressed in the attenuated
virus. The results of this study are in contrast with this prediction where expression
of proteins encoded by ORF50 and A6 but not ORFA7 was observed in the
attenuated virus. In a study by Handley, the translocation of a region of the
attenuated C500 from the middle to the right-hand end of the unique DNA (see Fig
6.1) is also repeated at the left-hand end of the genome (Handley, 1993; Handley et
al, 1995). Sequence analysis of the left end of the attenuated genome has not been
performed to confirm this observation. It is therefore possible that more
rearrangements are present than has been described so far. If this is true, the
presence of a transcriptionally active ORF50 at the left end of the genome could
explain the expression of ORF50 protein in the attenuated virus. Likewise, the
translocation of the full ORFA6 sequence could explain the detection of ORFA6
protein in both virulent and attenuated C500. If so, the translocation of the full
ORFA6 sequence could also have consequences for the expression of the adjacent
gene, ORF A7 if its promoter sequences are within the sequence coding for ORFA6.
Alternatively, the presence of a mixed culture of virulent and attenuated viruses in
high pass C500 is a possibility. This hypothesis would not conflict with the
generally attenuated nature of the high pass C500 cultures as presence of a small
percentage of virulent virus in this culture could be detectable by causing infection of
BT cells whilst not being sufficient to induce disease.
The function of proteins encoded in ORF50, A6 and A7 in the virus life cycle
has not been demonstrated. However, protein database analysis indicated that the
protein encoded by ORF50 showed similarity to a protein sequence in bovine
herpesvirus 4 (BHV-4). This BHV-4 sequence is a homologue of the EBV BRLF1
gene product (R transactivator) an immediate early protein involved in the regulation
of EBV BZLF1 transcription (van Santen, 1993). The equivalent protein in HVS is
encoded by ORF50 and is situated in the middle of the unique DNA (Albrecht et al,
1992). As the ORFs of gammaherpesviruses are collinear (Roizman et al, 1992) the
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positional homologue of A1HV-1 ORFA6 is BZLF1 of EBV (Ensser et al, 1997).
BZLF1 encodes a Z transactivator, another immediate early protein. EBV BRLF1
and BZLF1 are expressed during viral replication (Countryman and Miller, 1985;
Farrell et al, 1989; Hardwick et al, 1988; Rooney et al, 1989). The homology of
A1HV-1 ORF50 and the positional homology of ORF A6 to the EBV BRLF1 and
BZLF1 respectively would suggest that the proteins encoded by ORF50 and A6
could be immediate early proteins. In EBV lytic replication requires both BRLF1
and BZLF1 gene products (Holley-Guthrie et al, 1990; Miller, 1990). If ORF50 and
A6 are functional homologues of BRLF1 and BZLF1, their expression in BT cells
showing viral CPE (a sign of lytic replication) could indicate their role in initiation of
lytic replication. However, structural nor functional homology between the proteins
encoded by ORF50, A6 and A7 with other proteins has been identified. In addition,
the expression of ORF50 and A6 in high pass C500 where virulence (or disease
induction) is lost suggests that ORF50 and A6 are not virulence factors.
The presence of ORF50 expression in high pass C500 could be explained in
another way. ORF50 of A1HV-1 also has homology to HVS ORF50 encoding HVS-
R transactivator (Albrecht et al, 1992; Ensser et al, 1997). Both ORF50 sequences
contain an intron and in HVS encode splice variants designated ORF50a and
ORF50b (Whitehouse et al, 1997). While ORF50a was transcribed from a promoter
present upstream of exonl (in the non-coding DNA strand of the neighbouring
ORF48), the shorter ORF50b was transcribed in the delayed early phase from a
promoter region within the second exon. If this is also true for ORF50 of A1HV-1, it
might explain the ability of sera to detect ORF50 protein in both low and high pass
C500. In other words, in high pass C500 the translocation of ORF50 to the right
terminal end only affects transcription from the first promoter. Therefore, the
presence of a promoter region in exon 2 of ORF50 could allow the expression of a
splice variant. The existence of a second promoter in ORF50 has yet to be
determined.
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6.4.2 Expression of ORF50, A6 and A7 in rabbit LGL cell lines
The detection of ORF50, A6 and A7 by IFAT was difficult to interpret owing
to non-specific reactivity using normal serum and in uninfected rabbit control cells.
This cross-reactivity is unlikely to be due to reactivity with other known herpesvirus
antigens as these sera were obtained from specific-pathogen free rabbits. The results
for the IFAT experiments were therefore inconclusive. The RT-PCR analysis
demonstrated low and variable levels of mRNA in the three cell lines tested and
suggest that the corresponding proteins are expressed at low levels and that levels of
expression differ between cell lines. This has also been shown for other viral genes
currently being analysed (H. Wright, personal communication). Alternatively,
mRNA with a short half-life may explain the variable levels of mRNA. The relative
insensitivity of immunofluorescence for detecting low levels of protein may
contribute to the difficulty in detecting ORF50, A6 and A7 at protein level.
MCF LGL cell lines have consistently been shown to contain viral DNA and
protein. The replicative state of virus in LGLs is unknown. While virions have yet
to be detected in LGLs, these cells can induce MCF when inoculated into rabbits.
All these features of LGLs suggest the presence of productive virus in these cells.
This hypothesis is supported by the findings of the present study. The detection of
mRNA for ORF50, A6 and A7 in BJ1859 and other LGL cell lines indicates that a
replicating virus is present at low levels and could explain the ability of LGLs to
transmit disease to rabbits. Recent work has shown that ORF50 of A1HV-1
transactivates ORF6, 57 and A9 (Frame and Dalziel, 1999). This is homologous to
the function of ORF50 of HVS (in turn homologous to EBV ORF50), which encodes
the R transactivator - an immediate early/ early protein - that transactivates ORF57
expression (Albrecht et al, 1992; Whitehouse et al, 1998). Therefore, if ORF A6 of
A1HV-1 is also a functional homologue of EBV BZLF1, ORF50 and A6 like EBV






The pathology associated with malignant catarrhal fever is characterised by
lymphocyte hyperplasia in lymphoid tissues, lymphoblast infiltration of non-
lymphoid tissues and widespread tissue necrosis followed by death. The
experimental transmission of MCF using lymphocyte cell suspensions from blood,
lymphoid and non-lymphoid tissue and the generation of lymphoblastoid cell lines
from such cell suspensions suggested that these cells may be important in MCF
pathogenesis.
Whether derived from A1HV-1 or OvHV-2-infected animals, lymphoblastoid
cell lines have the morphology of large granular lymphocytes (LGLs). More
importantly, the detection in LGL cell lines of MCF virus DNA or protein and the
ability of LGL cell lines to transmit MCF to experimentally inoculated rabbits
support their role in pathogenesis. However, the mechanism of virus-infected LGL-
mediated pathogenesis is not known.
The results of this study demonstrated several important phenotypic
differences between MCF virus-infected LGL cell lines and uninfected control cells.
Some of these findings confirmed previous observations such as the ability of LGLs
to survive and grow without the need for exogenous IL-2 for longer periods than
control cells (Reid et al, 1989). The expression of BLT esterase (a tryptase and
activation marker for cytotoxic cells (Griffiths and Mueller, 1991; Haig et al, 1996))
in IL-2-independent LGLs showed that the LGLs displayed the phenotype of
constitutively active and cytotoxic cells.
The most important and novel findings of this study were firstly that the
active and cytotoxic phenotype of LGL cell lines could be maintained by the
cytokine IL-15 (Chapter 3). At high doses, IL-15 could also develop increased
numbers of BLT esterase expressing cells in control lymphoblast cultures. Thus, IL-
15 is a potential stimulus for the generation and maintenance of LGL and cytotoxic
lymphocytes. Secondly, this study demonstrated the constitutive activation of the T
cell tyrosine kinases, Ick and fyn in LGL cells in the absence of exogenous IL-2
(Chapter 4). This suggested that virus infection of the LGLs was associated with the
activated phenotype of the LGLs, which was similar to that of mitogen-activated
control lymphocytes. The observed characteristics of the LGL cells reported here
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were associated with MCF vims infection of these cells. However, specific
interaction(s) between vims and host proteins have not been demonstrated.
Finally, the viral proteins encoded by ORF50, A6 and A7 of A1HV-1 C500
were of interest as the area of the genome encoding these proteins becomes
rearranged on attenuation of the vims (where attenuation is described as the loss of
disease induction). These proteins were thought to be putative virulence proteins and
their expression in LGLs may explain the ability of such cells to transmit disease.
The work presented in this study showed that the LGL cells expressed mRNA for
ORF50, A6 and A7 at variable levels (Chapter 6). Despite the difficulty in detecting
the protein products of ORF50, A6 and A7 in LGLs, the RT-PCR results suggested
that a low level of replicative A1HV-1 C500 may be present in LGL cell lines. This
conclusion is supported by the observation that ORF50 and A6 share positional
homology with EBV R and Z transactivators, which are required for the initiation of
EBV replication.
During lytic replication of attenuated C500 in BT cells, ORF50 and ORFA6
at DNA and protein level and ORFA7 at DNA level were detected (Chapter 6).
Thus, the detection of the proteins encoded by ORF50 and A6 in the attenuated C500
suggested two possibilities. Firstly, that these proteins may not be vimlence factors
as was initially proposed. Alternatively, the proposed rearrangement of the
attenuated genome may not represent all the genomic changes that occur on
attenuation. Furthermore, the detection of DNA encoding ORF50, A6 and A7 in the
attenuated C500 virus indicates that the loss of disease induction using attenuated
virus cultures may not be due to the physical loss of these genes but rather a loss of
transcriptional activity. An alternative explanation for the detection of ORF50 and
A6 protein in apparently attenuated C500 cultures could be the presence of vimlent
vims amongst the attenuated virus cultures at a level that is too low to induce
disease.
Mechanisms for LGL dysfunction
The ability of LGL cells to survive in culture without exogenous IL-2 for
longer periods than control cells and their dependence on cell density for optimal
growth suggested that their survival could be mediated though the production of
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endogenous cytokines. It had been proposed previously that immune dysregulation
was responsible for the pathogenesis of MCF. One hypothesis was that MCF virus-
induced production of IL-2 caused the initial proliferation of T cells (Schock 1996).
However, it was subsequently discovered that IL-2 was not transcribed by OvHV-2-
infected cell lines and no IL-2 activity could be detected in culture supernates
(Schock, 1996; Schock et al. 1998) despite the fact that some of these lines could
survive and grow in the absence of exogenous IL-2. Lack of IL-2 rnRNA has not
been measured in A1HV-1-infected LGL cell lines. However, the absence of IL-
2mRNA in OvHV-2-infected LGL cell lines would suggest that endogenous IL-2
production does not substitute for exogenous IL-2. It also suggests that IL-2
induction by LGLs following virus infection is not important in MCF pathogenesis.
This led to the hypothesis that other endogenous cytokines are responsible for the
proliferative and cytotoxic phenotype of the LGL cells. An investigation into the
cytokines expressed by OvHV-2-infected LGLs showed the presence of mRNA for
IL-4, IL-10, TNFa and IFNy while IL-2 and IL-ip could not be detected (Schock,
1996; Schock et al, 1998).
The temporal expression of these cytokines and therefore their role in MCF
virus-infected LGLs in vivo has not been determined. However, it would be possible
to speculate that TNFa and IFNy, with their antiviral activities, could limit spread of
virus to neighbouring cells (if the viruses do not have anti-TNF/IFN mechanisms of
immune evasion). In contrast, the expression of IL-4 and IL-10 could benefit virus
survival by inhibiting the response of Thl (helper T) cells that regulate antiviral
activities such as cytotoxicity and macrophage activation. In this respect, IL-10 is
encoded in the genomes of several herpesviruses including EBV where it is thought
to be expressed during lytic replication following primary infection thereby
inhibiting local T cell and NK cell-mediated immunity (Moore et al, 1993). In
OvHV-2-infected LGLs, the origin of the IL-10 mRNA (i.e. whether viral or cellular)
could not be determined (Schock et al, 1998). However, these cytokines do not
display activities that could induce LGL proliferation and auto-stimulation leading to
IL-2-independence in culture.
The cytokine IL-15, which is known to stimulate the proliferation of T cells
and NK cells and develop or maintain their cytotoxic phenotype (Grabstein et al,
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1994) was proposed as an alternative candidate. In addition, induction of IL-15 in
transformed T cells by HTLV-1 (the virus associated with an adult T cell leukaemia)
has been demonstrated. This virus induces the transcription of the IL-15 gene
through the binding of Tax-1 (a viral transactivating protein) to the promoter region
of the IL-15 gene. It was shown that HTLV-1 infection or Tax-1 transfection led to a
3-fold increase in levels of IL-15 mRNA in T cells (Azimi et al, 1998). In this study,
LGL cells responded to human recombinant IL-15 in a dose-dependent manner. At
low concentrations IL-15 maintained or enhanced the cytotoxic phenotype of LGLs
but not control cells. These results suggests that LGL cells express receptors for IL-
15 and that IL-15 can substitute for or co-stimulate with IL-2 in maintaining the
active cytotoxic phenotype of LGL cells in vitro.
Whether IL-15 is produced by LGL cells or by another cellular source in vivo
is not known. An attempt was made to test the hypothesis that A1HV-1 or OvHV-2
might induce IL-15 production in infected cells that stimulate proliferation and
cytotoxicity of the LGL cells. Analysis of IL-15 mRNA expression in LGL cell lines
by RT-PCR did not demonstrate the induction of IL-15 in these cells. However the
primers used for the detection of IL-15 in rabbit LGL cell lines were based on the
bovine IL-15 sequence (which has a high degree of sequence identity to the IL-15
sequence of other species) as the sequence for rabbit IL-15 has not been reported
(Chapter 3). In addition, the antibody to IL-15 did not detect rabbit or bovine IL-15,
therefore the production of IL-15 by LGLs or cells in tissues of MCF-affected rabbits
could not be determined. The absence of a reliable positive control for detection of
rabbit IL-15 was also a problem. Time constraints meant that positive controls for
rabbit or bovine IL-15 could not be performed. All the data available on the
expression of IL-15 in various cell types come from human or murine studies. From
these, IL-15 was produced most readily in cell lines (frequently of epithelial or
fibroblast origin) and in activated monocyte enriched PBMCs (Grabstein et al, 1994).
Given more time, a more comprehensive study of IL-15 expression in cell lines or
normal macrophages from cattle may reveal a source of IL-15 that is detectable using
the primers used for the RT-PCR analysis. Alternatively, new primers could be
constructed that have a greater chance of hybridising with IL-15 of rabbit origin.
This work is currently underway. As for the detection of rabbit or bovine IL-15 by
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western blot, this can only be achieved if known IL-15 mRNA+ cells express protein
that can be detected by putative cross-species reactive anti-IL-15 antibodies.
Antibodies specific for rabbit or bovine IL-15 have not been developed.
Consequently, whether IL-15 is expressed in LGL cells in vitro or in vivo is not
known.
The fact that LGLs respond to hrIL-2 and that IL-2Ra has been detected on
some cell lines would indicate that this response is mediated through the high affinity
IL-2R (IL-2RaPy). With an affinity or Ka of 10"11 M the high affinity IL-2R can be
stimulated by as little as lOpM of IL-2 (Minami et al, 1993). The affinity of the IL-
15 receptors has been most thoroughly examined in the murine system. Activated
peripheral blood T cells express only one type of IL-15 receptor (IL-15R) - the high
affinity receptor comprising the subunits IL-15Ra and IL-2RPy - with a K<j of 10"11 M
(Giri et al, 1995a). In contrast with T cells, murine NK cells express a small number
of high affinity IL-15 receptors (IL-15Ra/IL2RPy) along with intermediate affinity
IL-15 receptors comprising only the IL-2Rpy subunits (Ka = 10"10M). Therefore,
irrespective of whether LGLs are T cells or NK cells the results, by extrapolation
from murine studies, would suggest that LGLs would be capable of responding to IL-
15. This was proven in vitro by the IL-15 response assays described in Chapter 3.
Thus, although production of IL-15 by LGLs was not demonstrated in this study it is
possible to speculate that if LGLs or other cells in vivo did produce even small
quantities of IL-15, it is possible that LGLs could respond.
Given the chemoattractant properties of IL-15 (Oppenheimer-Marks et al,
1998; Sancho et al, 1999) it is tempting to speculate that recruitment of LGL cells in
response to IL-15 may explain the lymphoblast infiltration of non-lymphoid tissue
and lymphoproliferation observed in MCF. The source of IL-15 in vivo may be
virus-infected LGLs or more likely inflammatory cells in affected tissue.
Accumulation of virus-infected lymphoblast cells to non-lymphoid tissue could be
mediated by production of IL-15 in the tissues following virus infection. Subsequent
proliferation of recruited lymphoblasts may provide new target cells for virus
infection.
The production of IL-15 may also promote the clearance of MCF virus-
infected cells by developing and activating cytotoxic T lymphocytes (CTLs) or NK
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cells. The production of IL-15 as a host defence mechanism against viral infection
has been reported. For example, IL-15 enhances stimulation and proliferation of
virus-specific cytotoxic T cell responses in HIV infection (Chehimi et al, 1997;
Kanai et al, 1996). In HHV-6 and HHV-7 infection activation of NK cell activity via
IL-15 has also been reported (Atedzoe et al, 1997; Flamand et al, 1996). If IL-15 is
involved in a host defence mechanism during MCF infection, it does not seem to be
protective in that the disease is largely fatal. The persistence of virus and the high
mortality rates due to MCF may be due to the infection of antiviral effector cells (i.e.
CTLs and NK cells) by the MCF viruses.
IL-15 has been implicated in disease pathogenesis of inflammatory diseases
such as rheumatoid arthritis and ulcerative colitis (Kirman and Nielsen, 1996;
Mclnnes et al, 1996, 1997). In addition, the progression of hepatitis C virus (HCV)-
associated chronic liver disease has been related to high levels of serum IL-15
(Kakumu et al, 1997). Furthermore, in LDGL (lymphoproliferative disease of
granular lymphocytes) proliferation and cytotoxicity of granular lymphocytes was
achieved via IL-15 produced by PBMC isolated from LDGL patients (Zambello et
al, 1997). This disease shares several characteristics with MCF including excessive
proliferation of primed granular lymphocytes (of T cell phenotype) against unknown
antigens. These cells did not express mRNA for IL-15 or IL-2. Phenotypic
similarity between the cells involved in LDGL and MCF-derived LGL cell lines now
extends to their response to IL-15. Hence, even if LGL cell lines do not express IL-
15 their ability to respond to IL-15 from another source may be an important part of
MCF pathogenesis. In this respect, the occasional observation of macrophage cell
lines derived from MCF-affected animals (Mushi and Rurangirwa, 198Id) would
suggest that monocytes (and possibly other antigen presenting cells) are also targets
for MCF virus infection and potentially another source of virus-induced IL-15.
The induction of IL-15 (if present) is not likely to be the only mechanism
responsible for the constitutive activation of LGL cells. In other herpesviruses,
continuous growth and maintenance of virus in infected cells may be mediated
through the inhibition of apoptosis by the expression of the anti-apoptotic protein,
bcl-2 (Chapter 1). The fact that human herpesvirus 8 (HHV-8) (Boshoff and Weiss,
1998), EBV and HVS encode a bcl-2 homologue indicates the importance of bcl-2 in
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the virus life cycle. Viral bcl-2 may function by inhibiting apoptosis induced at the
early stages of virus infection allowing subsequent infection and transformation of
the infected cell. In A1HV-1 a bcl-2 homologue has been found and is encoded in
ORF A9 (Ensser et al, 1997). The expression of this ORE has been detected in LGL
cell lines (H Wright, personal communication) may, in part, explain their continuous
survival in vitro and the lack of requirement for exogenous IL-2. The expression of
viral bcl-2 may also play a role in the lytic virus cycle in vivo by delaying the
induction of apoptosis following viral infection of a cell and thus allowing viral
replication to proceed. Expression of bcl-2 could also mediate continuous survival of
the infected cell leading to immortalisation of the cell and allowing persistence of the
viral genome in a latent state. This function may be important in sheep where
OvHV-2 is thought to be latent in B cells (Baxter et al, 1997) or in the case of MCF-
recovered cows where the virus is thought to be latent (Plowright et al, 1972). The
putative anti-apoptotic-function of ORF A9 is currently being investigated.
There is another possible mechanism for the observed exogenous IL-2-
independent proliferation and cytotoxicity of the LGL cell lines. MCF virus-
infection of LGL cell lines was associated with the constitutive activation of the src
tyrosine kinases, Ick and fyn. These are non-receptor protein tyrosine kinases
(NRPTKs) expressed in T lymphocytes (Crabtree and Clipstone 1994) and are
involved in the early stages of cell surface receptor-mediated signalling. In MCF
virus-infected LGLs, the activation of Ick and fyn may indicate that MCF viruses
exert their lymphoproliferative effect at least in part by by-passing the signals
initiated from antigen or cytokine cell surface receptors. The consequence of
constitutive Ick and fyn activation in LGL cells is not known. Recently, the altered
activity of the mitogen-activated protein kinases (MAPKs) - erkl and erk2 - in LGL
cell lines has been demonstrated (Swa et al, in press). This analysis was performed
following the completion of the present study. The results showed that MAPK is
constitutively activated in LGL cells infected with the MCF viruses. In normal cells,
MAPKs can be activated by a variety of stimuli including those generated by the T
cell receptor and cytokine receptors (Schwartz and Baron, 1999). Lck and fyn are
known to activate the MAPKs via the activation of the GTP-binding protein ras and
the kinase raf (M inami et al, 1993; Pelech and Sanghera, 1992; Schwartz and Baron,
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1999). Therefore, constitutive activation of Ick, fyn and MAPK could be the
mechanism by which the virus-associated proliferative and possibly cytotoxic
phenotype of LGL cells is achieved.
The importance of kinase binding motifs is demonstrated by the HVS
proteins Tip and STP (encoded in ORF 1 by a bicistronic mRNA) and by the EBV
protein LMP-2A. These proteins in EBV and HVS have little sequence homology to
each other but the presence of kinase binding motifs is common to both. For
instance, the binding of the HVS protein Tip to the tyrosine kinase Ick is mediated by
two motifs on Tip that makes up the Ick-binding domain. The physical association of
Tip and Ick modulates Ick activity (Wiese et al, 1996) and leads to the activation of
other kinases downstream of Ick including the JAKs (Janus kinases) and the STATs
(signal transducers and activators of transcription). JAKs and STATs are signalling
molecules associated with cytokine receptor-mediated signalling. As Tip is required
for transformation of T cells (Duboise et al, 1998a) the activation of the JAK/STAT
pathway might indicate that transformation is achieved by by-passing the normal
cytokine receptor mediated proliferation signals. The activity of p21 ras was also
altered by HVS via the interaction of viral STP with ras. STP is another HVS
protein required for T cell transformation (Jung and Desrosiers, 1995) showing that
different downstream signalling pathways can be used by the virus to achieve the
same goal. Therefore, the deregulation of NRPTK activity by HVS may be an
important mechanism for virus persistence or dissemination. The EBV protein LMP-
2A also associates with NRPTKs. EBV is associated with lymphoproliferative
diseases and tumours in man infecting B cells, persisting in a latent state and
transforming B cells to continuous growth (Fields et al 1996; Sinclair and Farrell,
1995). During latency a limited number of genes are expressed including latent
membrane protein 2A (LMP-2A) (Farrell, 1995). This protein is one of the
transforming factors of EBV and is constitutively phosphorylated (Miller et al,
1995). LMP-2A has been shown to bind the B cell-specific kinases, lyn and syk that
mediate signals through the B cell receptor (Burkhardt et al, 1992; Longnecker and
Miller 1996). This binding is mediated through the presence of kinase binding
domains on LMP-2A (Burkhardt et al, 1992; Miller et al, 1995). The interaction of
LMP2A with lyn and syk downregulates the activity of lyn and syk following B cell
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receptor cross-linking. This interaction blocks the signals from the B cell receptor
and inhibits virus reactivation from latency (Miller et al, 1994). Therefore, LMP2A
is thought to play a role in allowing persistence of the virus in B cells by establishing
and maintaining latency.
The importance of NRPTKs to virus life cycles or pathogenesis is
demonstrated by the number of other viruses known to bind cellular kinases. For
example viral interaction with NRPTKs is demonstrated by the HIV protein nef - a
protein required for HIV replication and pathogenesis in vivo (Jamieson et al, 1994;
Kestler et al, 1991). The interaction of nef with NRPKs including Ick leads to altered
T cell activation pathways and enhanced infectivity (Collette et al, 1996; Du et al,
1995). The polyoma middle T antigen (mT) and HTLV-1 Tax (p40) also induce
activation of NRPTKs which is involved in the transformation of T cells
(Courtneidge, 1985; Courteidge et al, 1991). This demonstrates that modulation of
NRPTKs has been used by several viruses to maintain virus survival in the host cell.
The functional consequence of Ick, fyn and MAPK activation in LGL cell
lines is not known. The viral proteins of HVS and EBV illustrated above appear to
be involved primarily in maintenance of latency and cellular transformation.
However, MCF LGL cells exhibit infectivity in rabbits (thus are not wholly latent)
and are not associated with neoplasia in vivo (thus not transformed). Therefore,
direct homologies between virus/ host interactions in HVS/EBV-infected cells and
MCF virus-infected cells may not be present. However, viruses need not share
homologous proteins to share similar mechanisms of pathogenesis. A direct
comparison between the epidemiology and the lymphoproliferative disease caused by
herpesvirus saimiri and the MCF viruses has shown many similarities (Chapter 1).
Therefore, it is possible that HVS and the MCF viruses share similar pathogenic
mechanisms. In the case of EBV there seems little if any similarity between EBV
and MCF vims infection, at first glance. It appears that while all the viruses involved
are gammaherpesviruses, the disease caused by MCF is acute and usually lethal
while EBV infection of humans is chronic and largely asymptomatic with occasional
disease. However, a closer inspection suggests that the comparison made above is of
viruses at different stages of infection. A closer comparison can be made between
MCF and primary EBV infection that results in infectious mononucleosis (IM)
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(Rickinson and Kieff, 1996). Primary lytic infection of epithelial cells in the throat is
followed by viraemia and latent infection of B cells. The immunopathological
features of IM include increased numbers of activated T cells and virus-specific
antibodies in the blood, infiltration of internal organs by these T cells and
transformation of infected B cells. EBV-transformed B cells have been shown to
produce cytokines that activate T cells in vitro (Wallace et al, 1982). It is thought
that T cell proliferation associated with IM is the direct consequence increased
cytokine production by EBV-infected B cells (Foss et al, 1994). The mechanisms
underlying these processes may also explain the proliferation and infiltration of non-
lymphoid organs by T cells observed in MCF. The constitutive activation of Ick and
fyn and possibly other virus interactions with NRPTKs could facilitate the
dysregulation of the cytokine network and lead to activation and recruitment of
bystander cells.
Given the results of the present study and given that the positional homologue
of A1HV-1 ORF Al in FIVS is STP/Tip, functional analysis of ORFA1 is currently
being performed. While kinase-binding motifs have not been identified in A1HV-1
genes, interaction of virus proteins with cellular (possibly signalling) proteins is
being investigated.
The role of proteins encoded by ORF50, A6 and A7; putative virulence
proteins in AIHV-1 life-cycle and pathogenesis
Viral proteins that might be involved in the generation of the LGL phenotype
came from restriction enzyme analyses of the virulent and attenuated forms of
AIHV-1 C500 (Handley et al, 1995; H. Wright, personal communication) where
virulence was defined as the ability to cause disease. This work showed the presence
of a region of the AIHV-1 C500 genome that was rearranged after attenuation of the
virus (following extensive passage in culture). This rearranged region contained
three genes encoded by ORF50, A6 and A7. Therefore, the affect of the
rearrangements on these genes was associated with attenuation of AIHV-1 C500 or
loss of disease induction.
More recent investigation of the rearrangements in the AIHV-1 C500 genome
following attenuation (H. Wright personal communication) showed that ORF50, A6
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and A7 are found in the middle (~72-75kbp) of the virulent C500 genome. On
attenuation a part of this region of the genome was translocated to the right hand
terminus, inverted with respect to direction of transcription and inserted between the
terminal repeats and the end of the unique DNA (the coding region). The
translocated region at the right-hand end of the attenuated C500 virus contains all but
the promoter sequences of ORF 50 (which was located next to the terminal repeats)
and a truncated 5' portion of ORF A6 (which was found next to a truncated ORF
A10). ORF A7 remained in its original position in the middle of the genome (Fig
6.1). These rearrangements are therefore associated with attenuation of the virus.
The effect of the translocation on the expression of the proteins encoded by these
ORFs was not known. Therefore, whether or not the proteins encoded by ORF50,
A6 and A7 were virulence proteins were investigated (Chapter 6). From the
rearrangements described and assuming no point mutations (or other changes) affect
these genes, the expected transcription pattern would show the loss of ORF50
protein, the loss of ORFA6 protein and presence of ORFA7 protein in the attenuated
A1HV-1 C500 virus.
The results of this study showed that both ORF50 and ORFA6 protein
expression is present in BT cells infected with virulent and attenuated A1HV-1 while
ORFA7 protein expression was not detected in BT cells infected with either virus.
PCR detection of the DNA encoding ORF50, A6 and A7 showed that none of these
genes appeared to be truncated after attenuation of the virus as is suggested by the
rearrangements that occur at the right-hand end of the genome. These results may be
interpreted in different ways. Firstly, the rearrangements described at the right-hand
end of the genome may not be the only ones to occur on attenuation of the virus. In
the original assessment of the attenuated C500 genome, the translocated segment
found on the right-hand terminal position was repeated at the opposite end of the
unique DNA (Handley et al, 1995). Thus, it is possible that the complete ORFA6
sequence and a transcriptionally active ORF50 are present at the left-hand terminal
region. This would explain the presence of the proteins encoded by ORF50 and A6
in both virulent and attenuated C500. Sequence analysis of the left-terminal region
or the middle of the attenuated virus genome has not been determined. The
significance of the rearrangements of the A1HV-1 genome is still unclear and a more
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extensive evaluation of the translocations that occur on attenuation must be
performed.
The presence of ORF50 and A6 proteins in both virulent and attenuated
virus-infected BT cells would suggest that these proteins are not directly or solely
involved in the induction of disease. The absence of ORFA7 protein in the presence
of its DNA might suggest that this gene is not transcribed in either the virulent or the
attenuated virus. However, the presence of mRNA for ORF50, A6 and A7 in C500-
infected BT cells could not be determined due to the presence of excess viral DNA in
RT-PCR experiments, despite the use of DNase (Chapter 6). If ORFA7 transcription
is assumed in the virulent virus, the hypothetical translocation in the attenuated virus
of ORF50 and ORFA6 to the left end of the genome may also disrupt the upstream
regulatory sequences controlling ORFA7 transcription. The loss of ORFA7
following attenuation of A1HV-1 C500 could explain the loss of disease induction if
information regarding its positional homologue in EBV extends to functional
homology. ORFA7 has a positional homologue in EBV (i.e. BZLF2, which has
17.1% sequence identity to ORFA7). In EBV, BZLF2 encodes a glycoprotein (gp42)
(Li et al, 1995) that associates with the EBV surface glycoproteins gH and gl and
interacts with MHC class II (Li et al, 1997; Spriggs et al, 1996). Interference with
gp42 binding using antibodies or by deletion mutation blocks B cell transformation
and vims entry into the cell (Li et al, 1997; Miller and Hutt-Fletcher 1988; Wang and
Hutt-Fletcher 1998). Furthermore, release of virions (and therefore lytic replication)
was not disrupted in the gp42 deletion mutant. Therefore, the loss of transcription of
ORFA7 could explain the loss of disease induction and the presence of vims
replication in BT cells infected with attenuated virus.
Alternatively, the presence of ORF50 and A6 at protein level could suggest
the presence of a mixture of vimlent and attenuated virus in the high pass C500
cultures used in this study. Indeed, in Handley's work the Hindlll clone virl thought
to originate from the virulent C500 (Handley et al, 1995) was subsequently found to
be a sequence from the attenuated virus (H. Wright, personal communication).
Therefore, it is likely that the presence of even a small number of vimlent genomes
in high pass attenuated C500 virus cultures could account for the detection of ORF50
and A6 protein in high pass C500-infected BT cells. The attenuation of high pass
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C500 may not be compromised by this hypothesis. As attenuation refers to loss of
induction of disease, it is possible that the titre of virulent virus in high pass C500 is
too low for disease induction.
In LGL cell lines, the replicative state of the MCF viruses is unknown. The
results of this study showed the expression of ORF50, A6 and A7 mRNA in LGLs
and support the hypothesis that in LGLs there is at least a low level of virus
replication. The low and variable levels of mRNA encoding ORF50, A6 and A7 in
different LGL cell lines may indicate that not all cells in a cell line express these
genes. However, the presence of ORF50, A6 and A7 mRNA in LGLs does not
conclusively demonstrate the presence of a replicative virus as the whole set of lytic
genes need to be expressed for viral replication to occur. In the MCF viruses, lytic
genes have not been determined. In order to prove the presence of a replicative virus
in LGL cell lines a more extensive search for virions (e.g. by electron microscopy)
would need to be performed. Electron microscopy of OvHV-2-infected LGL cell
lines performed subsequent to this study has revealed the presence of herpesvirus
virions (H. Reid, unpublished observations) and supports the hypothesis that LGL
cell lines contain replicative virus.
The sequence homology of ORF50 and positional homology of ORFA6 to
immediate early proteins in EBV and HVS support the hypothesis that LGL cell lines
could contain replicating virus. ORF50 is the positional equivalent of EBV BRLF1
(an R transactivator) and HVS ORF50 (Ensser et al, 1997). EBV BRLF1 is
expressed in the immediate-early (I.E.) phase of the viral lytic replication cycle that
is followed by the delayed-early (D.E.) and late (L.) phase culminating in the
formation and release of mature virions (Honess and Roizman, 1974). The EBV R
transactivator is required for the reactivation of the lytic cycle in latently infected B
cells (Miller, 1990). ORF50 of HVS has also been demonstrated to act as a
transactivator expressed during the immediate early and delayed early phases of lytic
replication (Whitehouse et al, 1998). Recent investigations have revealed that
ORF50 of A1HV-1 has similar functions to ORF50 of HVS, as a transactivator of
ORF57, 6 and A9 (Frame and Dalziel, 1999). This work provides further evidence
for the presence of replicative virus in LGL cell lines. The positional homologue of
ORFA6 in EBV is BZLF1 (which has 19.5% sequence identity to the ORFA6
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sequence). This is another gene transactivator and co-operates with the BRLF1 gene
product in the switch from the latent to lytic cycle in B cells (Miller, 1990).
However, the function of ORFA6 protein has not been determined. The positional
homology of ORFA7 to EBV BZLF2, which encodes a glycoprotein with an role in
virus entry (Li et al, 1997; Miller and Hutt-Fletcher, 1988) also supports the
hypothesis that A1HV-1 in LGLs is capable of replication. The role of these A1HV-1
proteins in virus replication or disease induction needs to be assessed (e.g. by the
generation of virus gene deletion mutants). Work is currently in progress to generate
a ORF50 deletion mutant.
The translocation of the region of A1HV-1 C500 in the middle of the genome
to the right-hand terminal position may affect the transcription on attenuation of the
gene adjacent to the translocated region (i.e. the gene encoded in ORFA10).
Similarly, the loss of genes from the middle of the genome may affect transcription
of genes adjacent to ORF50 and A7 (i.e. the genes encoded in ORF48 and ORFA8).
Therefore, the effect of attenuation on the transcription of ORF48, A8 and A10
should be investigated. ORF A8 is particularly interesting, as it is a positional
homologue of EBV BZLF3 (gp350/220), MHV-68 M7 (gpl50) and HVS and EHV-2
ORF51 (Ensser et al, 1997; Stewart et al, 1996; Telford et al, 1995). The
glycoproteins gp350/220 mediate attachment of the virus to B cells via CD21 (CR2)
(Fingeroth et al, 1984) and plays a role in entry of virus into cells as antiserum
directed to gp350/220 inhibits EBV infection (Tanner et al, 1987). The protein is
therefore considered a virulence factor for EBV. The ORFs at the left terminal
location of A1HV-1 (i.e. Al and A2) may be affected if rearrangements also occur at
this end of the attenuated genome. A1HV-1 ORF Al and A2 have no sequence
homology to other herpesvirus genes. However, they share positional homology
with the HVS gene encoding Tip and STP - the two transforming factors (Duboise et
al, 1998a; Lee et al, 1997; Wiese et al, 1996).
The number and identification of genes expressed in infected LGL cells are
not known. In sheep, where OvHV-2 latently infects B cells, there is no apparent
disease. In disease-susceptible animals, rare cases of recovery from MCF have been
reported. In such cases, the virus also appears to become latent. Therefore, it is
possible that a protective immune response is present in such animals during the
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initial acute phase of the disease. The appearance of disease in susceptible animals
would indicate that viral gene expression in LGLs does not raise a protective immune
response. In addition, the infection by the MCF viruses of antiviral effector cells
may lead to the immune dysfunction and pathology associated with MCF.
Unfortunately, studies of latent gene expression in carrier animals cannot be
performed due to lack of information on OvHV-2 genes and lack of latently infected
cell lines from A1F1V-1-infected wildebeest. However, virus gene expression in
LGLs is currently being investigated that will be helpful in determining the
pathogenesis of MCF.
The work presented here has improved our understanding of LGL
dysfunction in MCF and identified possible means by which this dysfunction may
occur. Insights into MCF pathology have consequently been gained. The results
presented in this study form the basis for further work. For instance, A1HV-1
proteins will be expressed from a number of putative virulence genes to look for
binding to cellular signalling or other molecules. The putative anti-apoptotic
function of ORF A9, which encodes an A1HV-1 homologue of bcl-2, is currently
being investigated. An ORF50 deletion mutant virus is being generated to determine
the function of the protein encoded by this gene. The number of viral genes
expressed in LGL cells will also be investigated by mRNA analysis. The work on
IL-15 is currently being completed. Thus, the work presented in this thesis has
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Constitutive activation of Lck and Fyn tyrosine kinases in large granular
lymphocytes infected with the y-herpesvirus agents of malignant catarrhal fever




Large granular lymphocytes (LGL) with a T or natural killer (NK) lymphoblast morphology and
indiscriminate (non-major histocompatibility complex-linked) cytotoxicity for a variety of target
cells can be derived in culture from the tissues of animals infected with either alcelaphine
herpesvirus-1 (A1HV-1) or ovine herpesvirus-2 (OvHV-2). In this study, LGL survival in the
absence of exogenous interleukin-2 was inhibited by the protein kinase inhibitor genestein, but not
the p70 s6 kinase inhibitor rapamycin. Constitutive activation of the src kinases Lck and Fyn was
demonstrated in a bovine LGL line infected with OvHV-2 and in two rabbit LGL lines infected with
A1HV-1. The p44 erkl and p42 erk2 mitogen-activated protein kinases (MAPK) were also
constitutively activated in the LGLs but not control T cells. Lck and Fyn kinase activity in the
LGLs did not increase after mitogen (concanavalin A or concanavalin A plus phorbol ester)
stimulation of the cells, in contrast to control T cells. Control T cells, but not the LGLs, proliferated
after mitogen stimulation. An analysis of tyrosine phosphorylated proteins in the cells indicated that
the LGLs exhibited some similarities and differences to activated control T cells. The results
demonstrate that the activated phenotype of the LGLs, associated with malignant catarrhal fever
virus infection and in the absence of exogenous interleukin-2, involves constitutively activated Lck
and Fyn kinases. These are normally crucial for the initial activation of T cells via several cell-
surface receptors (e.g. the T-cell receptor and CD2). The inability of the LGLs to proliferate in
response to mitogen may be due to an inability of Lck and Fyn to become further activated after
mitogen stimulation.
INTRODUCTION
Malignant catarrhal fever (MCF) is a fatal lymphoproliferative
disease of farmed and wild ungulates.1"3 The known causative
agents are two y-herpesviruses, alcelaphine herpesvirus-1
(A1HV-1) and ovine herpesvirus-2 (OvHV-2). A1HV-1 infects
and replicates in blue wildebeest (Connochaetes taurinus),
causing no apparent disease. In contrast, when MCF-
susceptible species become infected they develop MCF, which
is usually fatal. OvHV-2 infects and replicates in sheep, which
do not become diseased. However, a proportion of cattle, deer,
or other susceptible species that are in the vicinity of infected
sheep can become infected and develop MCF which again is
normally fatal. Rabbits develop MCF after experimental
infection with A1HV-1 or OvHV-2 that is characteristic of
the disease in ungulates.1-3-4
Received 2 February 2000; revised 18 September 2000; accepted 21
September 2000.
Correspondence: Dr D. M. Haig, Moredun Research Institute,
Pentlands Science Park, Penicuik, EH26 0PZ, UK.
MCF is characterized by degenerative changes in multiple
tissues, associated with the infiltration of large numbers of
lymphocytes and hyperplasia of lymphoid organs. In OvHV-
2-infected cattle or rabbits, submandibular and mesenteric
(MLN) lymph nodes, appendix and spleen become enlarged.
This is followed by invasion of non-lymphoid tissue by
lymphocytes and tissue necrosis in both lymphoid and non-
lymphoid tissues.1-3,4 In A1HV-1-infected animals, the pathol¬
ogy is generally similar except that popliteal lymph nodes are
larger and MLN are smaller than in OvHV-2-induced disease.
The current hypothesis is that MCF is caused by the auto-
destruction of tissues by indiscriminately cytotoxic lympho¬
cytes, produced as a consequence of MCF virus infection.
Large granular lymphocytes (LGL) containing viral
transcripts can be derived from MCF virus-infected animal
lymph node, spleen, corneal and other affected tissues and
grown in culture.1 The LGL can transmit MCF when injected
into rabbits or other susceptible species. The LGL are normally
grown in medium containing interleukin-2 (IL-2), but can also
be grown in the absence of IL-2 and other exogenously added
cytokines. The phenotype of the cultured cells from OvHV-
2-infected cattle is generally characteristic of T cells or natural
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killer (NK) cells. CD4+ and CD8+ T cells as well as CD4~
CD8- T cells have been grown in culture.3'5,6
Characteristics of OvHV-2 virus-infected bovine T cells in
culture are: large granular lymphocyte morphology; the ability
to survive or grow in culture in the absence of exogenous 1L-2
(or other cytokines) for longer periods than non-infected cells;
constitutive non-major histocompatibility complex (MHC)
-associated cytotoxicity; T-cell or NK-cell surface alloantigen
phenotype; lack of IL-2 mRNA and protein expression; and
lack of mitogen-stimulated proliferation in culture.''3'6,7
Rabbit A1HV-1-infected LGLs have some of the above
properties but are not as well characterized.1'3 The viruses of
MCF have several features in common with other T-cell-tropic
•/-herpesviruses, particularly herpesvirus saimiri (HVS). HVS
naturally infects squirrel monkeys without disease but causes a
lymphoproliferative disease associated with lymphomas and
leukaemias of T-cell origin following infection of disease-
susceptible primates.8 HVS will infect human T cells in culture
that can be cytotoxic and srow in the absence of exogenous IL-
2.9
A common feature of HVS and Epstein-Barr virus (EBV)
•/-herpesviruses is the presence of viral proteins that interfere
with lymphocyte signal transduction molecules, particularly
the non-receptor protein tyrosine kinases (NRPTK)10 . In
EBV, latent membrane protein-2A (LMP-2A) binds to and
inhibits the activity of the B cell NRPTKs Lyn (a sre kinase)
and Syk11 HVS-transformed monkey and human T cells
contain stp and tip virus proteins.9'12'13 The tip protein is a
membrane protein that binds to and alters the function of the
NRPTK Lck (a sre kinase).
By targeting NRPTKs, many viruses have evolved an
effective mechanism for controlling the virus life cycle and
pathogenicity by altering the signalling pathways of infected
cells.10 The T-cell-associated sic kinases Lck and Fyn are
NRPTKs that are recruited to the T-cell receptor complex and
other receptor structures (e.g. CD4, CD8 and CD2) within
minutes ofT-cell stimulation via these receptors. They link with
a range of downstream signalling pathways including the ras/
raf-l/erk MAPK pathway to control T-cell activation,
proliferation and differentiation (reviewed in refs 14 and 15).
Lck and Fyn are therefore candidate molecules for interference
by the MCF viruses A1HV-1 and OvHV-2.
The genome sequence of A1HV-1 has recently been
elucidated.16 However, an amino acid homology search of
the virus open reading frames (ORFs) for putative binding
factors for host signalling molecules has been unsuccessful.
The objective of this study was to determine whether the IL-
2-independent growth of LGLs from MCF-affected animals
was associated with protein kinase modulation in the LGLs
compared to lymphocytes from uninfected control animals. In
particular, we wished to compare the activation status of the sre
kinases Lck and Fyn in A1HV-1- and OvHV-2-infected LGLs,




The fully virulent C500 strain of AIHV-1 was maintained by
passage in rabbits.1'3'5 The AIHV-1-infected LGL cell lines
1859 and 1860 were generated by injecting C500-infected rabbit
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Table 1. Phenotype of the MCF virus-infected cell lines
Cells Virus Surface phenolype (%)* BLT-esterase (%)+
1859 AIHV-1 CD5"(50%). CD4". >80
CDS + (50%). IgM"
1860 AIHV-1 CD5~. CD4-. >75
CDS+ (45%). IgM~
BJ1035 OvHV-2 CD2". CD4~, >90
CDS-, CD21 "
*CD+ cells were > 98% positive unless shown otherwise in parentheses.
tBLT-esterase+ cells detected by cytochemistry (result shown based on
two separate analyses). Control T cells (rabbit and bovine) were <5% BLT-
esterase+. except for one rabbit CDS + (95% positive) T-cell line that was
22% BLT-esterase+.
lymphoid cells intravenously into two rabbits. Two days after a
rise in rectal temperature above 403, the rabbits were killed.
MLN and spleen cells were harvested, single cell suspensions
were prepared and cultured at 5xl06 — lOxlO6 cells/ml in
Iscove's modified Dulbecco's medium (IMDM) containing
10% fetal calf serum (FCS) and 200 U/ml IL-2 (Eurocetus,
Amsterdam, the Netherlands) in 25-cm2 flasks. Large granular
lymphocytes developed after 1-3 weeks of splitting and refeed-
ing the cells with IL-2 on an approximately weekly basis. After
8 weeks the phenotype of the cells had stabilized (Table 1).
Virus genes and proteins were detected in the LGL using poly¬
merase chain reaction (PCR) for the AIHV-1 PI gene (ORF 50,
an early viral R-transactivator gene16) and indirect immuno¬
fluorescence using serum antibody to AIHV-1 proteins from
an infected rabbit, using techniques described previously.17'18
For the PI DNA PCR, a guanidinium isothiocyanate
extract of cells was analysed using the following primers: 5'
TTCTATTGTCCACTGCCTCATCTC; and 3' TGACTG-
TGGTTCACTTGCTTCCAG. PCR amplification was per¬
formed using the Expand " long template PCR (Boehringer
Mannheim, Mannheim, Germany). Amplified product (503 bp)
was analysed on agarose gels stained with ethidium bromide
and visualized under UV light.
For IL-2-independent growth, 1859 and 1860 LGL were
washed in medium and cultured in.24-well tissue culture plates
at 106/ml. For this study, the rabbit LGL were taken from
culture between 48 and 96 hr after deprivation of exogenous
IL-2, when cell viability was > 70%.
Control rabbit or bovine cells were peripheral blood
mononuclear cells (PBMC) derived from blood after centrifu-
gation over lymphoprep (Nyegard, Oslo, Norway). T-cell
blasts were also used. These were derived from 2xl06/ml
PBMC stimulated with 5 pg/ml concanavalin A (Con A) for
3 days. Then, 2 x 105 lymphoblasts/ml medium were expanded
for 1^1 weeks in 200 U/ml IL-2. The cells were split and refed
with the IL-2 and fresh medium every 3-5 days. The control
cells were negative for AIHV-1 or OvHV-2 viruses, using the
tests described above and below. For IL-2-independent growth,
106 rabbit or bovine T-cell blasts were cultured in IMDM. The
cells did not survive at >70% viability at 106/ml (or less) for
more than 30 hr and during this time the majority of viable
lymphoblasts reverted to a 'resting' medium/large lymphocyte
morphology.
The BJ1035 LGL cell line was derived from a cow naturally
infected with OvHV-2 in 1994.6 The T cells were routinely
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passaged in IMDM containing 200 U/ml IL-2. BJ 1035 was also
maintained for 12 weeks in IMDM without exogenous IL-2.
The cells were replenished with medium and readjusted to
106/ml approximately every week. The cells exhibited a dou¬
bling time of 7-8 days under these conditions. The presence of
OvHV-2 DNA in the cells was detected by PCR as described
previously.19 OvHV-2 virus proteins were detected within the
cells using antibodies from the serum of a convalescent cow and
an indirect immunofluorescence technique.
Antibodies
Murine monoclonal antibodies (mAb): anti-rabbit CD4 (clone
KEN-4); anti-rabbit CD8a (clone 12C6); anti-rabbit CD5
(clone KEN-5); anti-rabbit immunoglobulin M (IgM; clone
NRBM) were purchased from Serotec (Slough, UK). The
mAbs to bovine antigens: anti-bovine CD4 (clone CC8); anti-
bovine CD8 (clone CC63); anti-bovine CD2 (clone CC42);
anti-bovine CD21 (clone CC21) were gifts from the Institute
for Animal Health, Compton, Berkshire, UK. The murine anti-
phosphotyrosine'mAb (clone 4G10) was obtained from
Upstate Biotechnology (Lake Placid, NY). The murine anti-
Lck (clone 3A5), anti-Fyn (clone 15), and anti-phosphorylated
(activated) erkl (clone sc-7383) mAbs and the rabbit anti-erkl
antibody (sc-94) were purchased from Santa Cruz Biotechnol¬
ogy (Santa Cruz, CA). Isotype-matched control murine mAbs
to Border Disease virus antigens were a gift from G. Entrican
(Moredun Research Institute). The A1HV-1 and OvHV-2
antibodies were obtained from the serum of an A1HV-1-
infected rabbit and a cow that survived OvHV-2 infection,
respectively. The antibodies recognize uncharacterized virus
antigen(s) located in the nuclei and perinuclear areas of infected
cells. They do not react with uninfected cells.
Cell phenotype analysis
Cell-surface antigens were detected by indirect immunofluo¬
rescence and fluorescence-activated cell scan (FACscan) analy¬
sis (Becton Dickinson, Mountain View, CA) using standard
procedures.
Cytotoxic cell BLT-esterase activity was detected in the
LGL and control cells using the tryptase-specific substrate N-a-
benzyloxy-carbonyl-L-lysine thiobenzyl ester (BLT, Sigma,
Poole, UK) as described previously.20 BLT-esterase is
expressed by activated cytotoxic cells.20'21
Treatment of LGL cells by genestein and rapamycin
Virus-infected LGLs in IL-2-deficient IMDM were added to
wells of a 96-well tissue culture plate at 105 cells/well (100 |il/
well). The protein kinase inhibitor genestein (TCS, Botolph
Claydon, Buckingham, UK) was added to the wells to give final
concentrations of 1 jim, 10 |iM and 100 um. The 1035 LGL line
was also treated with the p70 s6 kinase inhibitor rapamycin
(TCS, UK) at 0-1 nM, 1 nM, 10 iim and 100 nM. Cell growth was
measured as the numbers of viable cells (determined by
nigrosine exclusion) per ml on day 3 of culture.
Cell activation and lysate production
Antibodies that cross-link the T-cell receptor and activate
rabbit and bovine T cells are not available. Instead, the T-cell-
stimulating mitogen Con A (1CN, Thame, UK) with and
without the phorbol ester 12-O-Tetradecanoylphorbol 13-
acetate (TPA; Sigma) was used in this study. For T-cell
proliferation, different concentrations of Con A (±TPA) were
used to stimulate 100 pi aliquots of 2 x 106 cells/ml IMDM
(2-5% FCS) in the wells of 96-well plates. After 2 days of
culture, the cells were incubated with 50 pi [3H]thymidine
(0-5 pCi/well) for a further 18 hr. Cells were harvested
onto membranes and [3H]thymidine incorporation measured
in a p-scintillation counter (Tri-carb 2500 TR, Packard,
Meriden, CT).
For cell stimulation, 10 pg/ml Con A was added (±5 ng/ml
TPA) to 5 x 106 or 107 PBMC or IL-2-deprived T cells or LGL
in 1 ml serum-free medium at 37° in microfuge tubes for
various periods of time. The doses of Con A and TPA used
were determined by dose-response kinase-activation (phospho¬
transferase) experiments. Activation reactions were stopped by
centrifugation of the cells at 10 000# for 10 seconds in a
microfuge at 4°. Supernatants were discarded and cells were
lysed with ice-cold lysis buffer (1% Triton-X, 150 mM NaCl,
1 mM sodium vanadate, 1 mM sodium fluoride, 10 mM Tris-
HC1 pH 7-5) containing protease inhibitors (Complete*,
Boehringer Mannheim). Then, 50 pi of lysis buffer was added
to cells for subsequent analysis of tyrosine-phosphorylated
proteins using the 4G10 antibody and Western blot. Prior to
immuno-precipitation, 1 ml of lysis buffer was added to cells.
Clarified lysates were obtained by centrifugation in a microfuge
at 10 000 g for 20 min at 4°. Protein concentrations in the 50 pi
lysates were within the 10-14 mg/ml range and in the 1 ml
lysates were within the 1-2 mg/ml range as determined by
bicinchoninic acid (BCA) assay (Pierce, Rockford, IL). For
sodium dodecyl sulphate-polyacrylamide gel electrophoresis
(SDS-PAGE), an equal volume of cell lysate from each cell
preparation was added to the wells of the gels, the amount
being expressed as cell-equivalents (i.e. the number of cells
lysed to make the lysate).
Immunoprecipitation and Western blot analyses
Lysates were precleared with murine or rabbit IgG-agarose for
1 hr at 4° followed by centrifugation and removal of the
agarose beads. Primary Lck, Fyn, or control mAb (final
concentration 1 pg/ml) was added to lysates for 1-2 hr at 4°;
20 pi of protein-A/G-agarose (Santa Cruz) was added and
lysates were incubated for 1 hr at 4°. Agarose immunoprecip-
itates were centrifuged and washed three times in lysis buffer.
A 5-pl sample (of 25 pi total volume) was taken at this stage
for Western blot analysis of immunoprecipitated Lck or
Fyn kinases. For the phosphotransferase assay, the agarose
complexes containing Lck and Fyn were washed twice more
with kinase buffer (20 mM Tris-HCl pH 7-5, 10 mM MgCL,
5 mM MnCI2).
For Western blot analysis, samples of lysate were boiled in
reducing sample buffer (containing 2-mercaptoethenol) and
proteins were separated by SDS-PAGE using 10% or 12%
Proseive-50 gels (FMC, Rockland, WA) and a Mini-Protean II
apparatus (Biorad, Hemel Hampstead, UK). Proteins were
transferred to nitrocellulose membranes using a semi-dry
transfer apparatus (Sigma). Membranes were blocked in 5%
non-fat milk (Marvel) for 1 hr, and dilutions of primary
antibodies were added in wash buffer (0 5% Tween-80 in
phosphate-buffered saline) for 1 hr (or overnight at 4°).
Membranes were washed (2 x 10 min) in wash buffer and the
horseradish peroxidase-conjugated goat anti-mouse (or anti-
rabbit) IgG second-stage antibody was added for 1-2 hr at
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room temperature. After a final wash, proteins were detected
using the enhanced chemiluminescence (ECL) method
(Amersham, Little Chalfont, UK). Control antibodies did
not immunoprecipitate antigen from cell lysates.
In vitro phosphotransferase assay
The activation of immunoprecipitated Fyn and Lck kinases
was assayed by kinase-mediated in vitro phosphotransferase of
('-yJ-ATP (Amersham) to the src kinase substrate acid-treated
rabbit muscle enolase (Sigma). Twenty-five microlitres of
kinase buffer containing 25 |im ATP (Sigma), 400 pg/ml acid-
treated enolase, and 320 pCi/ml (32y]-ATP was added to the
agarose immunocomplexes in microfuge tubes. The samples
were incubated at 30° for 10 min in a water bath. Then, 6 pi of
fourfold concentrated electrophoresis sample buffer (500 mM
Tris-HCl pH 6-8, 8% SDS, 20% glycerol, 0 012% bromophenol
blue, 8% P-mercaptoethanol) was added to the samples which
were incubated for a further 20 min at room temperature. The
samples were boiled for 5 min and fractions were separated by
SDS-PAGE using 10% or 12% Proseive gels. The gels were
fixed and stained with Coomassie blue (0-25% Coomassie blue
in 45% methanol, 10% acetic acid), destained (40% methanol,
10% acetic acid), dried and exposed to X-ray film. Kinase
activity was detected as a band of [32y]-ATP-phosphorylated
enolase (molecular weight 48 000). In order to quantify the
phosphorylation of enolase, the 48 000 MW enolase bands
were excised from the gels and radioactivity was measured in a
P-scintillation counter. Incorporation of [32y]-ATP into enolase
was calculated for each sample as follows: [counts per minute
(c.p.m.) enolase in the presence of kinase] —(c.p.m. enolase in
control samples without immunoprecipitated kinase).
Mitogen-activated protein kinases (MAPK) activation .
analysis
Activated p42 and p44 MAPK is phosphorylated on tyrosine
and threonine residues at positions 185 and 183. respectively,
and was detected in cell lysates by Western blot using the
p42/44 MAPK-phosphotyrosine-specific mAb sc-7383. Non-
phosphorylated MAPK was detected using the erk 1-specific
antibody sc-94 that cross-reacts with erk2.
RESULTS
Phenotype of MCF virus-infected cell lines
The LGL cell lines consisted of >96% LGL, of which >80%
stained positive for either A1HV-1 (1859 and 1860) or OvHV-2
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(1035) proteins by immunofluorescence. PI mRNA was
detected by reverse transcription (RT) -PCR in the rabbit
A1HV-1 + LGL but not in control rabbit cells. OvHV-2 DNA
was detected by PCR in the bovine 1035 LGL line, but not in
control uninfected bovine T cells.
In the absence of exogenous IL-2 for at least 4 days in the
cultures, the LGL survived or grew and maintained a
lymphoblastoid appearance and constitutive expression of
BLT-esterase, an activated cytotoxic cell tryptase (Table 1).
Table 1 shows the cell-surface phenotype of the MCF virus-
infected LGL cell lines. The phenotype of approximately half
of the cells of the AHV-1 + rabbit LGL could not be typed with
the available antibodies. The LGL did not contain B cells
(IgM~ or CD21 ~).
Control rabbit and bovine T cells (« = 12) derived from
Con-A-stimulated blood mononuclear cells (MNC) were:
CD5+ (>90%) or CD2+ (>90%) IgM" (<5%) or CD21"
( < 5%), CD4+ (range 8-90%) and/or CD8+ (range 4-95%).
Mitogen-stimulated MCF virus-infected LGL do not
proliferate in culture
Table 2 shows that Con A or Con A plus TPA stimulated a
proliferation signal ([3H]thymidine incorporation into dividing
cells) in control rabbit or bovine T-cell blasts that had been
deprived of exogenous IL-2 for approximately 30 hr. However,
the A1HV-1-infected rabbit LGL (1859 and 1860) and the
OvHV-2-infected bovine LGL line (1035) that had been
deprived of IL-2 for approximately 48 hr and 4 days,
respectively, did not respond to Con A or Con A/TPA
stimulation with any significant increase in [3H]thymidine
incorporation into the cells above that of unstimulated cells.
PHJThymidine incorporation into unstimulated LGL cells but
not into control uninfected T cells showed that at least a
proportion of the LGL (but not the control T cells) were
dividing in the absence of exogenous IL-2. Con A and Con A
plus TPA stimulated cell aggregate formation in both control
T cells and the LGL. This, along with a minor Con A dose-
dependent effect on [3H]thymidine incorporation into LGL
indicated that Con A was capable of stimulating a response in
the LGL.
Tyrosine phosphorylated proteins in total cell lysates
Tyrosine phosphorylated proteins were detected in the cell
lysates of control T cells deprived of IL-2 for 30 hr and MCF
Table 2. Mitogen-stimulated proliferation of LGL and control T cells
Stimulus 1859 LGL 1860 LGL 1035 LGL Bovine T cells Rabbit T cells
Medium control 2498 ±131 1292 ±22 1060 ±21 132 ±12 22 ± 1-2
Con A, 10 pg/ml 1349 ±126 1648 ±108 1368 ±102 2734 ±98 1030 ±68
Con-A, 5 pg/ml 2467 ±106 1825 ±146 634 ±5 4820 ±246 4307 ±249
6 on A, 2-5 pg/ml 2044+110 1342 ±98 856 ± 41 3160 ±148 2312 ±168
Con A (5) + TPA* 2264 ±242 1924 ± 110 1403 ±125 5204 ±124 1489 ±35
Con A (2-5)4-TPA 2402 ±114 1727 ±232 893 ±171 5796 ±342 4704 ±137
Con A (l-25)+TPA 2233 ±102 1650 ±78 1240 ±39 4668 ±236 3220 ±49
TPA 1245 ±68 1376 ±116 1448 ±71 896 ±72 130 ± 9
Data arc counts per minute + SEM from replicate samples in the [JH]thymidine incorporation assay. * TPA used at 5 ng/ml alone or in combination with
fon A used at the doses shown in parentheses (in pg/ml).
'■ 2001 Blackwcll Science Ltd, Immunology. 102. 44 -52
48 S. Su'a ct al.
(a) Control 1859 1860
MWxIO1 - 5 - 5 - 5 MWx10'
(b) MNC T cells 1035
MW x 103 - 5 5 10 - 5 10 MWxW
Figure 1. Phosphotyrosine proteins in LGL and control cell Iysates.
4G10 anti-phosphotyrosine Western blot of lysates from unstimulated
( —) cells or cells stimulated for 5 (5) or 10(10) min with 10 Ltg/ml Con
A and subjected to SDS-PAGE. (a) Control rabbit T cells and the
AH1V-1+ LGL 1859 and 1860. (b) Control bovine blood mononuclear
cells, control bovine T cells and the OvHV-2^ LGL 1035.
Table 3. Inhibition of LGL growth by gencstcin but not rnpamycin
1035 LGL 1859 LGL
Inhibitor (cells/ml) x 106 (cells/ml) x 10''
Genestcin
Medium control 1 43+0-23 1-1310-12
1 (J.M 1-33 ±0-28 0-9310-10
10 (1M 0-90 ±0-20 0-50 1 0-09*
100 |TM 0-48 ±012* 0-2610-10*
Rapamycin
Medium control 1-30 + 0-12 ND
01 nM 1-14 + 0-14 ND
1 ntu l-23±0-09 ND
10 nM 1-1010-22 ND
100 nM 1-2010-14 ND
Viable cell counts (mean + SEM for triplicate wells) performed after
3 days of culture. All cells set up at 106/ml on day 0. nd, not determined.
* PC0-01 compared with medium control values.
Genestein inhibits the IL-2-independent growth of LGLs
Table 3 shows that exogenous IL-2-independent survival/
growth of the OvHV2+ bovine LGL line 1035 and the A1HV-
1+ rabbit LGL line 1859 was inhibited in a dose-dependent
way by the protein kinase inhibitor genestein. The 1035 LGL
cell growth was not inhibited by rapamycin. The rapamycin
experiment was not performed on the rabbit LGLs as they
died during the course of these studies and could not be
resurrected from frozen stock.
virus-infected LGL deprived of IL-2 for at least 48 hr, with and
without Con A stimulation. This was to determine whether
infection with virus was associated with any differences in
tyrosine-phosphorylated protein expression between the LGL
cell lines and control T cells. In particular proteins phospho-
rylated within 10 min of Con A stimulation were compared, as
these are likely to reveal the NRPTKs.
The unstimulated rabbit AlHV-l-infected LGL cell lines
1859 and 1860 expressed phosphotyrosine proteins at MW of
approximately 21 000, 30 000, 38 000, 42 000, 48 000, 56 000
and 59 000 (Fig. la) that were also seen in repeated 4G10 blots.
Five minutes after Con A stimulation the intensity of some
bands (e.g. p30, p38, p42) decreased while there was an increase
in the intensity of a p50 band in the example shown (Fig. la),
but not in repeated analyses of the same LGL. Control rabbit
T cells expressed phosphoproteins with MW of approximately
38 000, 42 000, 55 000, 59 000, 70 000, 90 000 and 130 000
5 min after Con A stimulation (Fig. la).
Control stimulated bovine PBMNC or T-cell blasts and the
unstimulated and stimulated bovine OvHV-2-infected cell line
BJ1035 expressed phosphotyrosine proteins at approximately
21 000, 38 000, 48 000, 56 000, 59 000, 70 000 and 90 000
(Fig. lb). Control, unstimulated T-cell blasts exhibited low
level expression of phosphotyrosine proteins compared to
stimulated cells. Unstimulated PBMC did not express any
detectable phosphotyrosine proteins. BJ1035 cells, when
compared to unstimulated cells after stimulation with Con A
showed an increase in 48 000, 61 000, 70 000 and 90 000
protein staining with 4G10, whereas 56 000 and 59 000 protein
expression was not visibly altered.
Fyn and Lck kinases are constitutively active in the MCF
virus-infected cell lines
Figure 2 shows that Con A stimulated an increase in Fyn
activity in control cells whereas in the LGLs, Fyn was activated
in the absence of Con A and did not increase in activity after
Con A stimulation. In control cells, the degree of activation
was low or not detectable in 'rested' unstimulated cells, but was
high in cells stimulated for 5 min with Con A. Fyn kinase
activity had declined by 30 min compared to 5 min after
stimulation (Fig. 2a,d). In contrast, the Fyn kinases in the
1859, 1860 and 1035 cells were approximately equally activated
in both the unstimulated and Con-A-stimulated cells
(Fig. 2a,d).
Figure 2(b,c) shows that for each of the cell types, there was
an equal loading of enolase and an approximately equal
loading of immunoprecipitated Fyn in the gels.
Figure 3 shows that Lck kinase activated and phospho-
rylated enolase when Lck was immunoprecipitated from:
control rabbit blood mononuclear cells after Con A stimula¬
tion; control rabbit or bovine T cells particularly after Con A
stimulation; A1HV-1-infected 1859 and 1860 LGLs and the
OvHV-2-infected 1035 LGL cells either before or after Con A
stimulation (Fig. 3a,d). In contrast to the control cells, the
LGL exhibited Lck activation in the absence of Con A that did
not increase after Con A stimulation of the. cells (Fig. 3a,d).
Figure 3(b,c) show that for each of the cell types, there was an
equal loading of enolase (except for 1859 and 1860 cells in
Fig. 3(b) where the quality of the stained gel was poor on two
•f.'i 2001 Blackwcll Science Ltd, Immunology, 102, 44-52
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Figure 2. JFyn kinase activation in the LGL lines and control T cells, (a) Autoradiograph of SDS-PAGE gel showing enolase
phosphorylation by Fyn kinase immuno-precipitated from LGL and control rabbit (ra) and bovine (bo) T cells either unstimulated (0)
or stimulated with Con A (10 [ig/ml) for 5 min (5) or 30 min (30). (b) Coomassie blue stain, control for protein loading in each lane
(showing enolase band), (c) Western blot (anti-Fyn) control for immunoprecipitated Fyn loading, (d) Quantification of enolase
phosphorylation by P-scintillation counts per minute (c.p.m.) of enolase bands cut out of the SDS-PAGE gels. C. control T cells; 59,
1859 LGL; 60, 1860 LGL; 35, 1035 LGL; unstimulated (0) or stimulated for 5 or 30 min with Con A. Lysates from 8 x 106 cell
equivalents were loaded in each of the lanes of the gels. Note that a comparison of the intensity of Fyn-mediated enolase
phosphorylation between control and LGL cells, and between LGL cell lines may not be possible as different exposure times were
often used in the development of the autoradiographs. Furthermore, p-scintillation analysis of the enolase bands cut from the gels of
the different cell types did not always take place at the same relative time following the gel run.
occasions and is not shown) and an approximately equal
loading of immunoprecipitated Fyn in the gels.
In all experiments, enolase was not phosphorylated in
control samples containing enolase and [32y]-ATP without the
immunoprecipitated kinases, as detected after autoradiography
of the SDS-PAGE gels [e.g. Fig 3(a) compared to Fig. 3(b)], or
by P-scintillation assay of the excised enolase bands. The
inclusion of TPA with ConA as a stimulus for the cells
generated similar results (data not shown) to those shown using
ConA only.
P42/44 MAPK are constitutively activated in the LGLs
To determine whether activated Lck or Fyn was associated
with the activation of downstream signalling pathways, LGL
and control cell lysates were analysed for p42/44 MAPK
activation (phosphorylation). Figure 4(a,b) shows that the
LGL cell lines constitutively expressed phosphorylated MAPK
that did not increase in signal intensity after Con A stimulation
of the cells for 10 min. The control Con-A-stimuIated, IL-
2-deprived rabbit and bovine T cells expressed phosphorylated
MAPK, whereas the unstimulated cells expressed little or no
detectable phosphorylated MAPK.
DISCUSSION
T he infiltration of lymphoid and non-lymphoid tissues by large
lymphoblastoid cells and tissue necrosis are characteristic
features of MCF. The LGL isolated from the tissues of animals
with MCF exhibit an activated phenotype in culture. They are
' • 2001 Blackwell Science Ltd, Immunology, 102, 44-52
large lymphoblasts that can grow in the absence of exogenous
cytokines and are indiscriminately cytotoxic, killing various
target cells in a non-MHC-dependent manner.I-6"7'22
A mechanism for'the constitutive activation of the LGL is
provided by this study in which the sre kinases Lck and Fyn
were constitutively activated in the LGL in cultures lacking
exogenous IL-2, to the extent that further activation by the
mitogen Con A was not possible. The OvHV-2+ bovine LGL
line was the same in this respect as the two A1HV-1+ rabbit
LGL lines. The survival or growth of the LGL with a
lymphoblast morphology and activaled cytotoxic phenotype
(BLT-esterase+ - demonstrated in this study for the first time)
in the absence of exogenous IL-2 suggests that, at least in the
OvHV-2+ LGL where IL-2 is not produced, IL-2 is not
essential for the maintenance of an activated LGL phenotype.
The activation characteristics of the LGL are associated with
infection of the cells with MCF viruses, although no viral
proteins have so far been identified that interact with T-cell (or
any other cell) proteins. Control (uninfected) T lymphoblasts in
culture do not survive in the absence of exogenous IL-2 and do
not develop a LGL cytotoxic cell phenotype characteristic of
MCF virus-infected cells. PBMC and T-cell blasts were
appropriate controls in these experiments as they contain the
principal cell types that express Lck and Fyn kinases in
uninfected animals. Furthermore, the LGLs are most similar to
these normal cell types in spite of a phenotype altered by
infection. An issue that needs to be resolved is whether the
LGL are T cells or NK cells. Lck and Fyn are active in the early
stage of NK-cell activation, for example via Fey receptors."'1
However, Lck-deficienl, Fyn-deficient and ZAP-70-deficient
^,«.T/.pyJSOr W.VTI-IW-) -


























Figure 3. Lck kinase activation in the LGL lines and control T cells, (a) Autoradiograph of SDS-PAGE gel showing enolase
phosphorylation by Lck kinase immunoprecipitated from the LGL and control bovine (bo) and rabbit (ra) T cells either unstimulated
(0) or stimulated with Con A (10 pg/ml) for 5 min (5) or 30 min (30). (b) Coomassie blue stain, control for protein loading in each lane
(showing enolase band), (c) Western blot (anti-Lck antibody) control for immunoprecipitated Lck loading, (d) Quantification of
enolase phosphorylation by p-scintillation c.p.m. of enolase bands cut out of the SDS-PAGE gels. TC, control T cells, 59, 1859; 60,
1860; and 35, 1035 LGL. unstimulated (0) or stimulated for 5 min and 30 min with Con A. Lysates from 8 x 106 rabbit control and all
of the LGL cell equivalents were loaded in each of the lanes of the gels. Lysates from 4 x 106 bovine control cell equivalents were
loaded in each of the lanes of the appropriate gel. Note that a comparison of the intensity of Lck-mediated enolase phosphorylation
between control and LGL cells, and between LGL cell lines may not be possible as different exposure times were often used in the
development of the autoradiographs. Furthermore, (3-scintillation analysis of the enolase bands cut from the gels of the different cell
types did not always take place at the same relative time following the gel run.
1035 1859 1860 bo ra bo ra
+ -+ -+ - + +
Figure 4. Activation of p42/44 MAPK in the LGL lines and control
T cells, (a) Anti-phosphorylated p42/44 MAPK (erkl and erk2)
Western blot of whole cell lysates (1-5 x 106 cell equivalents/lane) of
LGL cell lines and control rabbit and bovine T cells either unstimulated
( —) or stimulated with Con A for 10 min ( + ). It is not clear whether
p42 or p44 or both forms of MAPK have been phosphorylated. (b)
Anti-p42/44 MAPK Western blot of the cell lysates described in (a).
Note that both p42 and p44 forms of MAPK have been detected.
mice do not exhibit defects in natural killing despite defects in
T-cell function.24 The conclusions of the present study are not
affected, but there will be a need in future studies to define
whether the LGL are T cells or NK cells.
The inhibition of 1035 LGL growth/survival in the absence
of IL-2 by genestein but not rapamycin (albeit in only one LGL
line studied) suggests that lL-2R-dependent signalling may not
be involved in IL-2-independent LGL growth. Rapamycin
inhibits biochemical events required for the progression of
IL-2-stimulated T cells from G) to S phase of the cell cycle.25
Furthermore, in a recent study, IL-2-independent growth of
HVS-transformed T cells was associated with constitutive
activation of the protein kinases Lck and ZAP-70 but not of
JAK/STAT kinases associated with interleukin signalling.26
Lck and Fyn are src kinases involved in the initiation of T-
cell activation via the T-cell receptor (TCR) or other structures
such as CD2, CD4, CD8 and the 1E-2 receptor.14,15 They are
the first known signalling molecules to be recruited to the TCR
after antigen or other external stimulation of the TCR. The
kinases become activated by phosphorylation of activation
motifs and phosphorylate immunoreceptor tyrosine-base
activation motifs (ITAMs) on TCR CD3 and C, chains. This
in turn initiates a series of signalling events that leads to T-cell
gene transcription and expression of an activated T-cell
phenotype. Lck and Fyn are enzymatically inactive in resting
cells.15,27 The constitutive action of inhibitory kinases such as
Csk and phosphatases such as CD45 ensure that the src kinases
are only active for a short period of time while recruited to a
relevant surface receptor, such as the TCR.28
Given this background, it was interesting that in the LGL,
Lck and Fyn were always activated regardless of Con A or Con
A and TPA stimulation. In control cells this was not the case
and in addition there was a predicted rapid up-regulation
followed by a decline of kinase activity after Con A
stimulation. In these experiments, it was not always possible
© 2001 Blackwell Science Ltd, Immunology, 102, 44-52
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to compare basal levels of the kinases in control cells versus the
LGLs. However, basal levels in the control cells probably
represent residual activated cells in an otherwise 'rested'
population. This was supported by the lack of kinase activity
in unstimulated PBMNCs in all cases. If Lck and Fyn were at
or near maximum activation in the LGL, then this would
explain why any further stimulation of the cells by mitogen did
not occur. An alternative explanation of the refractile response
of LGLs to the mitogen is that they did not express receptors
for Con-A (mannose-rich structures such as the TCR), as they
had an unusual phenotype compared to control T cells
(Table I). This was apparently not the case as the LGL and
the control T cells aggregated in the presence of Con A
(indicating Con-A-binding to the cells). Furthermore, there
was a tendency for the LGL to exhibit a small dose-dependent
response to Con A or Con A plus TPA (Table 2). A lack of
responsiveness of OvHV-2+ bovine LGL to Con A had been
reported previously.6 In this study the comparative lack of
responsiveness of A1HV-1+ rabbit LGL compared to control
rabbit T cells to Con A (or Con A plus TPA) is demonstrated
for the first time.
Interference with src kinase function (activation or inhibi¬
tion) in lymphocytes is a feature of other y-herpesvirus
infections.10-12 EBV LMP2A protein binds to and inhibits
the src kinase Lyn in B cells, preventing B-cell activation and
presumably preventing the re-activation of EBV from the latent
state in the B cells." HVS Tip binds to Lck and interferes with
Lck function in infected T cells.12 Interestingly, deletion of
either Tip or Stp in HVS-infected T cells inhibits the exogenous
IL-2-independent growth of the cells.9 With the full genome
sequence of A1HV-1 C500 strain available,16 the next stage of
this project is to determine which viral proteins (if any) are
responsible for the unusual LGL phenotype. In LGLs treated
with the tyrosine kinase inhibitor genestein, IL-2-independent
growth of the cells was inhibited. The identity of the tyrosine
kinases that have been inhibited by genestein in the LGL
remains to be determined, but Lck and Fyn must be candidates.
A direct association of transient Lck and Fyn kinase
activation and aspects of T-cell activation has been demon¬
strated in human and murine T cells.14"15 However, an
association of these kinases with the activation of cytotoxic
cell effector function is less clear. Different downstream
signalling pathways are engaged after Lck and Fyn activation
in T cells that control different aspects of T-cell activation. Of
particular interest is the ZAP-70 kinase, which is intimately
linked with src kinase regulation of T-cell activation. In
patients with ZAP-70 mutations, peripheral T cells do not
synthesize IL-2 and are refractile to TCR stimulation.29"30
Unfortunately there was no ZAP-70 antibody available to
study this kinase in the LGL. However, the ras/raf/erk (p42/44
MAPK) signalling pathway is downstream of Lck and Fyn and
known to be activated by these src kinases.31 In this study, p42/
44 MAPK was constitutively activated along with Lck and Fyn
in the LGL cell lines. Although p42/44 MAPK can be activated
by a variety of mitogenic stimuli, including those generated by
the TCR and cytokine receptors,31 it is likely that its activation
in the LGLs was by Lck and/or Fyn.
The examination of tyrosine-phosphorylated proteins in
LGL versus control T cells in general indicated both similarities
and differences. Between 5 and 7 phospholyrosine proteins
were detected in the 20 000-100 000 MW range in the LGL
and control cells within 3-5 min after mitogen stimulation.
Those of ~55 000-59 000 MW probably include Lck and Fyn.
The 70 000 band might be ZAP-70. In mouse and man Lck is a
doublet of 56 and 59 kDa in western blots and Fyn is a
59 000 MW protein. In this study, the dominant form of Lck
(where discernible) was the 59 000 MW moiety and Fyn in all
the bovine and rabbit cells was a 55 000 MW protein.
The present results are important as they demonstrate that
the earliest signalling molecules in T-cell activation are
constitutively active in MCF virus-infected LGL, and that
they cannot be further activated by mitogen stimulation. This is
important because it was also a possibility that signalling
molecules downstream of Lck and Fyn were activated,
bypassing the NRPTKs such that Lck and Fyn were not
required for the observed activation state of the cells.
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